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op. Jouw zelfstandigheid werd sterk op de proef gesteld omdat ik tijdens jouw 
stageperiode grotendeels afwezig was ivm het herstel van mijn knieoperatie en mijn 
verblijf in Denemarken. Maar jouw doorzettingsvermogen heeft ertoe geleid dat je 
een aanzienlijk aantal reacties hebt uitgevoerd. Suzanne, jouw enthousiasme werkt 
ontzettend aanstekelijk. Jij zette mijn onderzoek voort, toen ik begon met mijn 
nieuwe baan. Helaas wilde het niet lukken om de synthese van tanikolide te 
voltooien, ondanks verwoede pogingen, maar ik weet zeker dat je meer succes zult 
hebben in een eigen promotieonderzoek. Etienne, tijdens jouw korte stage, heb je een 
enorme hoeveelheid aminozuur amides gesynthetiseerd, waardoor ik ongestoord 
verder kon met het testen van de liganden. Marcel, jij hebt in twee korte stages een 
waardevolle bijdrage geleverd in de synthese van zowel 1- als 2-Np-box. Wouter, 
hoewel er helaas van jouw chemie maar weinig in dit proefschrift kon worden 
opgenomen, heb je uitstekend de reacties uitgevoerd en kwamen de stoffen die jij 
hebt gesynthetiseerd, allyl- en homoallylglycinamide, laatst nog een paar keer goed 
van pas. 
I would like to thank Prof. Karl Anker Jørgensen for his kind hospitality 
during my stay in Aarhus. Karl Anker, I really enjoyed the stimulating atmosphere 
in your lab. Wei Zhuang, thank you for the pleasant teamwork which led to a joint 
publication. Also, I would like to thank Rita Hazell for the nice collaboration and 
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Danish lab, in particular Kurt, Jacob, Lise, Mauro, Steen, Anders, Karsten, Nis, Sorin 
and Kumar. 
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Where Nature finishes producing its own species 
man begins, with the help of Nature, to create an infinity of species 
(Leonardo da Vinci) 
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1 General introduction: Bisoxazoline ligands in catalytic asymmetric synthesis 
1.1 Asymmetric catalysis 
Catalysis is a process that was recognised as having enormous potential 
almost two centuries ago. One of the first examples was published in 1834 by 
Faraday, who studied the reaction of hydrogen and oxygen on platinum. One year 
later, in 1835, Berzelius also investigated several reactions under which gas 
combustion and coined the word "catalysis" for these processes. The choice of this 
word – derived from the Greek word for dissolution, destruction or end – is quite 
unfortunate, since catalysis generally tends to be very productive rather than 
destructive.1 Catalysis can (arguably) be divided into three main branches: 
heterogeneous catalysis, homogeneous catalysis (both chemical) and enzymatic 
catalysis. Historically, heterogeneous catalysis has played a powerful role in the 
chemical industry due to the ease of recycling and the robustness of the catalysts. 
The first asymmetric version of a catalytic reaction, reported by Pasteur in 
1858, was an enzymatic reaction, i.e. the kinetic resolution of racemic ammonium 
tartrate using the organism Penicillium glauca.2 The first example of the use of an 
enantiopure non-enzymatic catalyst was reported exactly fifty years later by Bredig 
and Fajans, who demonstrated that camphorcarboxylic acid was decarboxylated in 
the presence of nicotine or quinidine.3 
In 2001, the importance of asymmetric catalysis4 was emphasized by the fact 
that the Nobel price in chemistry was awarded to three chemists for their work in 
this field.5 Knowles and Noyori were honoured for their work on catalytic 
enantioselective hydrogenation reactions, and Sharpless received this price for his 
work on catalytic enantioselective oxidation reactions. Particularly well-known is the 
enantioselective epoxidation using enantiomerically pure tartrate esters as the ligand, 
such as L-(+)-DET (1, Figure 1.1).6 Besides the so-called Sharpless epoxidation, which 
was also successfully applied on an industrial scale, he developed non-enzymatic 
asymmetric dihydroxylation and aminohydroxylation reactions. 
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(S)-BINAP
P P
OMe
MeO
3
(R,R)-DiPAMP
EtO2C
OHHO
CO2Et
1
L-(+)-DET
P
P
Ph
Ph
Ph
Ph
 
Figure 1.1 Enantiopure ligands developed by Sharpless, Noyori and Knowles, respectively 
In 1980, Noyori and coworkers developed a new type of atropisomerically 
pure diphosphine ligand, BINAP (2), effective in various kinds of asymmetric 
transformations and also applied on industrial scale.7 Knowles was the first to 
initiate a commercialised catalytic asymmetric synthesis employing an enantiopure 
transition metal complex, containing diphosphine ligand 3.8 This so-called Monsanto 
process, operative since 1974, involves an asymmetric hydrogenation using a chiral 
diphosphine rhodium catalyst to synthesise L-DOPA (6), which is used in the 
treatment of Parkinson´s disease (Scheme 1.1).  
 
MeO
AcO
CO2H
NHAc 3·[RhCOD]BF4
H2 MeO
AcO
CO2H
NHAc
HO
HO
CO2H
NH2
4 (S)-5
100% cy (95% ee)
6
L-DOPA  
Scheme 1.1 The Monsanto synthesis of L-DOPA 
Transition metal-catalysed enantioselective reactions have become a versatile 
tool in organic synthesis9 and for this reason in recent years, many optically active 
chelating ligands have been synthesised for a variety of catalytic reactions. However, 
there is no structural class of ligands that is universally suitable for all 
transformations. 
During the 1980s, the design, synthesis and application of enantiopure Lewis 
acids initiated a new area of development in asymmetric catalysis.10 Great interest 
has been focussed on nitrogen containing compounds, due to their availability from 
the ´chiral pool’ and their ideal properties in the complexation of transition metals.11 
Of special importance have been imine-containing compounds, attached to different 
functionalised side chains.12 
In 1988, a new class of conformationally rigid ligands was developed in the 
group of Pfaltz (Figure 1.2).13 These C2-symmetric semicorrins A, have been applied 
in cyclopropanations and conjugate reductions resulting in excellent 
enantiopurities.14,15 The bisoxazolines B can afford an analogous metal complex by 
removal of a proton at the methylene bridge in order to obtain the anionic ligand. An 
advantage of these ligands and their neutral analogues C and D, is their ready 
accessibility from the corresponding amino acids. The use of bisoxazolines D as 
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chiral ligands was first introduced in 1990 by Masamune and coworkers in copper-
catalysed cyclopropanations,16 directly followed by publications from the groups of 
Evans,17 Corey18 and Pfaltz.19 The great potential of these catalysts containing a chiral 
box ligand complexed to a Lewis acidic metal was immediatly recognised20 and has 
been extensively studied since.21  
N
R
N
R
CN
H
A
N
O
R
N
O
R
B
N
ON
R
N
O
R
R1
C
N
O
R
N
O
R
Me Me
D  
Figure 1.2 General structures of nitrogen-containing rigid C2-symmetric ligands 
1.2 Nomenclature 
The official IUPAC nomenclature for the bisoxazoline ligand D (R = Ph, 
Figure 1.2) is methyl (4S)-2-{1-[(4S)-4-benzene-4,4,5-trihydro-1,3-oxazol-2-yl]-1-
methylethyl}-4,4,5-trihydro-1,3-oxazole-4-benzene. Not surprisingly, ever since their 
use as ligands, trivial names have been used of which 2,2-bis-[(4S)-4-phenyl-1,3-
oxazolin-2-yl]propane has become the most common.22 Moreover, the general 
abbreviation for bisoxazoline has become ‘box’, and more specifically (S)-Ph-box for 
this particular ligand, while perhaps ‘officially’ (S,S)-Ph-box would have been a 
better choice. Nevertheless, since these nomenclature issues have already been 
adopted in literature, we foresee no confusion. 
1.3 Overview of different types of box ligands 
Already in the early 1970s, syntheses of various racemic bisoxazoline 
derivatives were reported.23 Since the late 1980s, enantiopure bisoxazolines have 
been prepared with the purpose of application in metal-catalysed enantioselective 
reactions. During the last decade, box ligands have emerged as highly 
enantioselective catalysts in a wide range of transformations such as Diels–Alder24 
and hetero-Diels–Alder reactions,25 aldol reactions,26 Michael additions,27 and 
Friedel–Crafts reactions.28 These conversions generally proceed via in situ formation 
of a chiral Lewis acid catalyst through bidentate complexation of the box ligand to a 
transition metal. So far, many variations at the core of the box ligand have been 
made, including variation of substituents (R1) on the bridging methylene group29 and 
introduction of additional stereocentres on the oxazoline rings (R2, R3) in such a way 
that the C2-symmetry is maintained (type E, Figure 1.3).30 Larger structurally 
deviating box-ligands lack the methylene spacer31 or feature a bridging pyridine 
moiety resulting in tridentate coordinating box ligands (type F).32 Recently, the group 
 
Chapter 1 
4 
 
of Pfaltz developed new types of non-C2-symmetric oxazoline-based P,N-ligands 
(type G), suitable for application in palladium-catalysed stereoselective reactions.33 
Notwithstanding, the box ligands of type E are generally most often applied 
and thus represent a class of ‘privileged’ structures that are readily accessible and 
amenable to straightforward modification in a variety of ways, e.g. different bridges 
and R-groups, including fused ring systems. 
N
O
R
Ar2P
GE
R3
R2 R3
R2
R1
N
O
R
N
O
R
R1
N
O
R
N
O
R
N
F  
Figure 1.3 General structures of bisoxazoline-based ligands 
The preparation of bisoxazolines is – almost without exception – performed 
as depicted in Scheme 1.2.34 The bisoxazoline is obtained from diamide I after 
activation of the hydroxyl group and subsequent ring closure. The diamide is 
prepared by condensation of diacid derivative K, which can be an ester, acid chloride 
or nitrile and amino alcohol J, resulting from reduction of the corresponding amino 
acid. The synthesis of 4,5-disubstituted bisoxazolines (E) have been reported by 
Desimoni and coworkers; they obtained both diastereomers from the same diamide 
by applying two different cyclisation conditions.35 Nowadays, several of these 
ligands are commercially available. 
N
OL
R
N
O
R
R
H2N
OH
R
H
N L
O
H
N
O R
X L
O
X
O
+HO OH
H I J K   
Scheme 1.2 General retrosynthesis of (S)-bisoxazolines (L = linker; X = leaving group) 
1.4 Recent applications of bisoxazoline ligands 
The use of enantiomerically pure box ligands in Lewis acid-catalysed 
processes has been well documented in several reviews, which have emerged over 
the past few years.22 Not surprisingly, the list of examples is dominated by reactions 
involving the commercially available box ligands 7 (Figure 1.4) Considering the 
abundancy of new examples of catalytic reactions involving these and other types of 
box ligands with excellent enantioselectivities, it would be excess to include them all 
in this Chapter. We decided to restrict ourselves therefore to summarising recent 
applications of bisoxazoline ligands of type E (Figure 1.3), since they are the main 
subject of this thesis. This summary is not comprehensive, but instead aims to 
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represent a judiciously chosen selection, providing, in our view, an impression of the 
state-of–the-art, scope and limitations of this particular type of ligand. 
N
O
R
O
R
Me Me
N N
O
Ph
Me
N
O
Ph
Me
Ph Ph
7 7e
diPh-box
t-Bu-box (7a): R = t-Bu
Ph-box (7b): R = Ph
i-Pr-box (7c): R = i-Pr
Bn-box (7d): R = Bn
 
Figure 1.4 Commercially available bisoxazoline ligands 
1.4.1 Effect of ligand bite angle 
Over the years, bite angle effects in metal-catalysed C-C bond formation have 
been extensively studied.36 Already in 1996, Davies and coworkers investigated the 
role of the bite angle of the box ligand on the enantiopurity.37 They synthesised a 
series of spirocyclic box ligands and applied them in the Diels–Alder reaction of N-
acryloyl oxazolidinone 8 with cyclopentadiene (Table 1.1). 
Table 1.1 Results of the Diels–Alder reaction in the presence of spirocyclic box ligands 10a 
N O
OO
NO
OO
N
O
N
O
R1R
Cu
TfO OTf
+
8
10 (10 mol%)
CH2Cl2, -50 °C
(S)-119 10
φ
θ
 
entry ligand R, R1 φ (°) endo/exo ee (%)b 
1 10a —CH2CH2— 110.6 44:1 96 
2 10b —CH2(CH2)CH2— 108.0 38:1 92 
3 10c —CH2(CH2)2CH2— 105.8 37:1 90 
4 10d —CH2(CH2)3CH2— 103.7 26:1 83 
5 10e Me, Me 104.7 49:1 83 
a Isolated yields were >90%. b Enantiomeric excesses of the endo product; the major 
enantiomer possessed in all cases the (S)-configuration.37 
They observed a direct correlation between the spiro ring size and the 
selectivity. Namely, as the spiro ring size decreased, the angle in the uncomplexed 
ligand (φ), and hence the ligand bite angle (θ) increased, resulting in an enhancement 
of the endo/exo selectivity as well as the enantioselectivity of the major endo 
product 11. Thus, the best results were observed in the presence of the copper 
complex of spirocyclopropyl box (10a), affording the Diels–Alder product with an 
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endo/exo selectivity of 44:1 and an excellent enantiopurity of the major endo product 
11 (96% ee). The analogous non-spirocyclic box ligand 10e, possessing an 
isopropylidene bridge, is obviously less strained (lower φ). This resulted in an 
evident decrease in enantiopurity to 83%, which was similar to the ee observed for 
the spirocyclohexane box complex (10d). Surprisingly, the endo/exo selectivity was 
increased to 49:1, whereas for the spirocyclic box ligand a decrease was observed 
with lower φ. 
1.4.2 Methyllithium addition to imines 
Denmark and coworkers investigated the effect of the ligand structure in a 
box-mediated asymmetric addition of methyllithium to imines, depicted in Table 1.2. 
In an early paper, they concluded that increase of the enantiopurity was achieved by 
enhancing the steric bulk of the C4-substituent.38 In additional studies, they 
investigated the influence of the bridging group by the bond angle modulation and 
varying the steric bulk.39 Surprisingly, it was found that the ligand bite angle played 
a minor role in the course of this addition reaction (entries 1-4). It was concluded that 
there was no dramatic correlation between enantioselectivity and any ligand 
geometry predicted from both molecular mechanics (MM2) and semi-empirical 
(PM3) calculations.  
Table 1.2 Results of the box-mediated addition of methyllitium to imine 12 
OMe
N
HPh
OMe
HN
MePh
N
O
N
O
(CH2)n
Lit-Bu t-Bu
12
13 or 14 (0.1-1 equiv)
MeLi (2 equiv)
toluene, -75 °C
(R)-15 13a-d
n = 1-4
φ
θ
N
O
N
O
RR
Lit-Bu t-Bu
14a-d
R = Me, Et, i-Pr, i-Bu
 
entry ligand n or Ra φ (°) yield (%)b ee (%)c 
1 13a 1 112.7 82 51 
2 13b 2 110.0 97 73 
3 13c 3 111.8 94 71 
4 13d 4 106.8 87 70 
5 14a Me 109.7 90 67 
6 14b Et nd 95 75 
7 14c i-Bu nd 95 85 
8 14d i-Pr nd 87 89 
a This column presents n for ligands 13 and R for ligands 14. b Isolated yields. c Enantiomeric 
excesses of the endo product; the major enantiomer possessed in all cases the (R)-
configuration.37 
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On the contrary, the size of the bridging substituents had a clear effect on the 
reaction selectivity. For reactions with aromatic imines such as 12, increase of the 
steric bulk of the R-group on the bridging methylene of box 14 resulted in an 
enhanced enantiopurity of the resulting amines (entries 5-8). However, olefinic and 
aliphatic imines followed the opposite trend, resulting in a decrease of ee with 
increasing steric bulk of the bridging substituents.  
1.4.3 Mannich reactions 
Recently, Jørgensen and coworkers reported a diastereo- and enantioselective 
direct Mannich reaction in the presence of the [Cu(OTf)2(t-Bu-box)] complex.40 They 
reacted a series of different β-keto esters with an activated N-tosyl-α-imino ester, of 
which an example is depicted in Scheme 1.3. The resulting optically active α-keto-β-
ester-α-amino acid derivatives such as 18 were obtained in high yield and 
enantiopurities up to 96% ee. Moreover, Mannich adduct 18 gave easy access to the 
corresponding anti-β-keto-α-amino acid derivative 19 via diastereoselective 
decarboxylation with only a slight loss of diastereomeric purity.  
O
Ot-Bu
Me
Me
O N
Ts
O
OEt
HN
CO2EtMe
O
Ts
CO2t-BuMe
HN
CO2EtMe
O
Ts
Me
+
1716
t-Bu-box
Cu(OTf)2
CH2Cl2, -20 °C
(R,R)-18
50% cy, dr 97:3, 95% ee
19
1) TMSOTf
2) NaHCO3
 
Scheme 1.3 Mannich reaction to optically active α-keto-β-ester-α-amino acid derivatives 
In addition, the group of Jørgensen applied imines of glycine esters in a 
Mannich reaction with imines, affording the corresponding optically active α,β-
diamino acid derivatives.41 In the presence of t-Bu-box in combination with CuClO4, 
the Mannich adduct was obtained with good diastereoselectivity (syn/anti 73:27), 
but without enantioselectivity (Scheme 1.4). However, to achieve an enantioselective 
Mannich reaction, they applied several novel phosphino-oxazoline P,N-ligands of 
which 22 gave the best results. 
N
O
Ar2PCO2MeNPh
Ph
N
Ts
Ph
22·CuClO4 N
CO2Et
Ph
Ph
Ph
NHTs
+
2120
THF, -20 °C
23
94% cy, syn/anti 79:21
97% ee/94% ee
22
 
Scheme 1.4 Mannich reaction to optically active α,β-diamino acid derivatives 
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1.4.4 Enantioselective Henry reactions 
Addition of nitromethane to both aromatic and aliphatic aldehydes in the 
presence of [Cu(OAc)2(box)] has been achieved in the group of Evans.42 Especially 
the indabox ligand in combination with Cu(OAc)2 (26) afforded the Henry adducts 
27 in good yield and with high enantiopurity (Scheme 1.5). Large scale experiments 
(50 mmol scale), at minimal catalyst loading (1 mol%) and high concentration (1 M), 
did afford optically active alcohol 27 without loss of either yield or enantiopurity, 
although extended reaction times were observed.  
HR
O
MeNO2
OH
R
NO2
N
O
N
O
MeMe
Cu
AcO OAc
+
25
26
24
26
EtOH, rt
(R)-27
R = 2-MeOC6H4: 92% (94% ee)
R = i-Pr: 93% (91% ee)  
Scheme 1.5 Henry reaction to optically active β-nitro-alcohols 
Preparation of β-nitro- α-hydroxy esters 29 from a variety of α-keto esters 28 
with nitromethane was achieved by Jørgensen and coworkers.43 They performed 
highly enantioselective Henry reactions in the presence of [Cu(OTf)2(t-Bu-box)] and 
triethylamine in excellent yields (Scheme 1.6). 
CO2MeR
O
MeNO2
OH
CO2MeR
NO2
+
2528
t-Bu-box
Cu(OTf)2
Et3N, rt
29
up to 99% cy
up to 94% ee
 
Scheme 1.6 Henry reaction to optically active β-nitro-α-hydroxy esters 
1.4.5 Synthesis of optically active proline derivatives 
Jørgensen and coworkers performed 1,3-dipolar cycloaddition reactions of 
azomethine ylides 30 with alkenes to afford highly functionalised pyrrolidines 
(Scheme 1.7).44 In the presence of [Zn(OTf)2(t-Bu-box)] and Et3N, the cycloadduct 32 
was formed in diastereomerically pure form, high yield and with up to 94% ee. 
CO2MeNAr
CO2Me N
H
MeO2C
Ar CO2Me
+
3130
t-Bu-box
Zn(OTf)2
Et3N, THF
32
up to 94% ee  
Scheme 1.7 1,3-Dipolar cycloaddition to highly functionalised proline derivatives 
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1.4.6 Synthesis of optically active β-lactams 
Recently, Fu and coworkers reported the use of box ligands in combination 
with CuBr in the intramolecular Kinugasa reaction, which involves the coupling of 
an alkyne to a nitrone generating an optically active β-lactam (Scheme 1.8).45 The use 
of i-Pr-box resulted in moderate enantiopurity (62%) and low yield. Next, they 
turned their attention to a newly developed class of ligands, phosphaferrocene-
oxazolines (e.g. 34), which then afforded β-lactam 35 in good yields (74%) and 
enantiopurities up to 90% ee. 
MeMe
Me Me
Me
P
Me
Me
Me N
O
i-Pr
N+
ArO-
N
ArO
33
Ar = p-carboethoxyphenyl
ligand
CuBr (5 mol%)
Cy2NMe (0.5 equiv)
MeCN, 0 °C
35
(R)-i-Pr-box: 39% (62% ee)
34: 88% (74% ee)
34
 
Scheme 1.8 Intramolecular Kinugasa reaction to β-lactam 35 
1.4.7 Aldol addition under silylation conditions 
Evans and coworkers developed conditions under which the aldol 
condensation products are silylated in situ. In the presence of a [Ni(II)(t-Bu-box)] 
complex and under silylating conditions, the aldol adduct 38 was formed as the sole 
product.46 The versatility of the resulting thiazolidinethiones as activated acids was 
demonstrated by easy conversion into the Weinreb amide 39 (Scheme 1.9).  
O
S N
Me
S
O
PhH
O
S N
Me
S
Ph
OTES
Me(OMe)NH2Cl
O
Me
Ph
OTES
N
MeO
Me
39
76% cy
+
3736
t-Bu-box
Ni(OTf)2(H2O)2
2,6-lutidine, TESOTf
toluene/CH2Cl2
-78 °C to -20 °C 38
96% cy
syn/anti 94:6, 96% ee
imidazole
 
Scheme 1.9 Aldol reaction of aldehydes and conversion into the Weinreb amide 
A big advantage of this approach is that in difficult aldol reactions with 
readily enolisable aldehydes such as acetaldehyde, propionaldehyde and 
isobutyraldehyde, self-condensation is completely suppressed. 
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1.4.8 Oxazoline formation using bisoxazoline ligands 
Evans and coworkers reported the synthesis of enantiomerically pure 
oxazolines in the presence of bisoxazoline-based catalysts.47 This involved an aldol 
reaction and subsequent rearrangement to the oxazoline, which was first reported by 
the groups of Suga and Ibata.48 In the presence of enantiopure aluminium catalysts, a 
range of aromatic aldehydes were found to be excellent substrates to be converted 
into 2-oxazoline-4-carboxylates 43 (Scheme 1.10). The resulting cis-oxazolines could 
be cleanly isomerised to their trans counterparts in the presence of a catalytic amount 
of base, thereby giving easy access to both diastereoisomers of the corresponding α-
amino-β-hydroxy acids. 
O
H
N
OAr OMe O
N
Ar
CO2Me
Ph
t-Bu
t-Bu
ON
t-Bu
t-Bu
ON
Al
X+
41
Ar = p-MeOC6H4
40
42 (5 mol%)
Na2SO4
toluene, MS 3Å
25 °C, 20 h
43
99% cy, dr 95:5
99% ee (cis)
42
X = SbF6
 
Scheme 1.10 Box-mediated formation of diastereo- and enantiomerically pure oxazolines 
Besides aluminium derived Lewis acids, [Cu(II)box] complexes were found to 
be excellent catalysts for this aldol reaction. Chelating aldehydes could be converted 
efficiently into the corresponding oxazolines with excellent stereoselectivities. For 
example, ethyl glyoxylate was reacted with oxazole 41 in the presence of [Cu(II)(t-
Bu-box)] quantitatively giving access to oxazoline 46 with excellent stereoselectivity 
(Scheme 1.11). 
N
OAr OMe
MO
CO2Et
H
H
+
O
OEt
H
O
N
OAr OMe O
N
Ar
CO2Me
CO2Et
+
41
Ar = p-MeOC6H4
4544
Cu(OTf)2(H2O)2
t-Bu-box (1 mol%)
THF, MS 3Å
-20 °C
(4R,5R)-46
>99% cy, dr 95:5
97% ee (cis)
 
Scheme 1.11 Box-mediated formation of diastereo- and enantiomerically pure oxazolines 
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1.5 Recyclable bisoxazoline ligands 
Over the years, various methods have been developed to recover and recycle 
box-based catalysts.49 Different strategies have been employed in the design of 
heterogenisation of enantiopure bisoxazolines, including immobilisation via covalent 
or non-covalent bonding, on organic or inorganic supports, and using soluble or 
insoluble polymers.50 Many examples are known of immobilised systems in which 
the box ligand is modified in such a way that the geometry of the ligand is likely to 
be altered. Herein, we would like to describe two examples in which the ligand is 
easily recovered without or with minor modifications on the core of the ligand. 
Ot-Bu
O
O OBz
N
O
N
O
Ph Ph
C8F17 C8F17
+
48
FC72/MeCN 
7 days, rt
4947 (S)-50
86% (77% ee)
49·CuOTf
 
Scheme 1.12 Allylic oxidation using enantiopure fluorous box ligands 
Very recently, a rather new concept of fluorous biphasic catalysis based on 
the temperature-dependent miscibility of organic and fluorous solvents was applied 
by Sinou and coworkers.51 Solubilisation of the catalyst was achieved by the use of 
readily accessible fluorinated box ligands, which could be recovered by liquid-liquid 
extraction with a fluorous solvent or solid-liquid separation via fluorous silica gel. 
These fluorous box ligands were applied in allylic oxidation and allylic alkylation 
reactions, resulting in good to excellent enantioselectivities, which are similar to 
those obtained for the non-fluorous analogues. For example, the allylic oxidation of 
cyclopentene was achieved in the presence of CuOTf and ligand 49 in 86% yield and 
with 77% ee (Scheme 1.12). Although the catalyst could not be recycled, the ligand 
was recovered quantitatively and reused without loss of activity or 
enantioselectivity. 
N
N
NTf2Ph
N2
H
OEt
O
Ph-box·CuCl2
Ph CO2Et
+
52
[Emim][NTf2]
[Emim][NTf2]
51 54
34% cy, cis/trans 67:33
47% ee/55% ee  
Scheme 1.13 Cyclopropanation reaction using ionic liquids 
 
 
 
 
 
Chapter 1 
12 
 
An interesting method of catalyst recycling without ligand modification is 
provided by the use of ionic liquids. The group of Mayoral performed 
cyclopropanation of styrene with ethyl diazoacetate in the presence of [Cu(II)box] 
complexed to three different ionic liquids.52 Cyclopropanation of styrene, depicted in 
Scheme 1.13, afforded cycloadduct 54 and the results are similar to those obtained 
with Cu(OTf)2 in CH2Cl2. These results indicated that the counterion of the metal was 
replaced by the anion of the solvent. Furthermore, it was demonstrated that the 
catalyst could be efficiently recycled without loss of activity or selectivity and that 
the polarity of the liquid heavily influenced the outcome of the reaction. So far, only 
preliminary research has been carried out. Nevertheless, this concept could provide a 
new and powerful method to recover and recycle box-based catalysts. 
1.6 Industrial applicability 
A relatively small number of enantioselective catalysts have been used in 
industrial processes. One obvious reason is the fact that the potential of 
enantioselective catalysis was recognised only recently. Moreover, application on 
industrial scale gives rise to some practical problems and challenges, e.g. special 
conditions required for the manufacturing of enantiopure products or for the nature 
of the catalytic process.53 Nevertheless, this area attracted considerable attention in 
life science and related fine chemical industries, due to its selectivity, cost-efficiency 
and minimal environmental impact. Other reasons include the fact that 
pharmaceuticals are increasingly sold as single enantiomer drugs, and that the 
development of short routes to enantiopure druglike scaffolds is an area of growing 
importance. 
Generally, the activity of the catalyst (in terms of turnover numbers), rather 
than its enantioselectivity is the major problem. Other important aspects are catalyst 
stability, sensitivity and selectivity. Moreover, removal of the catalyst from the 
product can be critical, not only for recycling, but also in the case of toxic heavy 
metal-catalysed reactions. All the above has resulted in the fact that this area is often 
still considered ‘academic‘ research. 
An example of a large scale application of a box ligand in an enantioselective 
reaction was reported by Abbott Laboratories (Chicago, USA).54 Barnes and 
coworkers developed an efficient synthetic route to the endothelin antagonist ABT-
546 (55), as depicted in Scheme 1.14. Endothelin-1 is of all vasoconstrictors, the most 
potent one. A selective antagonist for one of the receptor endothelins has been 
targeted as a possible therapeutic agent for cancer and congestive heart failure. In 
order to perform initial toxicology and phase I clinical trials on this compound, a 
considerable amount of ABT-546 had to be produced. 
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MeO O
O
N
HO2C
CONBu2
n-Pr
Me
Me
MeO O
O
NH
EtO2C
n-Pr
Me
Me
O
CO2Et
NO2
MeO O
O
n-Pr
MeMe
575655
ATB-546
1/2 TsOH
 
Scheme 1.14 Retrosynthesis of endothelin antagonist ABT-546 
In the synthesis of tetrasubstituted pyrrolidine ABT-546, intermediate 56 was 
resolved using tartaric acid, but in only 20% yield. Therefore, they aimed for a 
synthetic strategy towards nitroketone 57, based on an enantioselective Michael 
addition reaction. The most suitable catalyst for this transformation was Mg(OTf)2 in 
combination with box ligand 60. The ligand could be easily prepared from (1R,2S)-
aminoindanol (58) and diethyl malonimidate (59) in two steps (Scheme 1.15). 
N
O
N
ONH2
OH
NH
OEtEtO
NH
+
58 59
1) THF
2) BrCH2CH2Br
     LiHMDS
60
69%  
Scheme 1.15 Synthesis of box ligand 60, applied in enantioselective Michael addition 
Optimised conditions for the Michael addition were found in the presence of 
[Mg(OTf)260] and N-methylmorpholine (NMM), as depicted in Scheme 1.16. 
Performing the Michael addition on a 13 mol scale, nitroketone 57 was obtained in 
good yield (82%) and with high enantiopurity (88% ee). In addition, they found that 
the scope of the Michael reaction included a variety of ketoesters as well as 
malonates and nitroalkenes. 
O
O
OMe
NO2
O
OEt
O
n-Pr
MeMe
60 (4.4 mol%)
Mg(OTf)2 (4 mol%)
NMM (5.5 mol%)
CHCl3, MS 3Å
37 °C, 17 h
O
CO2Et
NO2
MeO O
O
n-Pr
MeMe+
61 62 57
0.1 mol scale: 73% (88% ee)
13 mol scale: 82% (88% ee)  
Scheme 1.16 Michael addition step in the synthesis to endothelin antagonist ABT-546 
Subsequent reduction in the presence of Raney nickel and further reduction 
with NaBH(OAc)3 afforded selectively the trans-trans substituted pyrrolidine 56 in 
91% yield over two steps, with less than 2% of diastereomeric products. 
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Crystallisation of the resulting pyrrolidine as the tartrate salt 63 proceeded in 
good recovery (77% yield, >97% ee) in contrast to the racemic pyrrolidine. The final 
steps were carried out as a one-pot sequence; i.e. the salt was converted into the 
corresponding free base and subsequent N-alkylation of the pyrrolidine and 
saponification afforded tosylate salt 55 with 84% yield (Scheme 1.17). In conclusion, 
the synthesis was accomplished in 11 linear steps from ethyl dimethylacrylate in 39% 
overall yield resulting in 4 kg of ABT-546. 
O
CO2Et
NO2
MeO O
O
n-Pr
MeMe
CONBu2
MeO O
O
N
EtO2C
n-Pr
Me
Me
MeO O
O
NH
EtO2C
n-Pr
Me
Me
TsOH
MeO O
O
N
HO2C
CONBu2
n-Pr
Me
Me
MeO O
O
NH
EtO2C
n-Pr
Me
Me
1) Raney-Ni, H2
2) NaBH(OAc)3
     HCl, MeCN
57 56
91%
1) NaOH, then TsOH
2) TsOH
      IPA/heptane
64 55
ATB-546
84% (4 steps)
1/2 D-tartaric acid
1) K2CO3
2) BrCH2C(O)NBu2
     NaHCO3
63
77% (97.4% ee)
D-tartaric acid
MeCN, MeOH
 
Scheme 1.17 Synthesis of endothelin antagonist ABT-546 
1.7 Research objectives and outline of this thesis 
This thesis deals with the synthesis and application of bisoxazolines, or more 
general oxazoline-based ligands, in enantioselective Lewis acid-catalysed reactions. 
The research especially focusses on the scope and limitations of various aryl-
substituted box ligands (D, R = aryl, Figure 1.2). 
Preparation of extended aryl-substituted box ligands from the corresponding 
amino acids is described in Chapter 2. These amino acids were obtained in 
enantiomerically pure form by an enzymatic resolution of the corresponding racemic 
amino acid amides. 
In Chapter 3, the scope and limitations of the new box ligands are 
investigated and compared to results previously reported in literature for similar 
reactions. Besides performing known reactions, the box ligands were tested in a 
number of new reactions, one of which led to a building block that was used in 
studies toward the natural product (+)-tanikolide. 
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In order to further characterise the catalysts – and thereby possibly acquire 
more insight into the frequently observed reversal of facial selectivity in going from 
alkyl- to aryl-substituted box ligands – various studies were initiated in Chapter 4, 
involving X-ray analysis, modelling and EPR studies. 
Chapter 5 describes the application of several box ligands in a novel tandem 
reaction involving an oxa-Michael addition and subsequent Friedel–Crafts type 
alkylation. 
Finally, Chapter 6 deals with the synthesis of a new mono-oxazoline ligand 
(PhOH-ox) and its application in diethylzinc addition to aldehydes. 
Parts of this thesis have been published55 or will be published in the near 
future. 
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2 A chemoenzymatic route to aryl-substituted bisoxazoline ligands1 
2.1 Introduction 
Bisoxazoline (box) ligands2 in combination with transition metals have shown 
to be excellent catalysts in a wide range of asymmetric transformations such as Diels–
Alder3 and hetero-Diels–Alder reactions4 and aldol condensations.5 So far, many 
variations at the core of the box ligand have been made. Although a wide range of 
differently substituted bisoxazoline ligands have been synthesised over the years, 
only a few ligands are currently commonly used (Scheme 2.1). This is particularly 
due to their ready availability from amino acids 2 and the fact that they are 
commercially available. Despite the versatility of these ligands, there is not a single 
ligand that gives optimal results in every type of conversion; the most suitable ligand 
for a given transformation is usually identified through a trial-and-error process. 
N
O
R
N
O
R
1
R
H2N
OH
2
O
i-Pr-box (1a): R = i-Pr
t-Bu-box (1b): R = t-Bu
Ph-box (1c): R = Ph
Bn-box (1d): R = Bn
 
Scheme 2.1 Retrosynthesis of commercially available bisoxazoline ligands 
A commonly observed trend is that with increasing steric bulk of the R-
substituent the enantioselectivity is enhanced. Another, more remarkable 
phenomenon is a frequently observed reversal of enantiofacial selectivity exhibited 
by alkyl- vs. aryl-substituted box ligands. The latter category has been less well 
studied and the steric influence of aryl substituents has never been extensively 
studied. Only one example of the use of the (2-naphthyl)bisoxazoline (2-Np-box) 
ligand has been reported by Desimoni and Faita.6 They showed that 2-Np-box in 
combination with Mg(OTf)2 induced an increase in enantioselectivity in the Diels–
Alder reaction of N-acryl-substituted oxazolidinone with cyclopentadiene compared 
to catalysis with Ph-box (from 70% to 77% ee). Hence, we concluded that a more 
extended aromatic system on the chiral ligand may have an even more pronounced 
effect on the enantioselectivity. Interestingly, a single example of the application of 
(1-naphthyl)bisoxazoline (1-Np-box) ligand in a similar type of asymmetric Diels–
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Alder reaction has been described by the Evans group.7 In this case, the 
enantioselectivity was also improved compared to Ph-box, but was still moderate in 
an absolute sense and considerably lower than for the alkyl-substituted ligands. 
Surprisingly, so far the synthesis of this (1-naphthyl)-substituted ligand has not been 
described by Evans or any other group. 
In order to investigate the contribution of electronic effects of the R-
substituent, a small series of para-substituted Ph-box ligands of varying electronic 
character were evaluated in the hetero-Diels–Alder reaction of a crotonyl 
phosphonate and ethyl vinyl ether by Evans and coworkers.4b However, no 
significant differences in enantioselectivity were observed: p-ClC6H4-box gave 89% 
ee, Ph-box 93% ee, and p-MeOC6H4-box 93% ee. Although no clear electronic effect 
was observed, possible dipole-dipole and Van der Waals attractions may still be 
partially responsible for the observed stereoselectivity, since these interactions do not 
vary with the π-donor capacity of the phenyl group. 
A new class of bisoxazoline ligands 3, bearing an additional ether substituent 
at the C5-position of both oxazoline rings, was investigated by Pericas and Muller.8 
They introduced aryl substituents at the regular C4-position, i.e. phenyl-, mesityl- 
and 1-naphthyl, and applied these ligands in the palladium-catalysed allylic 
alkylation reaction depicted in Scheme 2.2. The phenyl-substituted ligand afforded 
the allylic alkylation product with high enantiopurity (96% ee), which was similar to 
the result encountered in the presence of Ph-box lacking the C5-substituent. 
Surprisingly, increasing the bulk of the C4-substituent by introducing a mesityl-
group resulted in a decrease of both yield and enantiopurity (8% yield, 50% ee). 
Alternatively, extension of the phenyl substituent to a 1-naphthyl-group resulted in 
an enhanced yield and similar enantiopurity (100%, 96% ee). Considering these 
observations, we concluded that higher selectivities may well be reached by 
extending the aromatic substituents, rather than by introducing alkyl substituents on 
the phenyl-ring. 
PhPh
OAc
PhPh
MeO
O
OMe
O
N
O
Ar
O
Ar
Me Me
NPh2CHO OCHPh2
3a (Ar = Ph)
3b (Ar = mesityl)
3c (Ar = 1-Np)
3
[Pd(η3-C3H5)Cl]2
4 (R)-5
H2C(CO2Me)2
BSA, KOAc
60% (96% ee)
8% (50% ee)
100% (96% ee)  
Scheme 2.2 Allylic alkylation catalysed by [Pd(II)box] complexes 
As part of a research project aimed at controlling the enantioselectivity of 
catalytic processes by variation of the electronic and steric properties of substituents 
on bisoxazoline ligands, we became interested in aryl-substituted box ligands, and 
more specifically the steric influence of aryl substituents. This prompted us to 
synthesise a series of aryl-substituted bisoxazoline ligands such as 
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phenylbisoxazoline,9 (also commercially available), (1-naphthyl)-,1 (2-naphthyl)- and 
(9-anthryl)bisoxazoline (Figure 2.1). 
N
O
N
O
(S)-1e
N
O
N
O
(S)-1f
N
O
N
O
(S)-1g  
Figure 2.1 (1-Naphthyl)-, (2-naphthyl)-, (9-anthryl)bisoxazoline ligands 
We used these ligands to generate various new catalysts that were subjected 
to a range of reactions (e.g. Mukaiyama aldol and Michael reactions, hetero-Diels–
Alder processes, allylic oxidations and allylic alkylation reactions) to explore their 
enantioselective and catalytic properties and thus enable us to make a more extensive 
evaluation of the steric influence of the aryl substituents. Furthermore, we 
anticipated that we might be able to identify new reactions that could especially 
benefit from these types of ligands. This Chapter will deal with the ligand synthesis, 
while the scope and limitations of these ligands in asymmetric catalysis will be 
discussed in Chapter 3.  
2.2 Synthesis of (1-naphthyl)bisoxazoline (1-Np-box) 
Considering the few experiments that have been carried out with (1-
naphthyl)bisoxazoline ligand and the anticipated facile access to the required amino 
acid,10 we set out to develop a straightforward and efficient synthesis of this ligand, 
(S)-1-Np-box (1e).1 The retrosynthetic analysis in Scheme 2.3 illustrates that ligand 1e 
should be accessible from the corresponding enantiopure amino acid 2e,11 which in 
turn may be derived from the racemic amino acid amide 6a through an enzymatic 
resolution process that has been extensively studied in our group.10 The amide 6a 
was projected to be derived from 1-naphthaldehyde (7a). 
N
O
N
O
H2N
OH
O
H2N
NH2
O
OH
7a6a(S)-2e(S)-1e  
Scheme 2.3 Retrosynthesis of (S)-(1-naphthyl)bisoxazoline 
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As depicted in Scheme 2.4, the synthesis of (1-naphthyl)glycine amide (6a) 
started with a modified Strecker reaction (HCN prepared in situ in concentrated 
ammonia from equimolar amounts of NH4Cl and NaCN) on freshly distilled 1-
naphthaldehyde to give aminonitrile 8a. After the reaction had finished, immediate 
treatment with benzaldehyde in the presence of NaOH (pH 10) led to conversion of 
the amino function into the Schiff base with concomitant partial hydrolysis of the 
cyanide group. This process presumably proceeds in an intramolecular fashion 
through the five-membered ring N,O-acetal 9a.12 Subsequent hydrolysis of the 
benzaldimine under the influence of concentrated HCl in acetone resulted in the 
crystalline HCl-salt of the desired amino acid amide 6a, which could be obtained as 
the HCl-free amino acid amide by treatment with base and a simple extraction. 
Nevertheless, the HCl-salt was used in the subsequent enzymatic resolution step. 
The whole sequence was efficiently carried out in 62% overall yield with only a 
single purification step at the end (precipitation from acetone).10 
OH
NH3/MeOH
NH4Cl, NaCN
N
Ph
NH2
O
conc. HCl
CNH2N
NaOH
PhCHO
HCl.H2N
NH2
O
HO-
O
N NH
Ph
H
H+
7a 9a
acetone
6a.HCl
94%
8a
10a
66% from 7a  
Scheme 2.4 Synthesis of (1-naphthyl)glycine amide 
Starting from the HCl-salt of the amino acid amide 6a, both (S)- and (R)-(1-
naphthyl)glycine were accessible through enzymatic resolution using enzymes from 
different sources, i.e. Pseudomonas putida ATCC 12633 and Ochrobactrum anthropi 
NCIMB 40321 (Table 2.1). Subjection of racemic 6a.HCl to an L-specific 
aminopeptidase present in whole cells of the microorganism Pseudomonas putida 
ATCC 1263310 (pH = 8.3, T = 37 °C) led to a mixture of the corresponding (R)-amide 
6a and (S)-acid 2e in good yield and with reasonably high enantioselectivity (45% 
yield, 99% ee and 43% yield, 89% ee, respectively). The amide could be conveniently 
removed from the basic water layer (pH 10) by simple extraction with CH2Cl2, after 
which both compounds were further purified by ion exchange chromatography.  
The relatively low enantiopurity of the resulting acid requires some further 
discussion. It is possible that the active site of the enzyme is not completely specific 
for the (S)-(1-naphthyl)glycine amide, but also converts a small amount of the (R)-
amide. An alternative explanation may be found in the possible presence of a 
racemase in the Pseudomonas putida whole cells. If formation of the acid is followed 
 
A chemoenzymatic route to aryl-substituted bisoxazoline ligands 
23 
 
by (relatively slow) racemisation, this may also account for the observed low 
enantioselectivity.13 
Another drawback in this enzymatic reaction was the low solubility of the 
amino acid amide, which caused the resolution to proceed very slowly since the 
enzyme optimum lies around pH 9. The solubility problem was overcome by 
applying an L-specific amidase from the microorganism Ochrobactrum anthropi 
NCIMB 4032114 (pH = 6.5, T = 50 °C) possessing a good activity at lower pH and 
being able to withstand a higher reaction temperature. The use of this amidase 
resulted in an improvement of both yield and enantioselectivity giving both the (R)-
amide and (S)-acid in >98% ee. The elegance of this approach was further enhanced 
due to the fact that the corresponding (R)-acid could also be obtained in good yield 
and without loss of enantiopurity (74%, 99% ee) via hydrolysis of (R)-6a using a non-
selective amidase present in whole cells from Rhodococcus erythropolis NCIMB 11540 
(pH 8.0, 37 °C).15 
Table 2.1 Enzymatic resolution of amino acid amide 6a 
HCl.H2N
NH2
O
6a.HCl
Rhodococcus
erythropolis
NCIMB 11540
(pH 8.0, 37 °C)
(R)-6a
H2N
NH2
O
H2N
OH
O
H2N
OH
O
(S)-2e
(R)-2e
74%
+
enzyme
 
enzyme source (R)-6a (S)-2e 
(conditions) yield (%)a ee (%)b yield (%)a ee (%)b 
Pseudomonas putida ATCC 12633 
(pH 8.3, 37 °C) 
45 99 43 89 
Ochrobactrum anthropi NCIMB 40321 
(pH 6.5, 50 °C) 
50 99 49 99 
a Isolated yields. b Enantiomeric excesses were determined by NMR (see: Section 2.5). 
Having the required amino acid in hand, (S)-1-Np-box ligand (1e) was 
synthesised according to a previously reported method (Scheme 2.5).16 Thus, 
reduction of (S)-(1-naphthyl)glycine (2e) in the presence of LiAlH4 in refluxing THF 
afforded the corresponding amino alcohol (S)-11a, after which subsequent acylation 
with dimethylmalonyl dichloride resulted in diamide (S)-12a in 71% yield. This 
diamide was then smoothly cyclised via tosylation to the desired bisoxazoline, which 
was purified via recrystallisation to finally afford enantiopure (S)-1e. 
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CO2HH2N
LiAlH4
(S)-2e
THF, reflux
H2N
OH
(S)-11a
N
O
N
O
O O
Cl Cl H
N
O
H
N
O
OHHO
(S)-12a
71% from (S)-2e
Et3N, CH2Cl2
0 °C
TsCl, Et3N
DMAP, CH2Cl2
(S)-1e
85%  
Scheme 2.5 Synthesis of (S)-(1-naphthyl)bisoxazoline (1e) 
In summary, the synthesis of the (S)-1-Np-box ligand (1e) was accomplished 
in 60% overall yield starting from (1-naphthyl)glycine (2e) and in 37% overall yield 
from 1-naphthaldehyde (7a). The crystal structure of (S)-1e was determined, thereby 
unambiguously confirming its structure (Figure 2.2).17 
 
Figure 2.2 Crystal structure of (S)-1-Np-box (1e) 
2.3 Synthesis of (2-naphthyl)bisoxazoline (2-Np-box) 
To enable us to make a more extensive evaluation of the steric influence of the 
aryl substituent, we also synthesised (2-naphthyl)bisoxazoline (2-Np-box, 1f) via a 
similar route. Although the synthesis of 1f was already accomplished by the group of 
Desimoni and Faita,6 we applied our own pathway to prepare this ligand. 
Similar to (1-naphthyl)glycine amide, (2-naphthyl)glycine amide was formed 
upon treatment of 2-naphthaldehyde (7b) with modified Strecker conditions, 
followed by partial hydrolysis of the resulting aminonitrile 8b. As shown in Scheme 
2.6, this resulted in formation of the crystalline HCl-salt of the desired amino acid 
amide, which was extracted from the basic water layer with dichloromethane to give 
the free amino acid amide 6b in 70% overall yield from 2-naphthaldehyde.10 
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OH
NH4Cl, NaCN
CNH2N
NaOH, PhCHO
NH3/MeOH
N
Ph
NH2
O
1) conc. HCl
    acetone
H2N
NH2
O
NH3/MeOH
7b 8b
2) basic workup
10b
81% from 7b
6b
86%  
Scheme 2.6 Synthesis of (2-naphthyl)glycine amide 
Subjection of racemic 6b.HCl to an L-specific aminopeptidase from the 
microorganism Ochrobactrum anthropi NCIMB 4032114 (pH = 6.5, T = 50 °C) led to a 
mixture of the corresponding (R)-amide 6b and (S)-acid 2f (Scheme 2.7). The workup 
consisted of removal of the whole cell rests by filtration, followed by lowering of the 
pH to 2 in order to precipitate the (S)-acid 2f (46% yield). Unfortunately, we were 
unable to determine the enantiopurity at this point due to the insolubility of the acid. 
Raising the pH to 9 resulted in precipitation of the (R)-amide 6b (33% yield) which 
was of moderate enantiopurity (75% ee). Interestingly, extraction of the resulting 
aqueous layer afforded the remaining (R)-amide 6b (10% yield) with an excellent ee 
of 97%. 
HCl.H2N
NH2
O
6b.HCl (R)-6b
33% (75% ee)
and 10% (97% ee)
H2N
NH2
O
(S)-2f
46%
H2N
OH
O
+
Ochrobactrum
 anthropi
pH 6.5, 50 °C
 
Scheme 2.7 Enzymatic resolution of amino acid amide 6b 
Optically active (2-naphthyl)glycine (2f) gave access to (S)-2-Np-box (1f) in 
the same fashion as previously described (Scheme 2.8).16 Since (S)-(2-
naphthyl)glycinol is a known compound,6 comparison of the optical rotation after the 
LiAlH4 reduction of 2f gave a strong indication that the enantiopurity of the (S)-(2-
naphthyl)glycine obtained by enzymatic resolution was excellent (>95% ee). 
Moreover, in the subsequent acylation step, we would expect to see the formation of 
diastereomers in case of a moderate enantiopurity of the starting amino acid, which 
was not the case. Base-catalysed cyclisation of diamide 12b resulted in the desired 
enantiopure 2-Np-box ligand, which could be readily purified via recrystallisation. 
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1) LiAlH,
    THF, reflux
(S)-2f
O O
Cl Cl
H
N
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H
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26%
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O
2) Et3N, CH2Cl2
     0 °C
TsCl, DMAP
Et3N, CH2Cl2
(S)-1f
55%
 
Scheme 2.8 Synthesis of (S)-(2-naphthyl)bisoxazoline (1f) 
2.4 Synthesis of (9-anthryl)bisoxazoline (9-Ant-box) 
Initially, we anticipated to synthesise the 9-anthryl-substituted bisoxazoline, 
which has hitherto not been described in literature, via an identical approach as 
shown above for the two naphthyl-substituted bisoxazolines (Scheme 2.3). However, 
from the start we encountered severe problems when applying the same sequence to 
the exceptionally bulky and lipophilic 9-anthraldehyde. Especially the insolubility of 
the precursors and resulting products in the modified Strecker reaction led to slow 
conversions and low yields. Eventually, in our hands it turned out to be impossible 
to obtain the desired amino acid amide via this route in acceptable yields, which 
prompted us to explore other routes that would lead to this ligand. 
EtOH, reflux
CNN
OF3C
HN
13 (S)-15
HO
7c
NN
Ot-Bu
t-Bu t-Bu
O t-Bu
Al
NH2 14
 
Scheme 2.9 Approaches to enantiopure (9-anthryl)glycine 
Initially, we chose to investigate a non-biocatalytic route, i.e. application of 
the recently described enantioselective cyanide addition to N-allylimines, using 
salen-catalyst 14 (Scheme 2.9).18 Allyl-9-anthracenemethanimine (13), which is a 
crucial intermediate in this approach, was synthesised according to literature.19 
However, when applying this methodology we were never able to isolate the desired 
adduct 15. 
We then turned our attention to a classical chemical approach based on N-
acyliminium ion chemistry that should lead to the (9-anthryl)glycine amide 19.20 
Starting from benzyl carbamate and glyoxylic acid monohydrate, the spontaneously 
formed N,O-acetal was methylated in acidic methanol to obtain 16 in two smooth 
steps according to literature.21 Next, this carbamate was allowed to react with 
anthracene via the corresponding N-acyliminium ion (Scheme 2.10).22 Optimisation 
 
A chemoenzymatic route to aryl-substituted bisoxazoline ligands 
27 
 
studies revealed that propionic acid as a co-solvent was superior to formic and acetic 
acid in this particular case. In addition, the reaction time had to be restricted to one 
hour in order to avoid decomposition of both anthracene and the electrophilic 
aromatic substitution product 17 by sulfuric acid. Having the Cbz-protected methyl 
ester 17 in hand, we initially chose to deprotect the amine function prior to 
converting the methyl ester into the corresponding amide. Removal of the Cbz-group 
was achieved using catalytic Pd/C and ammonium formate as hydrogen donor 
resulting in amino ester 18.23 However, despite several attempts, we were unable to 
form the (9-anthryl)glycine amide (19) by amidolysis of methyl ester 18. Therefore, 
the order of steps was changed and the N,O-acetal 16 was first converted into the 
corresponding amide 20 in aqueous ammonia.24 Delicate electrophilic addition of 
anthracene to form 21 was achieved in a mixture of sulfuric acid and propionic acid 
in a satisfactory yield of 70%. However, the carefully chosen conditions for the 
removal of the Cbz-moiety – catalytic transfer hydrogenation in the presence of 
Pd/C and ammonium formate – did not result in the desired (9-anthryl)glycine 
amide 19. In addition, several other hydrogenation and hydrolysis conditions were 
tested, but all were equally unsuccessful.  
OMe
HN
OMe
OCbz
OMe
HN
NH2
OCbz
HN
NH2
OCbz
HN
OMe
OCbz
Pd/C
HCO2NH4
EtOH, reflux
H2N
NH2
O
H2N
OMe
O
16 17
72%
conc H2SO4
(10% v/v)
EtCO2H, 0 °C 18
96%
20
100%
21
70%
conc H2SO4
(10% v/v)
EtCO2H, 0 °C 19
NH3/H2O
(25%)
 
Scheme 2.10 Synthesis of (9-anthryl)glycine amide derivatives 
Due to the various difficulties that we encountered in the synthesis of 
enantiopure 9-Ant-box, we again changed our strategy. We also envisaged that (9-
anthryl)glycine amide might lead to additional problems during the subsequent 
enzymatic resolution, since it might well be even less soluble in the aqueous buffers 
than its naphthyl counterparts. In order to find an alternative method to obtain 
optically pure 2-(9-anthryl)glycinol, a classical resolution approach was pursued. 
Synthesis of the racemic HCl-salt of amino alcohol 11c was accomplished via LiBH4-
reduction25 of methyl ester 17, subsequent deprotection of the amine in the presence 
of LiOH and acidic workup (Scheme 2.11). 
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HN
OMe
OCBz
THF, reflux
LiBH4
HN
OH
CBz
1) LiOH, reflux
    H2O/EtOH
2) acidic workup HCl.H2N
OH
17 22
90%
11c.HCl
80%  
Scheme 2.11 Synthesis of 2-(9-anthryl)glycinol 
Surprisingly, the free amino alcohol was relatively unstable, but the 
decomposition could be significantly slowed down by conversion into the 
corresponding HCl-salt. This suggests that the instability of HCl-free 11c was caused 
by the presence of a basic nitrogen atom near the anthracene moiety. This is in 
agreement with findings of Stack and coworkers, who observed that the yield for the 
synthesis of 9-aminomethylanthracene greatly varied,26 a result that in our view 
could well be explained by a similar decomposition event. 
In order to resolve racemic 2-(9-anthryl)glycinol into both enantiomers, we 
turned our attention to the so-called ‘Dutch Resolution’ process. This technology has 
been developed and is exploited by Syncom (Groningen, The Netherlands), and 
makes use of so-called ‘families’ of resolving agents.27 Over the years, this 
methodology has been proven to be highly practical for the efficient resolution of 
many compounds.28 Thus, attempts were made to resolve the amino alcohol 11c in 
the presence of various phosphoric acids and tartaric acids, but in these cases the 
crystallisations always led to racemic mixtures and therefore this approach was also 
abandoned.  
Finally, the amino alcohol was resolved using preparative chiral HPLC (on a 
Chiralpak AD column) to afford both enantiomers with excellent enantiopurity; (R)-
11c.HCl with 90% ee and (S)-11c.HCl with 98% ee. Assignment of the absolute 
configuration of both enantiomers was achieved by circular dichroism (CD) 
measurements that were performed in collaboration with the group of Frelek (Polish 
Academy of Sciences, Warsaw, Poland; see: Section 2.6). 
HCl.H2N
OH
O O
Cl Cl
(S)-11c.HCl
Et3N
CH2Cl2
0 °C
H
N
O
H
N
O
OHHO
(S)-12c
77%
CH2Cl2
-78 °C
DAST
N
O
N
O
(S)-1g
93%
 
Scheme 2.12 Synthesis of (S)-(9-anthryl)bisoxazoline (1g) 
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The enantiomerically pure (S)-2-(9-anthryl)glycinol (11c) was converted into 
the corresponding (S)-9-Ant-box (1g) in two steps (Scheme 2.12). First, acylation of 
(S)-2-(9-anthryl)glycinol resulted in diamide (S)-12c in a good yield. Under the 
conditions reported by Evans13, i.e. in the presence of two equivalent of tosyl 
chloride, only one of the oxazoline-rings was formed while the other alcohol 
remained unreacted. Alternatively, treatment with (diethylamino)sulfur trifluoride 
(DAST) led to smooth double cyclisation to give the desired (S)-9-Ant-box (1g) in 
93% yield.29 
2.5 Determination of the enantiopurity by 1H NMR spectroscopy 
The enantiopurity of the amino acids and amino acid amides can be 
determined by HPLC analysis. However, in order not to be completely dependent on 
HPLC techniques, we also used an 1H NMR method that was invented by Dr. D. 
Schipper (DSM, Delft, The Netherlands) to determine the enantiopurity. 
In this assay, the amino acids 2 and amino acid amides 6 were reacted with 
(S,S)-4-(benzoyloxy)-2,5-dioxotetrahydro-3-furanyl benzoate ((S,S)-DBTAAN, 23) to 
give a diastereomeric mixture of products 24 (Scheme 2.13). The doublets of the two 
indicated hydrogens of the DBTAAN-moiety in the coupling product 24 produce 
different chemical shifts for the two diastereoisomers so that the ee can be calculated 
from the integral values. Additionally, in the aromatic region of the spectra two 
different, fully separated triplets can be observed. However, it was assumed that 
integration of the aforementioned doublets (at 5-6 ppm) would be more accurate. 
O
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O
O
Ph
Ph
O
O
O
H
H
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H2N
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O
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Ph
O
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O
H
H
H
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2 (X = OH)
or 6 (X = NH2) 24
Na2B4O7
D2O/CD3CN
 
Scheme 2.13 Reaction of amino acids and amino acid amides with (S,S)-DBTAAN 
For instance, in this fashion the enantiopurity of (1-naphthyl)glycine (2e, R = 
1-Np, X = OH) with (S,S)-DBTAAN was determined (Figure 2.3). The 1H-NMR 
spectra clearly show the doublets for the asymmetric hydrogens of racemic 24a (R = 
1-Np, X = OH). By integration of the other signals, the ee of (S)-2e – obtained from 
the resolution with Ochrobactrum anthropi – appeared >98% (case c), while the 
product from the resolution with Pseudomonas putida showed an ee of 89% (case b). In 
the event of other amino acids and amides, comparable 1H-NMR spectra were 
obtained and therefore enantiopurities could be determined in an analogous manner. 
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Figure 2.3 1H-NMR spectra (300 MHz) upon reaction of (S,S)-DBTAAN with (a) rac-2e; (b) 
(S)-2e from reaction with Pseudomonas putida, ee = 89%; (c) (S)-2e from reaction with 
Ochrobactrum anthropi, ee >98% 
2.6 Determination of the absolute configuration by CD spectroscopy 
In contrast with known derivatisation methods to elucidate the absolute 
stereochemistry of the 9-anthryl amino alcohol, we chose to use a newly developed 
spectroscopic technique. Recently, it was found that circular dichroism (CD) may 
provide a convenient alternative for the direct determination of the absolute 
configuration of optically active amino alcohols.30 The group of Frelek (Polish 
Academy of Sciences, Warsaw, Poland) described the stereochemical assignment of a 
wide variety of amino alcohols based on CD spectra of the corresponding chiral 
rhodium complexes.31 In this approach, the amino alcohols are converted into 
cottonogenic derivatives via complexation with dirhodium tetraacetate, which then 
also acts as the auxiliary chromophore. 
The absolute configuration of both enantiomers of 2-(9-anthryl)glycinol was 
determined in collaboration with the group of Frelek. To compare the Cotton effect of 
(S)- and (R)-2-(9-anthryl)glycinol with other aryl-substituted amino alcohols, spectra 
of (S)-1-naphthyl and (S)-2-naphthyl were recorded in the presence of dirhodium 
tetraacetate (Figure 2.4). 
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Figure 2.4 CD spectra of (S)-2-(1-naphthyl)glycinol, (S)-2-(2-naphthyl)glycinol, (R)- and 
(S)-2-(9-anthryl)glycinol complexed to [Rh(OAc)4]2. 
The absolute stereochemistry was assigned based on the Cotton effect in the 
CD spectra at around 620 nm; this band originates from the  π*(Rh-Rh) to σ*(Rh-O) 
transition. A negative Cotton effect would indicate that the amino alcohol belongs to 
the L-series, which corresponds to the (S)-configuration and vice versa.31 
Both (S)-2-(1-naphthyl)- and (S)-2-(2-naphthyl)glycinol showed a negative 
Cotton effect around 620 nm, which is in agreement with the theory.31 In case of the 
two 2-(9-anthryl)glycinol enantiomers, indeed opposite Cotton effects were observed, 
which strongly point to the indicated absolute configurations. In other words, the 
enantiomer that eluted first from the preparative chiral column showed a positive 
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Cotton effect and therefore possessed the (R)-configuration, whereas the enantiomer 
in the second fraction had the (S)-configuration, concluding from the negative Cotton 
effect around 650 nm. 
2.7 Conclusions 
The (S)- and (R)-enantiomers of both (1-naphthyl)- and (2-naphthyl)glycine 
were accessible through enzymatic resolution using an L-specific aminopeptidase in 
good yield and excellent ee. These synthetically versatile amino acids could also be 
effectively transformed into the corresponding enantiopure bisoxazoline ligands. (S)-
1-Np-box was successfully synthesised in 60% yield from (S)-(1-naphthyl)glycine. 
(S)-2-Np-box was successfully prepared via a similar route in a comparable yield as 
the literature synthesis.  
During the synthesis of (S)-9-Ant-box, we encountered some problems in 
introducing the anthryl moiety. The bulky anthryl substituent led to a low solubility 
in aqueous solutions, and we also discovered that the presence of a free amine 
functionality caused decomposition of the anthryl-containing intermediates. 
Nevertheless, we succeeded in the synthesis of (S)-9-Ant-box from the corresponding 
amino alcohol, of which both enantiomers were obtained using preparative chiral 
HPLC.  
In addition, 1H NMR spectroscopy (in situ derivatisation with (S,S)-
DBTAAN) was applied to determine the enantiopurity of the amino acids and amino 
acid amides. Furthermore, assignment of the absolute configuration of the anthryl-
substituted amino alcohols was achieved by circular dichroism (CD) measurements 
in the presence of dirhodium tetraacetate. 
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for elucidation of the absolute stereochemistry of the 2-(9-anthryl)glycinols 
enantiomers by CD spectroscopy.  
2.9 Experimental section 
General methods 
All reactions were carried out under an atmosphere of dry nitrogen or argon. 
Standard syringe techniques were applied for transfer of dry solvents and air- or 
moisture-sensitive reagents. Flash chromatography was performed with Acros 
Organic silica gel (0.035–0.070 mm). Rf values are obtained using thin layer 
chromatography (TLC) on silica gel-coated plates (Merck 60 F254) with the indicated 
solvent (mixture). Melting points were determined using a Buchi melting point B-545 
apparatus and are uncorrected. IR spectra were recorded on an ATI Mattson Genesis 
Series FTIR spectrometer; absorptions are reported in cm-1. NMR spectra were 
recorded with Bruker DMX 200 and DMX300 spectrometers from CDCl3 solutions 
(unless otherwise reported) using TMS as internal standard; shifts are given in ppm. 
Optical rotations were determined with a Perkin Elmer 241 polarimeter. Mass spectra 
were measured with a Fisons (VG) Micromass 7070E apparatus. Elemental analyses 
were carried out using a Carlo Erba Instruments CHNS-O EA 1108 element analyser. 
 
Materials 
Solvents were distilled from appropriate drying agents immediately prior to use. 
Unless stated otherwise, all chemicals were purchased and used as such. 1- and 2-
Naphthaldehyde were distilled before use. (S,S)-DBTAAN, whole cells of 
Pseudomonas putida ATCC 12633 and a cell-free extract containing the Ochrobactrum 
anthropi NCIMB 40321 L-amidase were kindly provided by DSM. Dowex 50W × 4 
(Fluka) was used for ion exchange chromatography with 2 N NH4OH as the eluent 
and 2 N HCl as regeneration agent. 
 
Representative experimental procedure for the ee-determination by 1H-NMR 
To a solution of the amino acid 2e (2.8 mg, 14 µmol) in a Na2B4O7 buffer (0.4 M in 
D2O, 0.5 mL), (S,S)-dibenzoyl tartaric anhydride ((S,S)-DBTAAN, 50 mM in CD3CN, 
0.5 mL, 15 µmol) was added in three portions; after each portion the sample was 
shaken vigorously for 5 min. The sample was left overnight to react before 1H-NMR 
was measured: 1H-NMR (D2O/CD3CN, 300 MHz): δ = 5.98 (d, J = 2.5 Hz, (S)-2e), 5.81 
(d, J = 3.3 Hz, (R)-2e), 5.46 (d, J = 2.5 Hz, (S)-2e), 5.45 (d, J = 3.0 Hz, (R)-2e) (other 
signals are omitted for clarity). 
 
General experimental procedure for CD measurements of chiral amino alcohols 
For CD measurements, the solid amino alcohol (1-5 mg) was dissolved in a stock 
solution of [Rh(OAc)4]2 (6-7 mg) in CHCl3 (1 mL) so that the molar ratio of the stock 
complex to ligand was about 1:0.5 to 1:0.7. Some of the ∆ε´-values were very small, 
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but nevertheless the signal-to-noise ratio in each case was better than at least 10:1. At 
rt, CHCl3 solutions of the chiral complex were stable for several days. UV/Vis 
spectra were recorded on a Cary 100 spectrophotometer in CHCl3. CD spectra were 
recorded at rt with a Jasco 715 spectropolarimeter using CHCl3 solutions (spectral 
band with 2 nm, sensitivity 10 × 10-6 or 20 × 10-6 ∆A-unit/nm). Depending on the 
S/N-ratio, the λ-scan speed was 0.2 or 0.5 nm/s. 
 
N-Benzylidene-(1-naphthyl)glycine amide (10a) 
To a solution of NaCN (5.97 g, 122 mmol) in methanol (100 mL) was 
added concentrated ammonia (25% in H2O, 90 mL), NH4Cl (6.50 g, 
121 mmol) and 1-naphthaldehyde (19.9 g, 121 mmol). After stirring 
for 5 h at rt, the reaction was complete according to TLC 
(Et2O:heptane 1:1). 
To the reaction mixture was added toluene (100 mL), aqueous 1 N NaOH (122 mL, 
122 mmol) and benzaldehyde (12.9 g, 121 mmol). After stirring for 1 h, a precipitate 
was formed, which was collected by filtration, washed with heptane and dried in 
vacuo. Benzaldimine 10a was isolated as a white solid (23.0 g, 66% from 1-
naphthaldehyde) and directly used for the next step: 1H-NMR (CDCl3, 200 MHz): δ 
8.25 (s, 1H), 7.88-7.47 (m, 12H), 7.24 (bs, 1H), 5.94 (bs, 1H), 5.67 (s, 1H); 13C-NMR 
(CDCl3, 50 MHz): δ 174.5, 163.3, 135.6, 135.4, 134.3, 131.6, 131.1, 129.0, 128.9, 128.8, 
128.6, 127.3, 126.6, 126.0, 125.5, 124.6, 73.7; Rf (Et2O): 0.21. 
 
(1-Naphthyl)glycine amide (6a) 
To a solution of 10a (11.0 g, 38.2 mmol) in acetone (500 mL) was 
added concentrated HCl (3.7 mL, 37.5 mmol). After stirring for 1 h at 
rt, a precipitate was formed, which was collected by filtration, 
washed with acetone and dried in vacuo. The amide 6a was isolated 
as its HCl-salt (8.48 g, 94%). Extraction of an aqueous solution of the 
HCl-salt (pH 10, 500 mL) with CH2Cl2 (3 × 200 mL) afforded the HCl-free product as 
a white, crystalline solid (8.01 g, 89% from 10a): IR: νmax (cm-1) = 3263, 3318, 3064, 
1657, 1624; 1H-NMR (CDCl3, 200 MHz): δ = 8.15 (d, J = 7.6 Hz, 1H), 7.84 (m, 2H), 7.58-
7.41 (m, 4H), 6.84 (bs, 1H), 5.69 (bs, 1H), 5.19 (s, 1H); 1H-NMR (CD3OD, 300 MHz): δ 
= 8.23 (d, J = 8.5 Hz, 1H), 7.85 (m, 2H), 7.58-7.43 (m, 4H), 5.21 (s, 1H); 13C-NMR 
(CD3OD, 75 MHz): δ = 178.9, 138.5, 132.5, 129.9, 129.6, 127.5, 126.8, 126.5, 126.2, 124.5, 
56.9; Rf (CHCl3/MeOH/NH3(25%) 60:45:20): 0.45; HRMS(EI) calcd for C12H12N2O 
200.0950, found 200.0949. 
 
(S)-(1-Naphthyl)glycine ((S)-2e) and (R)-(1-naphthyl)glycine amide ((R)-6a) using 
Pseudomonas putida L-aminopeptidase 
A solution of 6a.HCl (2.28 g, 9.65 mmol) in H2O (135 mL) 
was brought to pH 8.3 using aqueous KOH (5 M). After 
addition of aqueous MnSO4 (10 mM, 11.5 mL, 0.12 mmol) 
and whole cells of Pseudomonas putida ATCC 12633 (2.17 
N
Ph
NH2
O
H2N
NH2
O
H2N
OH
O
H2N
NH2
O
+
 
A chemoenzymatic route to aryl-substituted bisoxazoline ligands 
35 
 
g), the mixture was shaken for 90 h at 37 °C. The mixture was cooled to rt and the 
aqueous layer was extracted with CH2Cl2 (3 × 75 mL). Both layers were filtrated over 
Hyflo to remove the enzyme residue. The aqueous layer was changed to pH 5 and 
purified by ion exchange chromatography. Removal of the solvent afforded acid (S)-
2e as an off-white solid (0.834 g, 43%). After removal of the solvent from the CH2Cl2 
layer, amide (R)-6a was obtained as a light brown solid (0.791 g, 41%): the ee was 
determined by 1H-NMR using (S,S)-DBTAAN to be 73% for (S)-2e and 99% for (R)-
6a. 
 
(S)-(1-Naphthyl)glycine ((S)-2e) and (R)-(1-naphthyl)glycine amide ((R)-6a) using 
Ochrobactrum anthropi L-amidase 
A solution of 6a.HCl (12.0 g, 50.7 mmol) in H2O (85 mL) 
was brought to pH 6.5 using aqueous KOH (5 M). After 
addition of aqueous ZnSO4 (80 mM, 1.5 mL, 0.12 mmol) 
and a cell-free extract containing the L-amidase from 
Ochrobactrum anthropi NCIMB 40321 in water (2 mL), the total weight of the mixture 
was brought to 120 g by addition of water. The mixture was shaken for 70 h at 50 °C, 
after which an extra 2 mL of cell-free extract was added and the mixture was shaken 
for another 20 h. After cooling the mixture to rt, the mixture was filtrated over Hyflo. 
The resulting clear solution was brought to pH 9 by addition of aqueous KOH (5 M) 
and extracted with CH2Cl2 (3 × 250 mL). The aqueous layer was then changed to pH 
5 and purified by ion exchange chromatography. Removal of the solvent resulted in 
isolation of acid (S)-2e as an off-white solid (5.04 g, 49%): the ee was determined by 
1H-NMR using (S,S)-DBTAAN to be 99%; [α]D25 –7.9 (c 0.05, H2O) [lit.32 for (R)-2e 
[α]D25 +8.0 (c 0.05, H2O)]; IR: νmax (cm-1) = 3047, 1695, 1618, 1570, 1514; 1H-NMR (D2O, 
200MHz): δ = 8.13-7.98 (m, 3H), 7.66-7.54 (m, 4H), 5.50 (s, 1H); 13C-NMR (CD3OD, 
75MHz): δ = 173.9, 135.6, 133.7, 132.7, 130.6, 130.0, 128.0, 127.7, 127.2, 126.5, 124.3, 
56.5; Rf (CHCl3/MeOH/NH3(25%) 60:45:20): 0.65. 
After concentration of the CH2Cl2 layer, (R)-6a was obtained as a white solid (5.59 g, 
43%); the ee was determined by 1H-NMR using (S,S)-DBTAAN to be 99%; [α]D25 –114 
(c 0.5, MeOH); 1H-NMR (CD3OD, 300MHz): δ = 8.24 (d, J = 8.5 Hz, 1H), 7.85 (m, 2H), 
7.56-7.41 (m, 4H), 5.21 (s, 1H). 
 
(R)-(1-Naphthyl)glycine ((R)-2e) 
To a 5% solution of (R)-6a (100 mg, 0.50 mmol) in a phospate buffer 
pH 8 (500 mL of 0.1 M NaH2PO4 + 467 mL of 0.1 M NaOH) was added 
50 mg of dried whole cells of Rhodoccocus erythropolis NCIMB 11540 
and the reaction mixture was stirred at 37 °C for 48 h. The reaction 
mixture was filtrated over Hyflo, the filtrate was acidified and purified via ion 
exchange chromatography to give (R)-2e (74 mg, 74%) as a white solid. Analytical 
data were identical to the literature data.32 
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(S)-2-(1-Naphthyl)glycinol ((S)-11a) 
To a suspension of acid (S)-2e (3.50 g, 17.4 mmol) in THF (250 mL) at 0 
°C was added LiAlH4 (6.70 g, 176 mmol) in four portions. After 
refluxing for 17 h, the mixture was cooled to 0 °C and quenched 
through addition of H2O (6 mL), aqueous NaOH (4 M, 6 mL) and H2O 
(15 mL) over a period of 15 min. After stirring for 30 min at rt, the mixture was 
filtrated. The residue was washed with EtOAc (3 × 150 mL) and the combined 
filtrates were concentrated in vacuo to yield amino alcohol (S)-11a as a yellow solid 
(2.94 g, 90%): [α]D25 +83 (c 0.50, MeOH) [lit.33 for (R)-11a [α]D25 –85 (c 0.50, MeOH)]; 
1H-NMR (CDCl3, 300MHz): δ = 8.11 (d, J = 8.9 Hz, 1H), 7.88 (d, J = 7.5 Hz, 1H), 7.79 
(d, J = 8.2 Hz, 1H), 7.62-7.46 (m, 4H), 4.92 (dd, J = 3.9, 8.0 Hz, 1H), 3.96 (dd, J = 3.9, 
10.7 Hz, 1H), 3.67 (dd, J = 8.0, 10.7 Hz, 1H); 13C-NMR (CD3OD, 75MHz): δ = 138.8, 
135.3, 132.4, 129.7, 128.8, 127.2, 126.6, 126.5, 124.2, 123.7, 68.6, 53.8; Rf 
(CHCl3/MeOH/NH3(25%) 60:45:20): 0.88.  
 
N,N’-bis[(S)-2-hydroxyl-1-(1-naphthyl)ethyl]-2,2-dimethylpropanediamide ((S)-12a) 
A solution of amino alcohol (S)-11a (1.20 g, 6.44 mmol) 
and Et3N (4.6 mL, 33.2 mmol) in CH2Cl2 (40 mL) was 
cooled to 0 °C. A solution of 2,2-dimethylmalonyl 
dichloride16a (562 mg, 3.3 mmol) in CH2Cl2 (15 mL) was 
added via a cannula. After stirring for 90 min, CH2Cl2 (40 mL) was added and the 
mixture was washed with aqueous HCl (1 M, 150 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 100 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 (150 mL) and the aqueous layer was extracted with 
CH2Cl2 (100 mL). The combined organic layers were washed with brine (150 mL) and 
the aqueous layer was extracted with CH2Cl2 (100 mL). The combined organic layers 
were dried (MgSO4) and concentrated in vacuo. The resulting brown solid was 
recrystallised from EtOAc, yielding diamide (S)-12a as an off-white solid (1.24 g, 
79%): mp 99 °C; [α]D25 –39 (c 0.50, MeOH); IR: νmax (cm-1) = 3337, 3047, 2971, 2933, 
2876, 1642, 1522; 1H-NMR (CD3Cl, 200 MHz): δ = 8.04 (m, 2H), 7.89-7.76 (m, 4H), 7.48 
(m, 4H), 7.35 (m, 4H), 7.18 (d, J = 7.9 Hz, 2H), 5.96 (m, 2H), 4.10-3.94 (m, 4H), 3.92 (bs, 
2H), 1.50 (s, 6H); 13C-NMR (CD3Cl, 50 MHz): δ = 174.1, 134.3, 134.0, 131.0, 129.1, 
128.7, 126.8, 126.0, 125.3, 123.5, 122.9 (2C), 65.6 (2C), 51.9 (2C), 50.2, 23.9 (2C); 
C29H30N2O4.½H2O calcd C 72.63, H 6.52, N 5.84, found C 72.36, H 6.32, N 5.67; Rf 
(EtOAc/MeOH 95:5) = 0.41. 
 
2,2-Bis[(S)-4-(1-naphthyl)-1,3-oxazolin-2-yl]propane ((S)-1e) 
To a solution of (S)-12a (2.32 g, 4.93 mmol), DMAP (65 mg, 
0.53 mmol) and triethylamine (3.5 mL, 25.2 mmol) in 
CH2Cl2 (125 mL) was added a solution of tosyl chloride 
(1.98 g, 10.4 mmol) in CH2Cl2 (40 mL) via cannula. After 
stirring at rt for two days, the mixture was washed with 
saturated aqueous NH4Cl (200 mL) and the aqueous layer was extracted with CH2Cl2 
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(3 × 200 mL). The combined organic layers were washed with saturated aqueous 
NaHCO3 (400 mL), the aqueous layer was extracted with CH2Cl2 (3 × 300 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo to yield the 
crude product as an off-white solid. Purification by column chromatography 
(EtOAc/heptane 4:6) resulted in isolation of (S)-1e as a white solid (1.82 g, 85%). The 
product was purified by recrystallisation (EtOAc/heptane): mp 59 °C; [α]D25 +180 (c 
0.50, CDCl3); IR: νmax (cm-1) = 3057, 2981, 2893, 1657; 1H-NMR (CDCl3, 200 MHz): δ = 
7.90-7.75 (m, 6H), 7.60-7.40 (m, 8H), 5.99 (dd, J = 8.1, 10.1 Hz, 2H), 4.96 (dd, J = 8.0, 
10.2 Hz, 2H), 4.13 (t, J = 8.1 Hz, 2H), 1.80 (s, 6H); 13C-NMR (CDCl3, 300 MHz): δ = 
170.6, 138.4, 133.8, 130.5, 129.0, 127.8, 126.2, 125.7, 125.6, 123.4, 122.7, 75.1, 66.2, 39.3, 
24,6; HRMS(EI) calcd for C29H26N2O2 434.1994, found 434.1996; C29H26N2O2.¼H2O 
calcd C 79.34, H 6.08, N 6.38, found C 79.36, H 5.84, N 6.23; Rf (EtOAc/heptane 4:6) = 
0.23. 
 
Crystal structure determination of (S)-1-Np-box ((S)-1e) 
The crystal data and a summary of the data collection 
and structure refinement are given in Table 2.2. The 
structure was solved by the program CRUNCH.34 All 
non-hydrogen atoms were refined with anisotropic 
temperature factors. The hydrogen atoms were placed at 
calculated positions, and refined isotropically in riding mode. Selected bond 
distances and angles are given in Tables 2.3 and 2.4, respectively (for atomic 
numbering vide infra).35 Geometrical calculations revealed neither unusual geometric 
features, nor unusual short intermolecular contacts.35 The calculations revealed no 
higher symmetry and no (further) solvent accessible areas. 
 
Table 2.2 Crystal data and structure refinement for 1-Np-box 1e 
Crystal colour transparent 
colourless 
θ range for data 
collection 
5.00 ° to 25.00 ° 
Crystal shape 
Crystal size 
Empirical formula 
rather regular thick 
platelet 
0.29 x 0.26 x 0.11 mm 
C29H26N2O2 
Index ranges -13 ≤ h ≤ 13 
-9 ≤ k ≤ 9 
-14 ≤ l ≤ 14 
Formula weight 434.52 Reflections collected 22993 
Temperature 293(2) K unique 24020  
Radiation 
(graph. monochrom.) 
Wavelength 
MoKα 
 
0.71073 Å 
[Rint] 
Reflections observed 
[Io > 2σ(Io)] 
0.0492 
2986 
Crystal system 
space group 
Monoclinic 
P 21 
Absorption correction SADABS multiscan 
correction36 
Unit cell: 
no. of  reflections 
22993 Refinement method Full-matrix 
least-squares on F2 
θ range 5.000 to 25.000 Computing SHELXL-9737 
N
O
N
O
O2
18
2 3
1
17 4
O1
N2 N1
5
6
10
11
9
12
8
13
1415
7
1629
2021
2223
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27 28
25
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a 11.2514(17) Å Data 4020 
b 7.7746(13) Å restraints 1 
c 14.283(3) Å parameters 300 
α 90 ° Goodness-of-fit on F2 1.035 
β 
γ 
112.621(13) ° 
90 ° 
SHELXL-97 weight 
parameters 
0.0394, 0.0606 
Volume 
Z 
1148.8(3) Å3 
2 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0450 
wR2 = 0.0782 
Calculated density 
Absorption coefficient 
1.256 Mg/m3 
0.079 mm-1 
R indices 
(all data) 
R1 = 0.0731 
wR2 = 0.0850 
Diffractometer NoniusKappaCCD 
with area detector 
Absolute structure 
parameter 
0.8(13) 
scan f and w scan Largest diff. peak 0.100 e/Å3 
F(000) 460 Largest hole  -0.127 e/Å3 
 
Table 2.3 Bond distances of the non-hydrogen atoms (Å) of 1-Np-box 1e 
C(1)-C(17) 1.496(3) C(6)-C(7) 1.502(3) C(19)-C(20) 1.504(3) 
C(1)-C(4) 1.501(3) C(7)-C(16) 1.358(3) C(20)-C(29) 1.363(3) 
C(1)-C(3) 1.534(3) C(7)-C(8) 1.423(3) C(20)-C(21) 1.422(3) 
C(1)-C(2) 1.536(3) C(8)-C(13) 1.412(3) C(21)-C(22) 1.409(3) 
O(1)-C(4) 1.353(2) C(8)-C(9) 1.415(3) C(21)-C(26) 1.418(3) 
O(1)-C(5) 1.426(3) C(9)-C(10) 1.351(3) C(22)-C(23) 1.363(3) 
N(1)-C(4) 1.251(3) C(10)-C(11) 1.386(4) C(23)-C(24) 1.381(4) 
N(1)-C(6) 1.466(3) C(11)-C(12) 1.346(4) C(24)-C(25) 1.340(4) 
O(2)-C(17) 1.358(2) C(12)-C(13) 1.415(4) C(25)-C(26) 1.415(4) 
O(2)-C(18) 1.438(3) C(13)-C(14) 1.408(4) C(26)-C(27) 1.397(3) 
N(2)-C(17) 1.260(2) C(14)-C(15) 1.336(4) C(27)-C(28) 1.341(4) 
N(2)-C(19) 1.472(3) C(15)-C(16) 1.395(4) C(28)-C(29) 1.410(4) 
C(5)-C(6) 1.538(4) C(18)-C(19) 1.529(3)   
 
Table 2.4 Bond angles of the non-hydrogen atoms (°) of 1-Np-box 1e 
C(17)-C(1)-C(4) 105.89(17) C(8)-C(7)-C(6) 120.24(17) N(2)-C(19)-C(18) 103.24(16) 
C(17)-C(1)-C(3) 110.11(17) C(13)-C(8)-C(9) 117.2(2) C(20)-C(19)-C(18) 114.41(17) 
C(4)-C(1)-C(3) 111.32(17) C(13)-C(8)-C(7) 118.96(19) C(29)-C(20)-C(21) 119.1(2) 
C(17)-C(1)-C(2) 110.40(17) C(9)-C(8)-C(7) 123.80(19) C(29)-C(20)-C(19) 120.8(2) 
C(4)-C(1)-C(2) 108.21(18) C(10)-C(9)-C(8) 121.7(2) C(21)-C(20)-C(19) 120.08(18) 
C(3)-C(1)-C(2) 110.8(2) C(9)-C(10)-C(11) 120.7(3) C(22)-C(21)-C(26) 117.6(2) 
C(4)-O(1)-C(5) 105.96(18) C(12)-C(11)-C(10) 119.9(2) C(22)-C(21)-C(20) 123.2(2) 
C(4)-N(1)-C(6) 107.8(2) C(11)-C(12)-C(13) 121.3(2) C(26)-C(21)-C(20) 119.3(2) 
C(17)-O(2)-C(18) 104.76(14) C(14)-C(13)-C(8) 119.0(2) C(23)-C(22)-C(21) 121.6(2) 
C(17)-N(2)-C(19) 106.51(15) C(14)-C(13)-C(12) 122.0(3) C(22)-C(23)-C(24) 120.6(3) 
N(1)-C(4)-O(1) 118.1(2) C(8)-C(13)-C(12) 119.1(2) C(25)-C(24)-C(23) 119.9(3) 
N(1)-C(4)-C(1) 126.1(2) C(15)-C(14)-C(13) 121.1(2) C(24)-C(25)-C(26) 122.1(3) 
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O(1)-C(4)-C(1) 115.7(2) C(14)-C(15)-C(16) 120.1(2) C(27)-C(26)-C(25) 122.7(2) 
O(1)-C(5)-C(6) 104.62(16) C(7)-C(16)-C(15) 121.9(2) C(27)-C(26)-C(21) 119.0(2) 
N(1)-C(6)-C(7) 113.01(18) N(2)-C(17)-O(2) 118.12(17) C(25)-C(26)-C(21) 118.3(2) 
N(1)-C(6)-C(5) 103.01(19) N(2)-C(17)-C(1) 127.22(18) C(28)-C(27)-C(26) 121.2(2) 
C(7)-C(6)-C(5) 113.45(19) O(2)-C(17)-C(1) 114.64(17) C(27)-C(28)-C(29) 120.5(2) 
C(16)-C(7)-C(8) 118.9(2) O(2)-C(18)-C(19) 103.35(16) C(20)-C(29)-C(28) 120.9(2) 
C(16)-C(7)-C(6) 120.8(2) N(2)-C(19)-C(20) 112.67(17)   
 
N-Benzylidene-(2-naphthyl)glycine amide (10b) 
To a solution of NaCN (15.5 g, 0.32 mol) in methanol (250 mL) was 
added concentrated ammonia (25% in H2O, 225 mL), NH4Cl (16.9 g, 
0.32 mol) and 2-naphthaldehyde (49.2 g, 0.32 mol). After stirring 
overnight at rt, the reaction was complete according to TLC 
(Et2O/heptane 1:1). 
To the reaction mixture was added toluene (300 mL), aqueous NaOH 
(1 M, 315 mL, 0.32 mol) and benzaldehyde (32.0 mL, 0.31 mol). After stirring for 1 h, 
a precipitate was formed, which was collected by filtration, washed with heptane 
and dried in vacuo. Benzaldimine 10b was isolated as an off-white solid (72.9 g, 81% 
from 2-naphthaldehyde) and directly used for the next step: mp 148 °C; IR: νmax (cm-
1) = 3443, 3286–3058, 1684, 1640, 1580, 1359; 1H-NMR (CDCl3, 200 MHz): δ = 8.37 (s, 
1H), 7.82-7.48 (m, 12H), 7.13 (s, 1H), 5.63 (s, 1H), 5.17 (s, 1H); 13C-NMR (CDCl3, 50 
MHz): δ = 173.7, 163.2, 136.4, 135.2, 133.1, 132.8, 131.3, 128.5, 128.3, 128.3, 127.8, 127.4, 
126.2, 126.0, 125.9, 124.7, 76.9; HRMS(EI) calcd for C19H16N2O 288.1263, found 
288.1256; Rf (Et2O/heptane 1:1): 0.12. 
 
(2-Naphthyl)glycine amide (6b) 
To a solution of 10b (72.9 g, 0.25 mol) in acetone (3.00 L) was added 
concentrated HCl (24.7 mL, 0.24 mol). After stirring for 1 h at rt, a 
precipitate was formed, which was collected by filtration, washed with 
acetone and dried in vacuo. The amide 6b was isolated as its HCl-salt 
(61.7 g, 88%): 1H-NMR (DMSO-d6, 200MHz): δ = 7.99-7.60 (m, 7H), 5.02 
(s, 1H). Extraction of an aqueous solution of the HCl-salt (pH 10, 500 mL) with 
CH2Cl2 (3 × 200 mL) afforded the HCl-free product as an off-white, crystalline solid 
(41.2 g, 86% from 10b): mp 163 °C; IR: νmax (cm-1) = 3366, 3297, 3053, 1660, 1641, 1576, 
1405, 1294; 1H-NMR (DMSO-d6, 200MHz): δ = 7.90-7.45 (m, 7H), 4.47 (s, 1H); 1H-
NMR (CD3CN, 298K, 300MHz): δ = 7.94-7.78 (m, 4H), 7.58-7.42 (m, 3H), 6.89 (bs, 1H), 
5.81 (bs, 1H), 4.56 (s, 1H); 13C-NMR (CD3CN, 75MHz): δ = 129.2, 128.8, 128.6, 127.3, 
127.0, 126.8, 126.2, 118.4, 61.0; HRMS(EI) calcd for C12H12N2O 200.0950, found 
200.0945; Rf (Et2O/heptane 1:1): 0.06. 
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(S)-(2-Naphthyl)glycine ((S)-2f) and (R)-(2-naphthyl)glycine amide ((R)-6b) using 
Ochrobactrum anthropi L-amidase 
A solution of 6b (78.8 g, 0.39 mol) in H2O (3.00 L) was 
brought to pH 6.5 using aqueous KOH. After addition of 
aqueous ZnSO4 (1.13 g, 3.9 mmol) and a cell-free extract 
containing the L-amidase from Ochrobactrum anthropi 
NCIMB 40321 in water (20 mL), water was added to attain 
a 2% suspension of the amide. The mixture was shaken for 
18 h 30 at 50 °C. After cooling to rt, the mixture was brought to pH 2.0 using aqueous 
H2SO4. The mixture was filtrated to afford acid (S)-2f as a white solid (44.8 g 
including approximately 20% salts, 46%): since the amino acid was not soluble in any 
common solvent (D2O, CD3CN, CD3OD, DMSO-d6), at this stage no spectroscopic 
data were collected; HRMS(EI) calcd for C12H11N2O 201.0790, found 201.0783. 
The resulting clear filtrate was brought to pH 9 by addition of aqueous KOH (5 M), 
so that a precipitate was formed, which was collected by filtration, affording amide 
(R)-6b (25.8 g, 33%) as a white solid. The aqueous layer was then concentrated in 
vacuo to a volume of 1.5 L (pH 9) and extracted in portions of 400 mL with CH2Cl2 (3 
× 200 mL). The organic layer was dried (MgSO4) and concentrated in vacuo, 
affording amide (R)-6b as a white solid (7.2 g, 10%): the ee was determined by 1H-
NMR using (S,S)-DBTAAN to be 75% for the amide obtained by filtration and 97% 
for the amide obtained by extraction: 1H-NMR (CD3CN, 300MHz): δ = 7.94-7.78 (m, 
4H), 7.58-7.42 (m, 3H), 6.89 (bs, 1H), 5.81 (bs, 1H), 4.56 (s, 1H). 
 
 (S)-2-(2-Naphthyl)glycinol ((S)-11b) 
To a suspension of acid (S)-2f (5.00 g, 25.0 mmol) in THF (350 mL) at 0 
°C was added LiAlH4 (10.2 g, 268 mmol) in portions. After refluxing for 
18 h, the mixture was cooled to 0 °C and quenched through addition of 
H2O (9 mL), aqueous NaOH (4 M, 9 mL) and H2O (20 mL) over a period 
of 15 min. After stirring for 30 min at rt, the mixture was filtrated. The 
residue was washed with EtOAc (3 × 225 mL) and the combined filtrates were 
concentrated in vacuo to yield amino alcohol (S)-11b as a yellow foam (3.72 g, 81%): 
[α]D25 +39 (c 0.59, CHCl3) [lit.6 for (S)-11b [α]D25 +33.9 (c 1.39, CHCl3)]; IR: νmax (cm-1) = 
3360-2863, 2358, 2336, 1597, 1048; 1H-NMR (CDCl3, 300MHz): δ = 7.87-7.72 (m, 4H), 
7.52-7.40 (m, 3H), 4.20 (dd, J = 4.5, 8.1 Hz, 1H), 3.82 (dd, J = 4.5, 10.5 Hz, 1H), 3.63 (dd, 
J = 8.1, 10.5 Hz, 1H); 13C-NMR (CD3OD, 75MHz): δ = 139.4, 133.0, 132.6, 128.0, 127.5, 
127.4, 125.9, 125.6, 124.9, 124.5, 67.7, 57.4. 
 
N,N’-bis[(S)-2-hydroxyl-1-(2-naphthyl)ethyl]-2,2-dimethylpropanediamide ((S)-12b) 
A solution of amino alcohol (S)-11b (5.75 g, 30.8 mmol) and 
Et3N (22 mL, 159 mmol) in CH2Cl2 (200 mL) was cooled to 0 
°C. A solution of 2,2-dimethylmalonyl dichloride16a (2.69 g, 
15.8 mmol) in CH2Cl2 (70 mL) was added via a cannula. After 
stirring for 16 h, CH2Cl2 (200 mL) was added and the mixture 
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was washed with aqueous HCl (1 M, 300 mL). The aqueous layer was extracted with 
CH2Cl2 (3 × 200 mL). The combined organic layers were washed with saturated 
aqueous NaHCO3 (300 mL) and the aqueous layer was extracted with CH2Cl2 (200 
mL). The combined organic layers were washed with brine (300 mL) and the aqueous 
layer was extracted with CH2Cl2 (200 mL). The combined organic layers were dried 
(MgSO4) and concentrated in vacuo. The resulting brown solid was recrystallised 
from EtOAc, yielding diamide (S)-12b as an off-white solid (3.74 g, 52%): mp 160 °C; 
[α]D25 +122 (c 0.55, CHCl3); [α]D25 +99 (c 0.20, 96% EtOH) [lit.6 for (S)-12b [α]D25 +85.0 
(c 0.20, 95% EtOH)]; IR: νmax (cm-1) = 3378, 2976, 2868, 2487, 1632, 1411, 1044; 1H-NMR 
(CD3OD, 300 MHz): δ = 7.74-7.61 (m, 8H), 7.44-7.32 (m, 6H), 5.22 (dd, J = 4.8, 7.5 Hz, 
2H), 3.91 (dd, J = 5.1, 11.4 Hz, 2H), 3.84 (dd, J = 7.5, 11.4 Hz, 2H), 1.55 (s, 6H); 13C-
NMR (CD3OD, 75 MHz): δ = 175.4, 137.9, 134.4, 133.9, 128.9, 128.6, 128.3, 126.8, 126.5, 
126.3, 125.6, 65.8, 57.3, 51.6, 24.4. 
 
2,2-Bis[(S)-4-(2-naphthyl)-1,3-oxazolin-2-yl]propane ((S)-1f) 
To a solution of (S)-12b (1.02 g, 2.20 mmol), DMAP (29 mg, 
0.24 mmol) and triethylamine (1.52 mL, 10.9 mmol) in 
CH2Cl2 (55 mL) was added a solution of tosyl chloride (1.00 
g, 5.25 mmol) in CH2Cl2 (25 mL) via cannula. After stirring 
at rt for 90 min, the mixture was washed with saturated 
aqueous NH4Cl (85 mL) and the aqueous layer was 
extracted with CH2Cl2 (3 × 85 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 (170 mL), the aqueous layer was extracted with CH2Cl2 
(3 × 130 mL). The combined organic layers were dried (MgSO4) and concentrated in 
vacuo to yield the crude product as an off-white solid. Purification by column 
chromatography (EtOAc/heptane 4:6) resulted in isolation of (S)-1f as a white solid 
(0.53 g, 55%). The product was purified by recrystallisation from EtOAc: mp 172 °C 
[lit.6 for (S)-1f mp 173-174 °C]; [α]D25 –246 (c 0.55, CHCl3) [lit.6 for (S)-1f [α]D25 –233 (c 
0.55, CHCl3)]; IR: νmax (cm-1) = 30.49, 2977, 2939, 2897, 1653; 1H-NMR (CDCl3, 300 
MHz): δ = 7.82-7.66 (m, 8H), 7.47-7.31 (m, 6H), 5.41 (dd, J = 7.5, 9.9 Hz, 2H), 4.74 (dd, J 
= 8.1, 9.9 Hz, 2H), 4.26 (t, J = 7.8 Hz, 2H), 1.75 (s, 6H); 13C-NMR (CDCl3, 75 MHz): δ = 
170.2, 139.4, 133.1, 132.7, 128.5, 127.7, 127.4, 125.9, 125.6, 125.4, 124.4, 75.4, 69.8, 39.2, 
24.7; HRMS(EI) calcd for C29H26N2O2 434.1994, found 434.1988. 
 
Methyl 9-anthryl-benzyloxycarbonylaminoacetate (17) 
To a solution of 1621 (0.93 g, 3.7 mmol) and anthracene (0.65 g, 3.6 
mmol) in propionic acid (18 mL) at 0 °C was added concentrated 
sulfuric acid (2.0 mL, 10% v/v) dropwise and stirred for 1 h. The 
slightly yellow solution was poured into ice-saturated NaHCO3 
(saturated aqueous, 100 mL) and extracted using CH2Cl2 (3 × 85 mL). 
The organic layer was dried (MgSO4) and concentrated in vacuo. Purification by 
column chromatography (EtOAc/heptane 1:5) resulted in isolation of methyl ester 17 
as an off-white solid (1.0 g, 72%): mp 160 °C; IR: νmax (cm-1) = 3369, 3051, 2958, 1728, 
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1714, 1518, 1306, 1221; 1H-NMR(CDCl3, 300 MHz): δ = 8.50 (s, 1H), 8.37-8.24 (m, 2H), 
8.05 (d, J = 8.4 Hz, 2H), 7.63-7.52 (m, 2H), 7.52-7.44 (m, 2H), 7.35-7.29 (bs, 5H), 6.99-
6.93 (m, 1H), 6.04-5.97 (m, 1H), 5.19-5.03 (m, 2H), 3.64 (s, 3H); 13C-NMR (CDCl3, 75 
MHz): δ = 172.1, 155.4, 135.4, 131.1, 129.3, 129.0, 128.7,  128.0, 127.7, 127.6, 127.2, 126.7, 
124.6, 122.8, 67.0, 52.7, 52.1; HRMS(EI) calcd for C25H21NO4 399.1471, found 399.1471; 
Rf (EtOAc/Heptane 2:1) = 0.45. 
 
Methyl 2-amino-2-(9-anthryl)acetate (18) 
To a solution of 17 (301 mg, 0.75 mmol) in ethanol (36 mL) was 
added ammonium formate (98 mg, 1.6 mmol) at reflux was added 
Pd/C (15 mg). After 18 h at reflux, the mixture was filtrated over 
Hyflo and concentrated in vacuo. Purification by column 
chromatography (EtOAc/heptane 2:1) afforded amino methyl ester 18 as a slighty 
yellow solid (191 mg, 96%): 1H-NMR (CDCl3, 300 MHz): δ = 8.47 (s, 1H), 8.27 (d, J = 
9.0 Hz, 2H), 8.04 (d, J = 7.5 Hz, 2H), 7.56-7.44 (m, 4H), 6.03 (s, 1H), 3.61 (s, 3H), 2.21 
(bs, 2H); Rf (EtOAc/heptane 2:1) = 0.14. 
 
2-[(Benzyloxycarbonyl)amino]-2-methoxyacetamide (20) 
A solution of 16 (2.02 g, 8.0 mmol) in concentrated ammonia (25% in 
H2O, 20 mL) was stirred for 5 h at rt. The solution was concentrated in 
vacuo to yield amide 20 as a white solid (2.0 g, 100%): IR: νmax (cm-1) = 
3364, 3309, 3199, 2994, 1663; 1H-NMR (CDCl3, 300 MHz): δ = 7.27-7.40 (m, 5H), 6.50 
(bs, 1H), 5.93-5.85 (m, 2H), 5.30 (d, J = 9.0 Hz, 1H), 5.14 (s, 2H), 3.42 (s, 3H); 13C-NMR 
(CDCl3, 75 MHz): δ = 169.4, 155.8, 135.3, 128.0, 127.8, 127.6, 80.9, 67.0, 55.2; 
C11H14N2O4 calcd C 55.46, H 5.92, N 11.79. found C 54.96, H 5.83, N 11.15; Rf 
(EtOAc/Heptane 1:1) = 0.14. 
 
2-(9-Anthryl)-2-[(benzyloxycarbonyl)amino]acetamide (21) 
To a solution of amide 20 (238 mg, 1.00 mmol) and anthracene (163 
mg, 0.91 mmol) in propionic acid (9.0 mL) at 0 °C was added 
concentrated sulfuric acid dropwise (1.0 mL, 10% v/v) stirred for 1 h. 
The solution was poured into ice-saturated NaHCO3 (saturated 
aqueous, 50 mL) and extracted using CH2Cl2 (3 × 40 mL). The organic layer was dried 
(MgSO4) and concentrated in vacuo. Purification by column chromatography 
(EtOAc/heptane 1:2) afforded amide 21 as a brown solid (282 mg, 70%): 1H-NMR 
(CDCl3, 300 MHz): δ = 8.50 (s, 1H), 8.29 (bs, 2H), 8.03 (d, J = 7.5 Hz, 2H), 7.53-7.44 (m, 
4H), 7.26 (s, 5H), 6.96 (d, J = 7.2 Hz, 1H), 5.95 (d, J = 7.0 Hz, 1H), 5.06 (m, 2H); Rf 
(EtOAc/Heptane 1:5) = 0,36. 
 
2-(9-Anthryl)-2-[(benzyloxycarbonyl)amino]ethanol (22) 
To a solution of methyl ester 17 (0.70 g, 1.76 mmol) in THF (20 mL) at 
0 °C was added LiBH4 (2.0 M in THF, 1.7 mL, 3.4 mmol). After 
stirring for 18 h at reflux, the reaction was quenched using EtOAc (2 
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mL) and saturated aqueous NaHCO3 (3 mL). After addition of brine (30 mL), the 
reaction mixture was extracted using CH2Cl2 (3 × 30 mL). The organic layer was 
dried (MgSO4) and concentrated in vacuo. The obtained off-white solid was 
crystallised from CH2Cl2/hexane, yielding CBz-protected amino alcohol 22 as a 
white, crystalline solid (0.59 g, 90%): mp 134 °C; IR: νmax (cm-1) = 3322, 3057, 1695, 
1533, 1525, 1251, 1063, 1032; 1H-NMR(CDCl3, 400 MHz): δ = 8.46 (s, 1H), 8.38 (d, J = 
8.9 Hz, 2H), 8.07-8.02 (m, 2H), 7.58-7.52 (m, 2H), 7.52-7.44 (m, 2H), 7.38-7.27 (m, 5H), 
6.38 (dt, J = 4.7, 8.2 Hz, 1H), 5.76 (d, J = 4.7 Hz, 1H), 5.21-5.07 (m, 2H), 4.71-4.59 (m, 
1H), 4.15-4.07 (m, 1H), 3.49 (bs, 1H); 13C-NMR (CDCl3, 75 MHz): δ = 155.2, 135.7, 
131.5, 129.5, 128.7, 128.4, 128.3, 128.1, 127.9, 126.5, 125.1, 124.8, 123.8, 67.5, 67.2, 54.8; 
HRMS(EI) calcd for C24H21NO3 371.1521, found 371.1521; Rf (EtOAc/MeOH 9:1) = 
0.69. 
 
2-(9-Anthryl)glycinol HCl-salt (rac-11c.HCl) 
To a solution of CBz-protected amino alcohol 22 (50 mg, 0.14 mmol) 
in EtOH (1.5 mL) was added aqueous LiOH (2.0 M, 1.5 mL, 3.0 
mmol). After stirring for 2 h at reflux, the reaction was quenched 
using saturated aqueous NH4Cl (5 mL). The reaction mixture was 
extracted using EtOAc (2 × 10 mL). The combined organic layers were dried (MgSO4) 
and concentrated in vacuo, yielding amino alcohol rac-11c as an off-white solid (33 
mg, quant): IR: νmax (cm-1) = 3380-2840, 2244, 1942, 1618, 1447, 1038; 1H-NMR(CDCl3, 
300 MHz): δ = 8.46 (d, J = 7.8 Hz, 2H), 8.28 (s, 1H), 7.95-7.86 (m, 2H), 7.44-7.19 (m, 
4H), 5.51 (dd, J = 5.0, 9.5 Hz, 1H), 4.30 (t, J = 10.3 Hz, 1H), 3.84 (dd, J = 5.0, 10.9 Hz, 
1H) 2.81 (bs, 3H); 13C-NMR (CDCl3, 75 MHz): δ = 131.4, 129.3, 128.2, 127.8, 127.2, 
126.7, 125.5, 124.5, 66.0, 53.0. A solution of rac-11c in EtOAc was added to aqueous 
HCl (2 M) to form the corresponding HCl-salt rac-11c.HCl as an off-white solid (38 
mg, 80%): mp 186 °C; IR: νmax (cm-1) = 3399, 3205, 2950, 2894, 1627, 1519, 1057; 1H-
NMR(CD3OD, 300 MHz): δ = 8.63 (s, 1H), 8.38 (d, J = 9.0 Hz, 2H), 8.12 (d, J = 8.4 Hz, 
2H), 7.72-7.63 (m, 2H), 7.58-7.50 (m, 2H), 5.95 (dd, J = 4.8, 9.6 Hz, 1H), 4.64 (dd, J = 
9.9, 11.7 Hz, 1H), 4.09 (dd, J = 4.8, 12.0 Hz, 1H); 13C-NMR (CD3OD, 75 MHz): δ = 
132.7, 131.3, 131.2, 130.8, 128.3, 126.0, 125.4, 123.7, 63.3, 54.2; HRMS(EI) calcd for 
C16H15NO 237.1154, found 237.1155; Rf (EtOAc/heptane 3:1) = 0.2-0.5. 
 
Resolution of 2-(9-anthryl)glycinol (11c) by preparative chiral HPLC (at Syncom) 
A solution of the amino alcohol HCl-salt rac-11c.HCl 
(250 mg, 0.67 mmol) in EtOAc was extracted using 
saturated aqueous NaHCO3 (5 mL) to yield the 
corresponding HCl-free glycinol rac-11c. Preparative 
chiral HPLC analysis of the racemic mixture on a 
chiralpack AD column (heptane with 0.5% EtOH and 0.2% Et3N) yielded both 
enantiomers of amino alcohol 11c. To a solution of glycinols (R)- and (S)-11c in EtOH 
was added aqueous HCl (2 M) to form in quantitative yield the corresponding HCl-
salts (R)-11c.HCl (80 mg, 90% ee) and (S)-11c.HCl (70 mg, 98% ee): the enantiomeric 
HCl.H2N
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excess was determined by HPLC on a Chiralpak AD column (heptane with 5% EtOH 
and 0.2% EtNH2, 0.5 mL/min): tR 39.3 min (R), 44.1 min (S); for (R)-11c.HCl (90% ee): 
[α]D25 +27 (c 0.28, MeOH); for (S)-11c.HCl (98% ee): [α]D25 –28 (c 0.25, MeOH). 
 
N,N’-bis[(S)-2-hydroxyl-1-(9-anthryl)ethyl]-2,2-dimethylpropanediamide ((S)-12c) 
To a solution of amino alcohol (S)-11c.HCl (40 mg, 0.17 
mmol) and Et3N (59 µl, 0.42 mmol) in CH2Cl2 (2 mL) at 
0 °C was added 2,2-dimethylmalonyl dichloride16a (14 
mg, 84 µmol). After stirring for 16 h, the reaction 
mixture was quenched using H2O (1 mL), CH2Cl2 (10 
mL) was added and the mixture was washed with aqueous HCl (1 N, 5 mL). The 
aqueous layer was extracted with CH2Cl2 (5 mL). The combined organic layers were 
washed with H2O (10 mL) and the aqueous layer was extracted with CH2Cl2 (5 mL). 
The combined organic layers were washed with saturated aqueous NaHCO3 (10 mL) 
and the aqueous layer was extracted with CH2Cl2 (5 mL). The combined organic 
layers were dried (MgSO4) and concentrated in vacuo. Purification by column 
chromatography (acetone/CH2Cl2 1:4 to 1:2) resulted in isolation of (S)-12c as an off-
white solid (74 mg, 77%): [α]D25 –55 (c 1.6, MeOH); IR: νmax (cm-1) = 3500-3100, 2924, 
2250, 1658, 1502, 1260, 1031; 1H-NMR (CDCl3, 300 MHz): δ = 8.39 (s, 2H), 8.32 (d, J = 
9.0 Hz, 4H), 7.97 (d, J = 8.7 Hz, 4H), 7.75 (d, J = 5.7 Hz, 2H), 7.57-7.36 (m, 6H), 6.56-
6.47 (m, 2H), 4.61 (dd, J = 8.7, 11.7 Hz, 2H), 4.26 (bs, 2H), 4.05 (dd, J = 3.9, 11.7 Hz, 
2H), 1.38 (s, 6H); 13C-NMR (CDCl3, 75 MHz): δ = 131.5, 129.5, 129.0, 128.7, 126.5, 
124.8, 123.5, 66.8, 54.1, 49.9, 23.8; Rf (EtOAc/heptane 2:1) = 0.29. 
 
2,2-Bis[(S)-4-(9-anthryl)-1,3-oxazolin-2-yl]propane ((S)-1g) 
To a solution of diamide (S)-12c (32 mg, 56 µmol) in 
CH2Cl2 (1 mL) at –78 °C was added (diethylamino)sulfur 
trifluoride (22 µl, 0.17 mmol). After stirring at rt for 10 
min, CH2Cl2 (10 mL) was added, the mixture was 
washed with saturated aqueous NaHCO3 (5 mL) and the 
aqueous layer was extracted with CH2Cl2 (5 mL). The combined organic layers were 
washed with saturated aqueous H2O (5 mL), the aqueous layer was extracted with 
CH2Cl2 (5 mL). The combined organic layers were dried (MgSO4) and concentrated in 
vacuo to yield the crude product as an off-white solid. Purification by column 
chromatography (EtOAc/heptane 1:3 to 1:2) resulted in isolation of (S)-1g as a white 
solid (28 mg, 93%), which was directly used for catalysis: IR: νmax (cm-1) = 3500-3050, 
3047, 2982, 2921, 1649, 1145; 1H-NMR (CDCl3, 300 MHz): δ = 8.42 (s, 2H), 8.37 (d, J = 
9.9 Hz, 4H), 8.00-7.94 (m, 4H), 7.39-7.34 (m, 8H), 6.81 (t, J = 10.8 Hz, 2H), 5.01 (dd, J = 
8.4, 11.4 Hz, 2H), 4.74 (dd, J = 8.4, 10.8 Hz, 2H), 1.84 (s, 6H); 13C-NMR (CDCl3, 75  
MHz): δ = 169.4, 131.5, 130.0, 128.6, 128.3, 126.7, 125.7, 124.5, 123.7, 73.8, 39.6, 24.5; Rf 
(EtOAc/heptane 1:3) = 0.23. 
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3 Investigation of the scope of aryl-substituted bisoxazoline ligands1 
3.1 Introduction 
Despite the variation of substituents introduced on the core of bisoxazoline 
ligands, there is not a superior ligand that gives the best results in every type of 
reaction. In case of alkyl substituents on C4, a common trend shows that increase of 
steric bulk of the substituent enhances the enantioselectivity. Thus, t-Bu-box 
generally results in better enantioselectivities than i-Pr- and Me-box. Very recently, 
the group of Moreno-Manas accomplished the synthesis of a new and even more 
bulky C4 alkyl-substituted bisoxazoline ligand, adamantyl-box (Adam-box).2 It was 
found that the use of this ligand in three different reactions resulted in similar 
enantioselectivity as previously observed for t-Bu-box (in all instances >95% ee).  
There are also reactions in which aryl-substituted box ligands provide better 
results than the alkyl-substituted analogues. The steric influence of aryl substituents 
has only once been studied by Desimoni and Faita and they observed that 
replacement of a phenyl by a 2-naphthyl substituent on the C4-position of the box 
ligand resulted in a slight increase of enantioselectivity.3 The differences between 
alkyl- and aryl-substituted box ligands are illustrated by a remarkable reversal of 
enantiofacial selectivity, which in several stereoselective reactions has been observed. 
A possible explanation may lie in the geometry of the metal centre, which will be 
further detailed in Chapter 4. 
3.2 Results and discussion 
The scope and limitations in catalytic enantioselective synthesis of (S)-1-Np-, 
(S)-2-Np- and (S)-9-Ant-box was probed via a series of reactions, i.e. Mukaiyama 
aldol and Michael reactions, hetero-Diels–Alder processes, allylic oxidations and 
allylic substitution reactions. The results will be discussed and compared to those 
obtained with (4S,5S)-diPh-box (1f)4 and commercially available (S)-Ph- and (S)-t-Bu-
box (Figure 3.1). Furthermore, we anticipated to identify reactions that could 
especially benefit from the use of box ligands with extended aryl groups. 
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Figure 3.1 Bisoxazoline ligands studied in this chapter 
3.2.1 Mukaiyama aldol reactions 
As a starting point, we tested aryl-substituted ligands in the Mukaiyama aldol 
reaction of methyl pyruvate (2) with silyl ketene acetal 3.5 Going from Ph-box (1b) to 
2-Np-box (1d), the effect of the steric influence is clearly shown by an increase of the 
ee, both in THF and in CH2Cl2 (Table 3.1, entries 2 and 4). The use of (4S,5S)-diPh-
box (entry 5) in CH2Cl2 afforded alcohol 4 with an improved ee of 68%. In contrast, 
the use of 1-Np-box in combination with Cu(OTf)2 only resulted in a decrease of 
enantioselectivity compared to Ph-box (entries 2 and 3). Apparently, 1-Np-box (1c) is 
not an appropriate ligand for this Mukaiyama aldol reaction, resulting in low 
enantioselectivity in THF (19% vs. 24% ee) and a total loss of enantioselectivity in 
CH2Cl2. A significantly higher ee (>94%) was observed in both solvents by using t-
Bu-box ligand (entry 1). Apparently, in this type of aldol reaction, the use of aryl-
substituted box ligands does not have a crucial influence on the stereochemical 
outcome of the reaction. 
Table 3.1 Results of the Mukaiyama aldol reaction 
Me
O
MeO
O
St-Bu
OTMS
St-Bu
OHO Me
MeO
O
+
2 3 (S)-4
box·Cu(OTf)2
-78 °C
 
entry ligand THF CH2Cl2 
  yield (%)a ee (%)b yield (%)a ee (%)b 
1 t-Bu-boxc 89 97 (S) >80 94 (S) 
2 Ph-boxc 73 24 (S) >80 46 (S) 
3 1-Np-box nd 19 (S) 75 3 (R) 
4 2-Np-box >95 31 (S) >95 60 (S) 
5 (4S,5S)-diPh-box 82 68 (S) — — 
a Isolated yields after chromatography. b Enantiomeric excesses were determined by chiral 
HPLC analysis on a Chiralcel OD column (hexane/IPA 99:1, 0.5 mL/min) or by GC analysis 
using a chiral β-CD column (150 °C). c Data correspond to literature values.5 
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3.2.2 Hetero-Diels–Alder reactions 
Another type of reaction in which methyl pyruvate was applied as the 
substrate in combination with [Cu(OTf)2box] complexes is the hetero-Diels–Alder 
reaction with Danishefsky´s diene (5).6 In both THF and CH2Cl2, we observed no 
significant differences between Ph-, 1-Np- and 2-Np-box (Table 3.2, entries 2-4). 
Replacement of Ph-box by 1-Np-box resulted in an increase in CH2Cl2 (13% to 19% 
ee, respectively) and a decrease in THF (35% to 22% ee, respectively). Comparing 2-
Np-box to Ph-box in THF, a similar excellent yield and a comparable enantiopurity 
(35% ee) was observed. An evident increase to 45% ee was seen in the presence of 9-
Ant-box (1e) in CH2Cl2 (entry 5). Clearly, the stereochemical outcome of this reaction 
is depending on the ligand that is used. The use of Ph- and 1-Np-box in THF led to a 
reversal of facial selectivity compared to t-Bu-box. Remarkably, 2-Np-box afforded 
the same enantiomer as was obtained in the presence of t-Bu-box. As mentioned 
before, this phenomenon of reversal of facial selectivity is generally observed by 
changing an alkyl- for an aryl-substituted box ligand. Interestingly, the 2-Np-box 
ligand, however, acts in a similar fashion as the alkyl-substituted box-ligands. 
Table 3.2 Results of the hetero-Diels–Alder reaction 
Me
O
MeO
O OTMS
OMe
OMe
MeO2C
O
+
2 5 (S)-6
box·Cu(OTf)2
-78 °C
 
 
entry ligand THF CH2Cl2 
  yield (%)a ee (%)b yield (%)a ee (%)b 
1 t-Bu-boxc 99 >95 (S) nd >98 (S) 
2 Ph-boxc 99 35 (R) nd 13 (S) 
3 1-Np-box 90 22 (R) nd 19 (S) 
4 2-Np-box >95 36 (S) — — 
5 9-Ant-box — — 82 45 (S) 
a Isolated yields after chromatography. b Enantiomeric excesses were determined by GC on a 
chiral γ-CD column (110 °C). c Data correspond to literature values.6 
3.2.3 Mukaiyama Michael addition reactions 
So far, extending the size of the aryl substituents on the box ligands did not 
give the desired enhancement in enantioselectivity. Therefore, we also decided to 
study a reaction, where the reaction centre is relatively remote from the coordination 
site, which may require an extended steric effect of the ligand. For example, we 
studied the Mukaiyama Michael reaction of silyl ketene acetal 3 with Knoevenagel 
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adduct 7 catalysed by [Cu(SbF6)2box] complexes in the presence of 1,1,1,3,3,3-
hexafluoro-propan-2-ol (HFIP), depicted in Table 3.3.7 
Indeed, we were pleased to find that catalysis by both 1-Np- and 2-Np-box 
afforded the addition product with good enantioselectivity (70% ee and 79% ee, 
respectively) being a significant improvement compared to Ph-box (52% ee). In this 
reaction, we also observed a reversal of enantiofacial selectivity: in this case, all aryl-
substituted box ligands afforded the opposite enantiomer compared to t-Bu-box. 
Again, the highest enantioselectivity was achieved using t-Bu-box as the ligand 
(>90% ee). From these results, it may be postulated that the use of extended aryl-
substituted bisoxazolines is more promising in reactions where the addition takes 
place at a functional group that is somewhat further away from the coordination site. 
Table 3.3 Results of the Mukaiyama Michael reaction 
Ph
MeO
O
OMe
O
St-Bu
OTMS
Ph
St-BuO
MeO
O
OMe
O
+
7 3 (S)-8
box·Cu(SbF6)2
HFIP, -78 °C
CH2Cl2/toluene
 
entry ligand yield (%)a ee (%)b 
1 t-Bu-boxc 99 >90 (R) 
2 Ph-boxc 67 56 (S) 
3 1-Np-box 55 70 (S) 
4 2-Np-box nd 79 (S) 
a Isolated yields after chromatography. b Enantiomeric excesses were determined by chiral 
HPLC analysis on a Chiralpak AD column (heptane/i-PrOH 98:2, 1.0 mL/min). c Data 
correspond to literature values.7 
3.2.4 Allylic oxidation reactions 
A completely different type of reaction in which bisoxazoline-based catalysts 
have been used, is the allylic oxidation of olefins. In the presence of tert-butyl 
perbenzoate as oxidant, cyclopentene can be converted into optically active benzoate 
11 (Table 3.4).8 Enantioselective formation of the C-O bond can be accomplished in 
the presence of 5 mol% of a Cu-catalyst. The catalyst complex was prepared from 
Cu(I), since Pfaltz and coworkers reported that a similar catalyst prepared from 
Cu(II) was distinctly less reactive and less selective.8c Recently, Thijs and coworkers 
performed the allylic oxidation of cyclopentene in the presence of [Cu(MeCN)4]PF6 in 
combination with (4S,5S)-diPh-box, affording benzoate 11 in 78% yield with 83% ee.8a 
In our hands, this reaction resulted in a comparable enantiopurity of 75% ee (Table 
3.4, entry 3). Although we did not determine isolated yields, the conversions seemed 
to be quantitative after a reaction time of four days based on GC analysis. In the 
presence of Ph- and 1-Np-box, benzoate 11 was obtained with only 42 and 45% ee, 
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respectively. Apparently, the presence of a phenyl substituent at the C5-position of 
the oxazoline ring is responsible for a significant increase in enantiopurity. 
Table 3.4 Results of the allylic oxidation of cyclopentene 
O
O
Ot-Bu
OBz
+
9 10 (S)-11
box·Cu(PF6)
CH2Cl2, rt
 
entry ligand ee (%)a 
1 Ph-box 42 (S) 
2 1-Np-box 45 (S) 
3 (4S,5S)-diPh-boxb 75 (S) 
a Enantiomeric excesses were determined by GC analysis using a chiral γ-CD column (125 °C). 
b Data correspond to literature values (78% cy, 83% ee).8a 
3.2.5 Allylic substitution reactions 
Another C-C bond forming process that affords optically active compounds 
in the presence of box ligands is the allylic substitution (Table 3.5).9 In addition, new 
non-symmetric P,N-ligands have been used9a and very recently, a new class of box 
ligands developed by Pericàs and Muller was applied in allylic substitutions.9b These 
latter box ligands bear, besides the regular substituent at C4, an additional ether 
substituent at the C5-position. Especially η3-allyl palladium complexes of aryl-
substituted box ligands led to excellent selectivities (see Section 2.1). 
Table 3.5 Results of the allyation of dimethyl malonate 
PhPh
OAc
MeO
O
OMe
O
PhPh
MeO
O
OMe
O
+
12 13 (R)-14
box
[Pd(η3-C3H5)Cl]2
BSA, KOAc
 
entry ligand yield (%)a ee (%)b 
1 t-Bu-box 0 — 
2 Ph-boxc >95 96 (R) 
3 1-Np-box >95 97 (R) 
4 2-Np-box >95 97 (R) 
a Isolated yields after chromatography. b Enantiomeric excesses were determined by chiral 
HPLC analysis on a Chiralpack AD column (hexane/i-PrOH 90:10, 0.8 mL/min). c Data 
correspond to literature values.9b 
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Therefore, we applied our series of aryl-substituted box ligands in the allylic 
substitution of (E)-1,3-diphenyl-2-propenyl acetate (12), using an in situ generated 
malonate nucleophile from dimethyl malonate (13), bis(trimethylsilyl)acetamide 
(BSA) and a catalytic amount of potassium acetate (Table 3.5).9 Surprisingly, in the 
presence of t-Bu-box the reaction did not proceed, whereas the use of Ph-, 1-Np- and 
2-Np-box afforded the desired product in high yield (>95%) and with excellent 
enantioselectivity (>95% ee). 
3.3 Reactions with imines 
In a search for new reactions involving box-derived catalysts, we replaced one 
of the complexing carbonyls by an imine functionality. In analogy with methyl 
pyruvate, which acts as a substrate in Mukaiyama aldol and hetero-Diels–Alder 
reactions, the corresponding α-iminoesters were synthesised and applied in these 
reactions.10,11 In the synthesis of different types of such imines, we noticed a 
significant difference in stability. This was also observed by Courtois and coworkers, 
who reported that the stability of N-alkylimines is dependent on the order of 
substitution of the N-substituent on the imine; thus, the order of stability is N-t-Bu > 
N-i-Pr > N-n-Pr.12 Therefore, we decided to synthesise relatively stable imines, with a 
secondary carbon attached to the nitrogen. We prepared imines 17a and 17b by 
addition of the corresponding amine to methyl glyoxylate hemiacetal, as depicted in 
Scheme 3.1.13 
OMe
OH
MeO
O
R R
NH2
CH2Cl2
H
N
MeO
O
R
R+
15 16
MS 3Å
17a (R = Me): 86%
17b (R = Ph): 85%  
Scheme 3.1 Synthesis of N-alkylimines imines 
3.3.1 Aza-Mukaiyama aldol reactions  
In order to develop an aza-version of the Mukaiyama aldol reaction, we 
applied imines 17a and 17b in a Strecker type reaction with silyl ketene acetal 3 
(Scheme 3.2). In the presence of t-Bu-box in combination with Cu(OTf)2, amines 18 
were formed, however, in low yield and virtually no enantioselectivity. We also 
prepared an N-methoxy-substituted analogue of imine 1714 and subjected it to similar 
aldol conditions. Unfortunately, no reaction took place and the imine was recovered 
after the reaction. Despite the fact that this imine is expected to coordinate more 
stongly to the metal, it is probably also significantly less reactive as a result of the 
electron-donating methoxy group. 
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N
MeO
O
St-Bu
OTMS
St-Bu
O
MeO
O
+
17a (R = Me)
17b (R = Ph)
3 18a (R = Me): 34% (2% ee)
18b (R = Ph): 47% (7% ee)
t-Bu-box
Cu(OTf)2
-78 °C
R
R NH
R
R
 
Scheme 3.2 Aza-Mukaiyama aldol reaction of imines 17 
3.3.2 Aza-Diels–Alder reaction 
Similar to the Mukaiyama aldol reaction, we wished to investigate an aza-
Diels–Alder reaction by applying imine 17b under the conditions that were 
previously described. Recently, Jørgensen and coworkers reported a similar aza-
Diels–Alder reaction on the N-tosyl-substituted analogue of imine 17.11a In the 
presence of t-Bu-box and Cu(OTf)2, the corresponding unsaturated piperidone was 
formed in 60% yield and with 10% ee; replacement of the catalyst by a [Zn(OTf)2(Ph-
box)] complex resulted in a slight increase of both yield and enantioselectivity (74% 
yield, 17% ee). 
Aza-Diels–Alder reaction of imine 17b in the presence of t-Bu-box in 
combination with both Cu(OTf)2 or Mg(OTf)2, afforded piperidone 19, but 
unfortunately with even lower enantioselectivities (Table 3.6, entries 1 and 2). 
Replacement of t-Bu-box by Ph-box resulted in a smooth conversion into Diels–Alder 
product 19, with moderate enantioselectivity; both Cu(II)- and Mg(II)-based catalysts 
resulted in a similar ee of 24% (entries 3 and 4). Although the use of Ph-box resulted 
in an enhanced enantioselectivity, we had the impression that the bulky substituent 
on the imine would always severely hamper coordination of the nitrogen to the 
catalyst and thus give poor selectivities. 
Table 3.6 Results of the aza-Diels–Alder reaction of imine 17b 
H
N
MeO
O
Ph
Ph
OTMS
OMe
N
O
Ph Ph
MeO
O
+
17b 5 19
box·Cu(OTf)2
THF, -78 °C
 
entry ligand Lewis acid yield (%)a ee (%)b 
1 t-Bu-box Cu(OTf)2 nd 2%c 
2 t-Bu-box Mg(OTf)2 nd 7% 
3 Ph-box Cu(OTf)2 >95% 24% 
4 Ph-box Mg(OTf)2 >95% 23% 
a Isolated yields after chromatography. b Enantiomeric excesses were determined by HPLC on 
a Chiralpak AD column (heptane/i-PrOH 97.5:2.5, 1 ml/min). c Absolute configuration of 
major enantiomer was not determined. 
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Clearly, the results with the imines were not very encouraging. While the 
reaction rate could be influenced by changing the nitrogen substituents, the 
enantioselectivities were in all cases rather low. This may either be due to the size or 
the electron-withdrawing effect of the nitrogen substituents (or even a combination 
of both), which lowers or even inhibits coordination to the metal ion. 
3.4 Approach towards a synthesis of tanikolide 
In a search for reactions that could favour the use of extended aryl-
substituted box ligands, we came across the silyl enol ether nucleophile 20.15 
Addition of this rather large nucleophile to methyl pyruvate in the presence of a 
Lewis acid in CH2Cl2 resulted in a mixture of dioxenone 21 and its TMS-protected 
analogue.16 The enantiopurity of the addition product was determined after removal 
of the silyl group by treatment of the mixture with TBAF (Table 3.7). In THF, solely 
unprotected alcohol 21 was obtained. In this reaction, a significant increase in 
enantioselectivity was observed by replacing Ph-box by 1-Np-box (16% to 51% ee in 
CH2Cl2 and 17% to 43% ee in THF). On the contrary, 2-Np-box only resulted in an 
improvement of enantioselectivity in CH2Cl2 (38% ee), whereas in THF dioxenone 21 
was obtained with only 10% ee. 
Table 3.7 Results of the addition reaction of silyl enol ether 20 to methyl pyruvate 
Me
O
MeO
O
O O
OTMS
HO Me O O
O
MeO
O
+
2 20 (S)-21
1) box·Cu(OTf)2
-78 °C
2) TBAF
 
entry ligand THF CH2Cl2a 
  yield (%)b ee (%)c yield (%)b ee (%)c 
1 t-Bu-box 76 74 (S)d >95 49 (S) 
2 Ph-box 68 17 (R) >95 16 (R) 
3 1-Np-box 82 43 (R) >95 51 (R) 
4 2-Np-box >95 10 (S) >95 38 (S) 
6 1g nd 26 (S) 95 18 (S) 
7 1h >95 40 (S) >95 23 (S) 
8 1i 78 39 (S) — — 
a In CH2Cl2, a mixture of TMS-protected and unprotected alcohol was observed. b Isolated 
yields after chromatography. c Enantiomeric excesses were determined by chiral HPLC 
analysis on a Chiralpak AD column (heptane/i-PrOH 95:5, 0.5 mL/min). d Geometry of the 
major enantiomer was tentatively assigned based on the outcome of the Mukaiyama aldol 
and hetero-Diels–Alder reaction to methyl pyruvate, with the use of (S)-t-Bu-box as ligand.6 
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Clearly, the stereochemical outcome of the reaction is strongly dependent on 
the ligand (vide infra). Interestingly, the use of Ph- and 1-Np-box led to a reversal of 
facial selectivity compared to t-Bu-box. In contrast, 2-Np-box afforded the same 
enantiomer as obtained in the presence of t-Bu-box. Again, this underlines the result 
of previous experiments (Section 3.2) that 2-Np-box to some extent resembles the 
behaviour of the t-Bu-box ligand. 
Besides the more conventional box ligands, we also applied the new 
substituted box ligands 1g-1i (Figure 3.2).17 The use of these ester-substituted box 
ligands in combination with Cu(OTf)2 in this addition reaction afforded dioxenone 21 
in good yield and with moderate enantioselectivity (Table 3.7, entries 6-8). The best 
result, however, for this addition was obtained using the [Cu(OTf)2t-Bu-box] 
complex in THF, resulting in 74% ee. In CH2Cl2, the 1-Np-box ligand performed 
slightly better than t-Bu-box, with the notification that the products were formed 
with opposite enantioselectivity. 
N
O
CO2R
Me
N
O
RO2C
Me
Ar Ar
1g (R = Me, Ar = Ph)
1h (R = Me, Ar = p-MeOC6H4)
1i  (R = t-Bu, Ar = Ph)  
Figure 3.2 Ester-substituted bisoxazoline ligands 1g-1i 
In a search for applications of dioxenones of types 21, we anticipated that the 
dioxenone structure might be a useful building block for a synthesis of the natural 
product (+)-tanikolide (22). This δ-lactone-containing bioactive compound was 
recently isolated from a lipid extract of the marine cyanobacterium Lymgbia 
majuscula, collected from Tanikeli Island, near Madagascar and exhibits antifungal 
activity against Candida albicans.18 Due to the presence of a quaternary carbon centre 
in the δ-lactone framework and its bioactivity, tanikolide has been an attractive target 
for synthetic organic chemists. So far, several syntheses of tanikolide have been 
reported, in racemic19 and enantiopure fashion.20 
We envisaged a completely new approach, involving the construction of the 
lactone moiety from the masked β-keto ester 23 (Scheme 3.3). This compound, in 
turn, may be obtained by reduction of the methyl ester that results from the addition 
of silyl enol ether 20 to α-keto ester 24. 
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O
HO
HOO OHO
(  )9
(  )9
O
MeO
O
(  )9 O O
OTMS
(R)-23(+)-22
(+)-tanikolide
+
24 20
 
Scheme 3.3 Retrosynthetic approach towards tanikolide 
The required α-keto ester 24 was obtained by addition of the Grignard 
reagent of 1-bromoundecane to dimethyl oxalate (Scheme 3.4).21 To study the 
required transformations in our synthesis of tanikolide, we initially prepared 
building block 27 in racemic form. Addition of dioxenone 20 in the presence of a 
[Cu(OTf)2bipyridine] complex afforded exclusively silylated tertiary alcohol 26. 
Deprotection of the resulting dioxenone 26 using TBAF was unsuccessful, but 
proceeded smoothly using HF·pyridine in CH2Cl2 in 81% yield.22 Subsequently, 
selective reduction of the ester in the presence of the dioxenone was accomplished 
using a mixture of BH3·SMe2 and NaBH4.23  
We anticipated that at elevated temperatures dioxenone 23 would undergo a 
retro-Diels–Alder reaction, to form the intermediate acylketene 28. Subsequent 
intramolecular attack of the proximate tertiary alcohol should then afford the desired 
lactone. Surprisingly, the intermediate ketene did not cyclise, but instead underwent 
a retro-aldol reaction leading to 1-hydroxytridecan-2-one (29). Indeed, aldol reactions 
are known to disfavour products bearing tertiary alcohols, whereas the 
corresponding secondary alcohol products are usually formed smoothly.24 
(  )9Br (  )9
O O
O
HO
HO (  )9 O
HO
HO O(  )9 HO
O
(  )9
RO O O
O
MeO
O
O
MeO
O
(  )9
1) Mg, I2, THF
OO
OTMS
BH3·SMe2
HF·pyridine
27 (R = H): 81%
26 (R = TMS): 93%
20
NaBH4, THF
25
2) (CO2Me)2
     Et2O
24
45%
bipy·Cu(OTf)2
THF, -78 °C
29
83%
23
74%
xylenes
reflux
28
 
Scheme 3.4 Synthesis of and retro-Diels–Alder reaction of dioxenone 23 
In evaluating alternative methods to synthesise the required lactone, we came 
across a route developed in the group of Kaneko.25 They described the synthesis of β-
keto γ-lactones in refluxing toluene via ring opening to the acyl ketene followed by 
intramolecular ketene trapping (method A, Scheme 3.5). However, application of this 
method on 6-(2-hydroxyalkyl)dioxenones did not afford β-keto δ-lactones but instead 
complex mixtures of dimers and trimers of the corresponding hydroxy acyl ketene 
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species. To circumvent this, they developed a new method in which the dioxenones 
were treated with K2CO3 in MeOH (method B). Under these conditions, potassium 
methoxide-mediated dioxenone ring opening took place, followed by base-catalysed 
cyclisation, giving access to both five- and six-membered lactones. 
We applied method B for the conversion of masked β-keto ester 23 into the 
corresponding six-membered lactone. However, treatment of dioxenone 23 in the 
presence of K2CO3 in MeOH did not afford a clean conversion into the corresponding 
lactone. It should be noted that Kaneko applied this method (K2CO3 in MeOH) only 
on systems bearing secondary alcohol groups.25 Apparently, the tertiary alcohol in 
our system is not sufficiently nucleophilic to induce clean lactonisation. 
O
R
HO
O
O O
OR
OH
O O
OR
OH O
R OMe
OHO
OO
O
R(  )n(  )n
(  )n (  )n
K2CO3
31
(n = 0,1)
34
(n = 0,1)
36
(n = 1)
toluene
reflux
30
(n = 0,1)
MeOH, rt
30
(n = 0,1)
Method A:
Method B:
OO
O O R
R O O
OO R
O
OO R
O
or
or
35
(n = 0)
33
(n = 1)
32
(n = 0)
 
Scheme 3.5 Formation of lactones from the corresponding 6-hydroxyalkyldioxenones 
Alternatively, an attempt was made to synthesise the lactone in two separate 
steps, again via ring opening of dioxenone 23 to the corresponding β-keto ester 
under reflux conditions. To avoid the retro-aldol reaction that occurs at elevated 
temperatures, both alcohols were protected as an isopropylidene acetal.26 As 
depicted in Scheme 3.6, the dioxenone was then opened under reflux conditions in 
the presence of methanol to obtain the corresponding β-keto methyl ester and its enol 
tautomer (as a 4:1 mixture).27 We envisaged that deprotection of the alcohols would 
lead to attack of the primary alcohol onto the ketone, giving rise to the five-
membered lactol. Therefore, we tried to protect the ketone function using 
ethanedithiol and BF3·OEt2.28 Much to our surprise, the single product that was 
formed under these conditions turned out not to be the desired lactone, but furan 41. 
A plausible mechanism for this remarkable transformation is depicted in Scheme 3.6. 
In the presence of a Lewis acid, β-elimination of the tertiary hydroxyl substituent 
occurs, affording intermediate 39. As envisaged, subsequent attack of the primary 
alcohol onto the ketone afforded lactol 40, which was in situ dehydrated to furan 41. 
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MeO OMe MeOH
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81%
38
95%
toluene
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79%
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Scheme 3.6 Formation of furan 41 in the presence of Lewis acid 
Since the ultimate formation of undesired furan 41 was to a large extent 
attributed to the presence of the ketone function in 38, we decided to alter our 
strategy and perform a hydrogenation on dioxenone 23. A concomitant advantage is 
that protection of the primary and tertiary alcohols is no longer necessary. Thus, the 
dioxenone was reduced in the presence of a Rh-alumina catalyst under 35 bar of H2-
pressure.29 Subsequent treatment with p-toluenesulfonic acid at rt induced ring 
opening of the dioxanone and presumably in situ closure to lactone 43 (Scheme 3.7). 
Stirring in the presence of acetic anhydride then resulted in acetylation of the 
remaining alcohol functions. In the presence of DBU, the secondary acetate was 
eliminated to afford the α,β-unsaturated lactone 45. Unfortunately, at this point the 
amount of available material did not allow continuation of the synthesis, although in 
principle only two steps remain for the completion, i.e. hydrolysis of the primary 
acetate with K2CO3 in methanol and hydrogenation of the double bond according to 
a literature procedure.20c 
O O
O
HO
HO (  )9
O
OH
OHO
(  )9
O OAcO
OAc
ClCH2CH2Cl
reflux
O O
O
HO
HO
DBU
1) K2CO3
     MeOH
2) Pd/C, H2toluene O OHOO OAcO
(  )9 (  )9(  )9
(  )9
Ac2O
H2 (35 bar)
Rh/Al2O3
TsOH
23 42
94%
43
94%
toluene
44
83%
45
84%
22
 
Scheme 3.7 Towards a synthesis of (±)-tanikolide (22) 
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3.5 Conclusions 
Our studies towards the application of aryl-substituted box ligands afforded 
several interesting results. Firstly, the influence of enlargement of the C4-aryl 
substituent was not unambiguous, especially not in the Mukaiyama aldol reaction 
and in the hetero-Diels–Alder reaction. However, in the latter reaction, the use of 9-
Ant-box did result in an enhancement of the enantioselectivity (45% ee compared to 
13% ee for Ph-box). In the allylic substitution reactions, all aryl-substituted box 
ligands afforded the product in excellent yields and enantiopurities (>95% ee). 
A more evident effect of enlargement of the aryl substituent on the 
enantioselectivity was observed in the Mukaiyama Michael reaction, in which both 1-
Np and 2-Np-box resulted in a clear improvement of the enantiopurity. Evidently, 
the constructive influence of extension of the aryl substituent can be clearly observed 
in a reaction where the distance between reaction centre and coordination site is 
relatively large. 
Attempting to find new reactions, we performed the aza-version of the 
Mukaiyama aldol and the Diels–Alder reaction, affording the corresponding 
products, unfortunately with only low enantioselectivities. Addition of a more bulky 
nucleophile, i.e. silyl enol ether 20, to methyl pyruvate afforded masked α-keto esters 
21 in good yield and ee. This resulted in a remarkably higher enantioselectivity for 
especially 1-Np-box compared to the Ph-box. Addition to the extended α-keto ester 
24 resulted in an dioxenone, which was utilised as key intermediate in a synthetic 
approach towards natural product (+)-tanikolide. 
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3.7 Experimental section 
General methods 
For general experimental details, see Section 2.9. 
HPLC´s were run using a Shimadzu CLASS-VP instrument, equipped with a 
Chiralpak AD column and a Chiralcel OD column. GC´s were run using a Hewlett-
Packard 5890 instrument, equipped with a HP-1701 polar capillary column of Agilent 
(30 m, 0.25 mm ID, 0.25 µm film thickness) using N2 as carrier gas. For chiral GC, a 
Hewlett-Packard 6890 instrument was used, equipped with a BetaDEX 120TM fused 
silica capillary column of Supelco (60 m, 0.25 mm ID, 0.25 µm film thickness) and a 
 
Chapter 3 
60 
 
GammaDEX 120TM fused silica capillary column of Superco (30 m, 0.25 mm ID, 0.25 
µm film thickness) with H2 as carrier gas. 
 
Materials 
Silyl ketene acetal 3 was prepared according to the method published by Evans;30 2-
benzylidenemalonic acid dimethyl ester (7) was prepared according to the method 
published by Castedo and Dominguez;31 (E)-1,3-diphenyl-1-propenylacetate (14) was 
prepared according to the method published by Mayr;32 (2,2-dimethyl-6-methylene-
6H-[1,3]dioxin-4-yloxy)trimethylsilane (21) was prepared according to the method 
published by Krohn and Schafer.33 
 
Representative experimental procedure for the Mukaiyama aldol reaction to thioacetate 4 
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 
µmol) and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under 
vacuum for 0.5 h and THF (1.0 mL) was added to afford a blue 
solution.34 After stirring for 1 h, methyl pyruvate (2, 25 µL, 0.28 mmol) was added 
and the mixture was cooled to –78 °C. After addition of silyl ketene acetal 330 (83 µL, 
0.34 mmol), the mixture was allowed to warm to rt overnight. Et2O (10 mL) was 
added and the mixture was washed using saturated aqueous NaHCO3 (10 mL), H2O 
(10 mL) and brine (10 mL). The organic layer was dried (MgSO4) and concentrated in 
vacuo. Flash chromatography (EtOAc/heptane 1:9 to 1:4) afforded 4 as a colourless 
oil (58 mg, 89%): the ee was determined by HPLC to be 97%: OD column; hexane/i-
PrOH 99:1; 0.5 mL/min; tR(minor) = 14.9 min (R), tR(major) = 16.0 min (S); 1H-NMR 
(CDCl3, 200 MHz): δ = 3.80 (s, 3H), 3.72 (bs, 1H), 3.08 (d, J = 15.9 Hz, 1H), 2.83 (d, J = 
15.8, 1H), 1.45 (s, 9H), 1.41 (s, 3H). 
 
Representative experimental procedure for the hetero-Diels–Alder reaction to pyran 6 
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 µmol) 
and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under vacuum for 
0.5 h and distilled anhydrous THF (1.0 mL) was added. After stirring 
for 1 h, methyl pyruvate (2) (25 µL, 0.28 mmol) was added and the 
mixture was cooled to –78 °C. After addition of Danishefsky´s diene 5 (72 µL, 0.34 
mmol), the mixture was allowed to warm to rt overnight. Et2O (10 mL) was added 
and the mixture was washed using saturated aqueous NaHCO3 (10 mL), H2O (10 
mL) and brine (10 mL). The organic layer was dried (MgSO4) and concentrated in 
vacuo, affording 6 as a slightly yellow oil (47 mg, 99%): the ee was determined by GC 
to be >95%: chiral γ-CD column (110 °C), tR (minor) = 15.7 min (R), tR(major) = 16.4 
min (S); 1H-NMR (CDCl3, 300 MHz): δ = 7.54 (d, J = 12.6 Hz, 1H), 5.58 (d, J = 12.6 Hz, 
1H), 3.68 (s, 3H), 3.00 (d, 1.49, J = 16.5 Hz, 1H), 2.68 (d, J = 16.5 Hz, 1H), 1.49 (s, 3H). 
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Representative experimental procedure for the Mukaiyama Michael reaction to diester 8 
To a flame-dried Schlenk tube was added CuCl2 (7.3 mg, 54 µmol) 
and (S)-1a (17 mg, 59 µmol). The mixture was dried under vacuum 
for 0.5 h and distilled anhydrous CH2Cl2 (2.0 mL) was added. After 
stirring overnight, the solvent was removed in vacuo. The resulting 
fluorescent green solids were dissolved in CH2Cl2 (0.54 mL) and the flask was 
protected from light. After addition of AgSbF6 (37 mg, 0.11 mmol), the mixture was 
stirred for 4 h at rt. The white solids (AgCl) were removed by filtering the solution 
through an oven-dried glass pipette tightly packed with cotton. The resulting 
turquoise solution contained Cu(SbF6)2-tBu-box catalyst complex (0.1 M in CH2Cl2). 
Alkylidene malonate 731 (60 mg, 0.27 mmol) and 1,1,1,3,3,3-hexafluoro-2-propanol 
(HFIP) (50 µL, 0.46 mmol) were dissolved in toluene (0.7 mL) and the mixture was 
cooled to –78 °C. After addition of the Cu(SbF6)2-tBu-box catalyst solution (0.1 M in 
CH2Cl2, 0.54 mL, 54 µmol), the mixture was stirring for 1 h at –78 °C. Silyl ketene 
acetal 330 (0.10 mL, 0.41 mmol) was added and the mixture was allowed to warm to rt 
overnight. The mixture was concentrated in vacuo. Flash chromatography 
(EtOAc/heptane 1:5) afforded 8 as a white solid (94 mg, 99%): the ee was determined 
by HPLC to be >90%: OD column; hexane/i-PrOH 98:2; 1.0 mL/min; tR(major) = 14.1 
min (R), tR(minor) = 15.6 min(S); 1H-NMR (CDCl3, 200 MHz): δ = 7.34–7.19 (m, 5H), 
3.95 (dt, J = 5.4, 10.0 Hz, 1H), 3.80 (t, J = 10.0 Hz, 1H), 3.75 (s, 3H), 3.49 (s, 3H), 3.01–
2.84 (m, 2H), 1.31 (s, 9H). 
 
Representative experimental procedure for the allylic oxidation reaction to benzoate 11 
To a flame-dried Schlenk tube was added Cu(PF6)(CN)6 (7.5 mg, 20 µmol) and 
(S)-1b (7.6 mg, 22 µmol). The mixture was dried under vacuum for 0.5 h and 
distilled anhydrous CH2Cl2 (1.0 mL) was added. After stirring for 1 h, 
cyclopentene (9) (0.18 mL, 2.0 mmol) and tert-butyl peroxybenzoate (10) (38 µL, 0.2 
mmol) were added and the mixture was stirred for 4 days: the ee was determined 
from the crude reaction mixture by GC to be 73%: chiral γ-CD column (125 °C); 
tR(minor) = 11.1 min; tR(major) = 11.5 min (S); 1H-NMR (CDCl3, 300 MHz): δ = 8.06–
8.01 (m, 2H), 7.58–7.50 (m, 1H), 7.46–7.39 (m, 2H), 5.19–6.12 (m, 1H), 5.98–5.94 (m, 
2H), 2.45–2.29 (m, 2H), 2.04–1.98 (m, 2H). 
 
Representative experimental procedure for the allylic substitution reaction to acetate 14 
To a flame-dried Schlenk tube was added [Pd(η3-C3H5)Cl]2 (4.8 mg, 
13 µmol) and (S)-1b (13 mg, 39 µmol). The mixture was dried under 
vacuum for 0.5 h and distilled anhydrous CH2Cl2 (1.0 mL) was 
added. After stirring for 1 h, acetate 1232 (101 mg, 0.48 mmol), malonate 13 (0.14 mL, 
1.2 mmol), bis(trimethylsilyl)acetamide (BSA) (0.30 mL, 1.8 mmol) and KOAc (2 mg, 
20 µmol) were added and the mixture was stirred overnight. Et2O (10 mL) was added 
and the mixture was washed using saturated aqueous NH4Cl (10 mL), H2O (10 mL) 
and brine (10 mL). The organic layer was dried (MgSO4) and concentrated in vacuo. 
Flash chromatography (EtOAc/heptane 1:15) afforded 14 as a colourless oil (ca 150 
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mg, >95%): the ee was determined by HPLC to be 96%: AD column; hexane/i-PrOH 
90:10; 0.8 mL/min; tR(minor) = 17.3 min (S), tR(major) = 20.8 min (R); 1H-NMR 
(CDCl3, 300 MHz): δ = 7.31–7.13 (m, 10H), 6.45 (d, J = 15.9 Hz, 1H), 6.30 (dd, J = 8.4, 
15.6 Hz, 1H), 4.25 (dd, J = 8.4, 10.8 Hz, 1H), 6.30 (dd, J = 8.4, 15.6 Hz, 2H), 3.93 (d, J = 
10.8 Hz, 1H), 3.69 (s, 3H), 3.51 (s, 3H). 
 
Isopropylimino-acetic acid methyl ester (17a)12 
According to a procedure of Stella, imine 17a was synthesised.13 To a 
suspension of methyl glyoxylate hemiacetal (4.7 g, 39 mmol) and 
powdered mol sieves (3Å) in CH2Cl2 (10 ml) was added 
isopropylamine (3.4 ml, 39 mmol). After stirring overnight at rt, the 
mixture was filtrated and concentrated in vacuo, affording crude imine 17a as a 
yellow oil (4.3 g, 86%), which was directly used in the next reaction: 1H-NMR (CDCl3, 
300 MHz): δ = 7.73 (s, 1H), 3.88 (s, 3H), 3.67–3.55 (m, 1H), 1.27 (d, J = 6.3 Hz, 6H). 
 
Benzhydrylimino-acetic acid methyl ester (17b) 
According to a procedure of Stella, imine 17b was synthesised.13 To a 
solution of methyl glyoxylate hemiacetal (4.3 g, 36 mmol) and 
powdered mol sieves (3Å) in CH2Cl2 (10 ml) was added α-
aminodiphenylmethane (6.2 ml, 36 mmol). The temperature of the 
mixture was allowed to rise to 40 °C. After stirring for 2 days at rt, the mixture was 
filtered and concentrated in vacuo. Recrystallisation (heptane) afforded 17b as a 
white solid (7.7 g, 85%): 1H-NMR (CDCl3, 300 MHz): δ = 7.79 (s, 1H), 7.42–7.26 (m, 
10H), 5.68 (s, 1H), 3.88 (s, 3H). 
 
Mukaiyama aldol reaction to thioacetate 18a 
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 
µmol) and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under 
vacuum for 0.5 h and distilled anhydrous THF (1.0 mL) was 
added. After stirring for 1 h, imine (17a) (36 mg, 0.28 mmol) was 
added and the mixture was cooled to –78 °C. After addition of silyl ketene acetal 330 
(83 µL, 0.34 mmol), the mixture was allowed to warm to rt overnight and stirred for 
another 2 days. Et2O (10 mL) was added and the mixture was washed using 
saturated aqueous NaHCO3 (10 mL), H2O (10 mL) and brine (10 mL). The organic 
layer was dried (MgSO4) and concentrated in vacuo. Flash chromatography 
(EtOAc/heptane 1:4) afforded 18a as a yellow oil (25 mg, 34%): the ee was 
determined by HPLC to be 2%: OD column (heptane/i-PrOH 99.5:0.5, 0.5 ml/min), 
tR(major) = 19.7 min, tR(minor) = 23.1 min; 1H-NMR (CDCl3, 300 MHz): δ = 3.73–3.67 
(m, 1H), 3.69 (s, 3H), 2.79–2.72 (m, 3H), 1.73 (bs, 1H), 1.42 (s, 9H), 0.99 (d, J = 6.2 Hz, 
3H), 0.97 (d, J = 6.2 Hz, 3H); 1H-NMR (C6D6, 75 MHz): δ  = 3.81 (t, J = 6.4 Hz, 1H), 3.33 
(s, 3H), 2.79-2.68 (m, 3H), 1.37 (s, 9H), 0.92 (d, J = 6.2 Hz, 3H), 0.90 (dd, J = 6.2 Hz, 
3H). 
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Mukaiyama aldol reaction to thioacetate 18b 
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 
µmol) and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under 
vacuum for 0.5 h and THF (1.0 mL) was added. After stirring for 1 
h, imine 17b (71 mg, 0.28 mmol) was added and the mixture was 
cooled to –78 °C. After addition of silyl ketene acetal 330 (83 µL, 0.34 mmol), the 
mixture was allowed to warm to rt overnight and stirred for another 2 days. Et2O (10 
mL) was added and the mixture was washed using saturated aqueous NaHCO3 (10 
mL), H2O (10 mL) and brine (10 mL). The organic layer was dried (MgSO4) and 
concentrated in vacuo. Flash chromatography (EtOAc/heptane 1:4) afforded 18b as a 
yellow oil (51 mg, 47%): the ee was determined by HPLC to be 7%: OD column 
(heptane/i-PrOH 99.5:0.5, 0.5 ml/min), tR(minor) = 30.2 min, tR(major) = 35.4 min; 
1H-NMR (CDCl3, 300 MHz): δ = 7.43–7.18 (m, 10H), 4.92 (s, 1H), 3.72 (s, 3H), 3.60 (m, 
1H), 2.81 (d, J = 6.3 Hz, 2H), 2.36 (bs, 1H), 1.48 (s, 9H); Rf (EtOAc/heptane 1:4) = 0.4. 
 
Representative experimental procedure for the aza-Diels–Alder reaction of imine 17 
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 µmol) 
and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under vacuum 
for 0.5 h and THF (1.0 mL) was added. After stirring for 1 h, imine 17b 
(71 mg, 0.28 mmol) was added and the mixture was cooled to –78 °C. 
After addition of Danishefsky´s diene 5 (72 µL, 0.34 mmol), the mixture was allowed 
to warm to rt overnight. Et2O (10 mL) was added and the mixture was washed using 
saturated aqueous NaHCO3 (10 mL), H2O (10 mL) and brine (10 mL). The organic 
layer was dried (MgSO4) and concentrated in vacuo, affording 19 as a yellow oil (85 
mg, 95%), which could be purified by recrystallisation (EtOAc/heptane) afforded 19 
as orange solids: the ee was determined by HPLC to be 2%: AD column (heptane/i-
PrOH 97.5:2.5, 1 ml/min), tR (minor) = 35.2 min, tR (major) = 39.1 min; 1H-NMR 
(CDCl3, 300 MHz): δ = 7.49–7.24 (m, 10H), 6.85 (d, J = 7.7 Hz, 1H), 5.77 (s, 1H), 4.93 
(bd, J = 7.8 Hz, 1H), 4.23–4.19 (m, 1H), 3.79 (s, 3H), 2.91–2.84 (m, 2H); Rf 
(EtOAc/heptane 1:4) = 0.1. 
 
Representative experimental procedure for the Mukaiyama aldol reaction to dioxenone 21  
To a flame-dried Schlenk tube was added Cu(OTf)2 (10 mg, 28 
µmol) and (S)-1a (9.0 mg, 31 µmol). The mixture was dried under 
vacuum for 0.5 h and THF (1.0 mL) was added. After stirring for 
1 h, methyl pyruvate (2) (25 µL, 0.28 mmol) was added and the 
mixture was cooled to –78 °C. After addition of 2033 (66 µL, 0.34 mmol), the mixture 
was allowed to warm to rt overnight. Et2O (10 mL) was added and the mixture was 
washed using saturated aqueous NaHCO3 (10 mL), H2O (10 mL) and brine (10 mL). 
The organic layer was dried (MgSO4) and concentrated in vacuo, affording a mixture 
of addition product 21 and its TMS-protected analogue. 
Optional: To a solution of the crude mixture (0.28 mmol) in THF (10 mL) at –78 °C 
was added TBAF (1 M in THF, 0.28 mL, 0.28 mmol) and the orange solution 
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immediately became green. After stirring for 4 h at rt, saturated aqueous NH4Cl (5 
mL) was added. The mixture was extracted using Et2O (3 × 10 mL), dried (MgSO4) 
and concentrated in vacuo. 
This afforded alcohol 21 as a yellow oil (52 mg, 76%): the TMS/H ratio was 
determined by NMR analysis of the methoxy signal: 1H-NMR (300 MHz, CDCl3): δ = 
3.81 ppm (21), 3.73 ppm (TMS-protected 21); the ee was determined to be 74%: AD 
column; heptane/i-PrOH 95:5; 0.5 mL/min; tR(major) = 37.5 min (S), tR(minor) = 46.6 
min (R); IR: νmax (cm-1) = 3491, 2997, 2953, 2251, 1730; 1H-NMR (CDCl3, 300 MHz): δ = 
5.30 (s, 1H), 3.82 (s, 3H), 3.32 (bs, 1H), 2.84 (AB-d, J = 14.6 Hz, 1H), 2.57 (AB-d, J = 14.6 
Hz, 1H), 1.65 (s, 6H), 1.48 (s, 3H); 13C-NMR (CDCl3, 75 MHz): δ = 176.2, 168.7, 166.9, 
106.8, 96.2, 72.9, 53.0, 43.5, 27.0, 25.8, 24.0. 
 
 2-Oxotridecanoate (24) 
To a suspension of Mg (0.36 g, 15 mmol) and I2 (cat.) in THF (1 mL) 
was added dropwise a solution of bromide 25 (3.3 mL, 15 mmol) in 
THF (10 ml). The mixture was stirred for 1 h, resulting in a 
suspension containing the Grignard reagent. This was transferred dropwise via a 
cannula to a solution of dimethyl oxalate (1.60 g, 14 mmol) in Et2O (10 mL) at –78 °C. 
After stirring for 1 h at –78 °C, the mixture was quenched at –78 °C using aqueous 
HCl (1 M, 25 mL) and allowed to warm to rt. The aqueous layer was extracted using 
Et2O (3 × 10 mL) and the combined organic layers were washed with brine (50 mL), 
dried (MgSO4) and concentrated in vacuo. Flash chromatography (EtOAc/heptane 
1:9) afforded 24 as colourless oil (1.53 g, 45%): 1H-NMR (CDCl3, 300 MHz): δ = 3.85 (s, 
3H), 2.82 (t, J = 7.4 Hz, 2H), 1.71–1.53 (m, 2H), 1.38–1.17 (m, 16H), 0.94–0.82 (m, 3H); 
13C-NMR (CDCl3, 75 MHz): δ = 193.9, 161.3, 53.0, 39.5, 32.1, 29.8, 29.7, 29.6, 29.5, 29.4, 
29.1, 23.2, 22.9, 14.3. 
 
2-(2,2-Dimethyl-6-oxo-6H-[1,3]dioxin-4-ylmethyl)-2-trimethylsilyloxytridecanoic acid 
methyl ester 26  
To a flame-dried Schlenk tube was added Cu(OTf)2 (83 mg, 0.23 
mmol) and bipyridine (39 mg, 0.25 mmol). The mixture was 
dried under vacuum for 0.5 h and distilled anhydrous THF (10 
mL) was added. After stirring for 1 h, α-keto ester 24 (519 mg, 2.1 
mmol) was added and the mixture was cooled to 0 °C. After addition of 2033 (0.62 
mL, 3.2 mmol), the mixture was allowed to warm to rt overnight. Saturated aqueous 
NaHCO3 (25 mL) was added and the mixture was extracted using EtOAc (3 × 50 mL). 
The combined organic layers were washed using brine (50 mL), dried (MgSO4) and 
concentrated in vacuo, affording a mixture of addition product 27 (<5%) and its 
TMS-protected analogue 26 (main product). Flash chromatography (EtOAc/heptane 
1:4) afforded 26 as a colourless oil (906 mg, 93%): 1H-NMR (CDCl3, 300 MHz): δ = 
5.27 (bs, 1H), 3.73 (s, 3H), 2.70 (AB-d, J = 20.9 Hz, 1H), 2.58 (AB-d, J = 21.5 Hz, 1H), 
1.79–1.63 (m, 2H), 1.65 (s, 6H), 1.40–1.19 (m, 18H), 0.97–0.82 (m, 3H), 0.14 (s, 9H); Rf 
(EtOAc/heptane 1:4) = 0.29. 
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2-(2,2-Dimethyl-6-oxo-6H-[1,3]dioxin-4-ylmethyl)-2-hydroxytridecanoic acid methyl ester 
(27) 
To a solution of the dioxenone 26 (853 mg, 1.9 mmol) in CH2Cl2 
(10 mL) in a teflon vial was added HF·pyridine (65–70%, 5.0 mL, 
ca 0.18 mol). After stirring for 2 h at rt, the mixture was 
quenched using saturated aqueous NaHCO3 (150 mL) and 
extracted using CH2Cl2 (7 × 50 mL), dried (MgSO4) and concentrated in vacuo, 
affording dioxenone 27 as a yellow solid (0.58 g, 81%), which could be purified by 
recrystallisation (EtOAc/heptane) to obtain 27 as a white solid: 1H-NMR (CDCl3, 300 
MHz): δ = 5.26 (bs, 1H), 3.79 (s, 3H), 3.31 (bs, 1H), 2.79 (AB-d, J = 14.4 Hz, 1H), 2.55 
(AB-d, J = 14.4 Hz, 1H), 1.82–1.66 (m, 2H), 1.63 (s, 6H), 1.36–1.17 (m, 18H), 0.94–0.76 
(m, 3H); Rf (EtOAc/heptane 1:4) = 0.17. 
 
6-(2-Hydroxy-2-hydroxymethyltridecyl)-2,2-dimethyl-[1,3]dioxin-4-one (23) 
To a solution of the crude methyl ester 27 (431 mg, 1.12 mmol) in 
THF (40 mL) were added BH3·SMe2 (2.0 M in THF, 0.65 mL, 1.3 
mmol) and NaBH4 (80 mg, 2.1 mmol). After stirring for 4 h, the 
mixture was quenched using saturated aqueous NaHCO3 (10 mL) and THF was 
removed in vacuo. After addition of H2O (15 mL), the mixture was extracted using 
CH2Cl2 (5 × 50 mL) and EtOAc (2 × 100 mL), dried (MgSO4) and concentrated in 
vacuo, affording 23 as a yellow oil (296 mg, 74%) which was purified by flash 
chromatography (EtOAc/heptane 1:1) to obtain 23 as a white solid: 1H-NMR (CDCl3, 
300 MHz): δ = 5.33 (s, 1H), 3.51 (d, J = 4.8 Hz, 2H), 2.51 (AB-d, J = 13.8 Hz, 1H), 2.43 
(AB-d, J = 14.1 Hz, 1H), 2.25 (s, 1H), 1.99–1.88 (m, 1H), 1.71 (s, 6H), 1.59–1.47 (m, 4H), 
1.41–1.17 (m, 16H), 0.96–0.79 (m, 3H); Rf (EtOAc/heptane 1:1) = 0.22. 
 
1-Hydroxytridecan-2-one (29) 
A solution of dioxenone 23 (10 mg, 28 µmol) in xylenes (10 mL) was 
degassed for 1 h. After refluxing for 5 h, the mixture was concentrated 
in vacuo, affording crude 29  as a colourless oil (5 mg, 83%): 1H-NMR (CDCl3, 300 
MHz): δ = 3.63 (s, 2H), 2.40–2.39 (m, 1H), 1.92 (d, J = 10.8 Hz, 1H), 1.39–1.14 (m, 16H), 
0.97–0.75 (m, 3H). 
 
6-(2,2-Dimethyl-4-undecyl-[1,3]dioxolan-4-ylmethyl)-2,2-dimethyl-[1,3]dioxin-4-one (37) 
To a solution of dioxenone 23 (10 mg, 28 µmol) and pyridinium p-
toluenesulfonate (PPTS, 4 mg, 16 µmol) in CH2Cl2 (5 mL) was 
added 2,2-dimethoxypropane (18 µL, 0.15 mmol). After stirring 
overnight, the mixture was concentrated in vacuo. After addition of EtOAc (25 mL), 
the mixture was extracted using saturated aqueous NaHCO3 (2 × 10 mL), H2O (2 × 10 
mL) and brine (2 × 10 mL), dried (MgSO4) and concentrated in vacuo. Flash 
chromatography (EtOAc/heptane 1:4) afforded 37 as a colourless oil (9.0 mg, 81%): 
1H-NMR (CDCl3, 300 MHz): δ = 5.30 (s, 1H), 3.89 (AB-d, J = 8.7 Hz, 1H), 3.75 (AB-d, J 
= 8.7 Hz, 1H), 2.54 (AB-d, J = 13.8 Hz, 1H), 2.46 (AB-d, J = 13.8 Hz, 1H), 1.68 (s, 6H), 
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1.61–1.54 (m, 4H), 1.41 (s, 3H), 1.36 (s, 3H), 1.34–1.19 (m, 16H), 0.93–0.82 (m, 3H); Rf 
(EtOAc/heptane 1:1) = 0.72, Rf (EtOAc/heptane 1:4) = 0.31. 
 
4-(2,2-Dimethyl-4-undecyl-[1,3]dioxolan-4-yl)-3-oxobutyric acid methyl ester (38) 
To a solution of dioxenone 37 (9.0 mg, 23 µmol) in toluene (5 
mL) was added MeOH (40 µL, 99 µmol). After refluxing for 2 h, 
the mixture was allowed to cool down to rt and concentrated in 
vacuo, affording 38 as a colourless oil (8.0 mg, 95%): 1H-NMR 
(CDCl3, 300 MHz): δ = 3.88 (s, 2H), 3.72 (s, 3H), 3.52 (s, 2H), 2.94 (AB-d, J = 15.9 Hz, 
1H), 2.73 (AB-d, J = 15.9 Hz, 1H), 1.73–1.55 (m, 4H), 1.38 (s, 6H), 1.36–1.14 (m, 16H), 
0.92–0.80 (m, 3H); Rf (EtOAc/heptane 1:1) = 0.80, Rf (EtOAc/heptane 1:9) = 0.16. 
 
(4-Undecylfuran-2-yl)acetic acid methyl ester (41) 
To a solution of methyl ester 38 (8.0 mg, 22 µmol) in CH2Cl2 (5 
mL) were added 1,2-ethanedithiol (9 µL, 0.11 mmol) and 
BF3·OEt2 (11 µL, 87 µmol). After stirring overnight, saturated 
aqueous NaHCO3 (5 mL) and CH2Cl2 (5 mL) were added. The aqueous layer was 
extracted using CH2Cl2 (3 × 10 mL), dried (MgSO4) and concentrated in vacuo. Flash 
chromatography (EtOAc/heptane 1:9) afforded 41 as a colourless oil (5 mg, 79%): IR: 
νmax (cm-1) = 2926, 2846, 1748; 1H-NMR (CDCl3, 300 MHz): δ = 7.09 (s, 1H), 6.08 (s, 
1H), 3.71 (s, 3H), 3.62 (s, 2H), 2.42–2.39 (m, 2H), 1.61–1.48 (m, 4H), 1.38–1.19 (m, 16H), 
0.96–0.80 (m, 3H); 13C-NMR (CDCl3, 75 MHz): δ = 170.0, 147.4, 138.2, 126.4, 109.7, 
52.2, 34.1, 31.9, 29.8, 29.7, 29.7, 29.6, 29.6, 29.4, 29.3, 24.9, 22.7, 14.1; Rf (EtOAc/heptane 
1:9) = 0.43. 
 
6-(2-Hydroxy-2-hydroxymethyltridecyl)-2,2-dimethyl-[1,3]dioxan-4-one (42) 
To a solution of dioxenone 23 (18 mg, 51 µmol) in EtOAc (5 mL) 
was added Rh/Al2O3 (5 wt%, 20 mg, 10 µmol). After stirring for 4 
h under H2 (40 bar), the mixture was filtered through Hyflo and 
concentrated in vacuo. Flash chromatography (EtOAc) afforded 42 as a colourless oil 
(17 mg, 94%): 1H-NMR (CDCl3, 300 MHz): δ = 4.43–4.31 (m, 1H), 3.76 (AB-d, J = 12.0 
Hz, 1H), 3.54 (AB-dd, J = 2.4, 12.0 Hz, 1H), 2.55 (AB-dd, J = 8.4, 15.0 Hz, 1H), 2.45 
(AB-dd, J = 4.5, 15.0 Hz, 1H), 1.69–1.34 (m, 4H), 1.37 (s, 3H), 1.33 (s, 3H), 1.32–1.17 (m, 
18H), 0.93–0.81 (m, 3H); Rf (EtOAc) = 0.60. 
 
4-Hydroxy-6-hydroxymethyl-6-undecyltetrahydropyran-2-one (43) 
To a solution of dioxanone 42 (6 mg, 17 µmol) in toluene (5 mL) was 
added TsOH.H2O (5 mg, 26 µmol). After stirring overnight, the 
mixture was quenched using saturated aqueous NaHCO3 (10 mL) and 
extracted using CH2Cl2 (3 × 10 mL), dried (MgSO4) and concentrated in 
vacuo, affording 43 as a colourless oil (5 mg, 94%): 1H-NMR (CDCl3, 
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300 MHz): δ = 4.54–4.42 (m, 1H), 3.63 (AB-d, J = 11.4 Hz, 1H), 3.54 (AB-d, J = 11.7 Hz, 
1H), 2.89 (dd, J = 1.5, 5.4 Hz, 1H), 2.484–2.38 (m, 2H), 2.24–2.13 (m, 1H), 1.93–1.54 (m, 
4H), 1.45–1.09 (m, 16H), 1.01–0.78 (m, 3H); Rf (EtOAc) = 0.50. 
 
Methyl acetic acid 4-acetoxy-6-oxo-2-undecyltetrahydropyran-2-yl ester (44) 
To a solution of lactone 43 (5 mg, 16 µmol) in ClCH2CH2Cl (5 mL) was 
added acetic anhydride (50 µL, 0.53 mmol). After refluxing overnight, 
the mixture was quenched using saturated aqueous NaHCO3 (10 mL) 
and extracted using CH2Cl2 (3 × 10 mL), dried (MgSO4) and 
concentrated in vacuo. Flash chromatography (EtOAc/heptane 1:1) 
afforded 44 as a colourless oil (5 mg, 83%): IR: νmax (cm-1) = 2954, 2924, 2850, 2358, 
2336, 1748; 1H-NMR (CDCl3, 300 MHz): δ = 5.40–5.31 (m, 1H), 4.18–4.07 (m, 2H), 2.95 
(dd, J = 4.2, 17.4 Hz, 1H), 2.50 (dd, J = 8.1, 17.4 Hz, 2H), 2.35–2.24 (m, 1H), 2.10 (s, 
3H), 2.07 (s, 3H), 1.77– 0.76 (m, 23H); Rf (EtOAc/heptane 1:1) = 0.63. 
 
Methyl acetic acid 6-oxo-2-undecyl-3,6-dihydro-2H-pyran-2-yl ester (45) 
To a solution of lactone 44 (5 mg, 13 µmol) in toluene (5 mL) was 
added DBU (50 µL, 0.33 mmol). After stirring overnight, saturated 
aqueous NH4Cl (10 mL) was added and the mixture was extracted 
using CH2Cl2 (3 × 10 mL), dried (MgSO4) and concentrated in vacuo. 
Flash chromatography (EtOAc/heptane 1:1) afforded 45 as a colourless oil (4 mg, 
84%): 1H-NMR (CDCl3, 300 MHz): δ = 6.77–6.68 (m, 1H), 6.06–5.97 (m, 1H), 4.21–4.08 
(m, 2H), 2.51–2.45 (m, 1H), 2.43–2.28 (m, 1H), 2.08 (s, 3H), 2.11–2.02 (m, 2H), 1.80–0.71 
(m, 21H); Rf (EtOAc/heptane 1:1) = 0.49. 
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4 Mechanistic studies on aryl-substituted bisoxazoline ligands 
4.1 Introduction 
While exploring the scope of aryl-substituted bisoxazoline ligands, which is 
largely described in Chapter 3, we observed a reversal of enantiofacial selectivity 
between differently substituted box ligands. Other groups have also addressed this 
phenomenon, which is usually encountered in combination with copper(II). 
Although these groups have suggested a rationale over the years, so far there is no 
agreement on a suitable explanation. This phenomenon was first reported by the 
group of Jørgensen in the hetero-Diels–Alder reaction of glyoxylate esters and 
dienes, exemplified by the reaction between ethyl glyoxylate (2) and diene 3 in 
Scheme 4.1.1 They observed the formation of the same enantiomer of the Diels–Alder 
product 4 by applying different enantiomers of the ligand, i.e. (S)-t-Bu- and (R)-Ph-
box ((S)-1a and (R)-1b, respectively). Initially, they ascribed this reversal of selectivity 
to a geometrical change at the copper centre from distorted square planar for t-Bu-
box to tetrahedral for Ph-box. 
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Scheme 4.1 Reversal in enantiofacial selectivity in the Diels–Alder reaction to dihydropyran 4 
The group of Evans disagreed with the Jørgensen explanation based on 
structural and mechanistic studies. The opposite enantiofacial bias encountered in 
the hetero-Diels–Alder reaction of crotonyl phosphonates 5 and ethyl vinyl ether (6) 
catalysed by [Cu(II)t-Bu-box] and [Cu(II)Ph-box] complexes was investigated 
(Scheme 4.2).2 They referred to Elias and coworkers, who stated that the possibility of 
a planar-tetrahedral equilibrium of the copper(II) complex in solution is reduced 
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based on studies of bis(N-alkylsalicylaldiminato)copper(II) complexes.3 The group of 
Evans postulated that due to the observed endo selectivity, the transition state 
conformation could not possess a strict tetrahedral Cu(II) centre.2 In addition, they 
concluded that the [Cu(II)Ph-box] complex exhibits a reduced propensity to deviate 
from square planarity compared to the [Cu(II)t-Bu-box] complex, based on solid state 
crystallisation studies on Ph- and t-Bu-box complexed to Cu(H2O)2 both displaying a 
distorted square planar geometries with an average distortion of –9° and +33°, 
respectively. 
O(MeO)2P
Me
O
OEt O
Me
OEt(MeO)2P
O
5 6 (2R,4R)-7
box·Cu(SbF6)2
CH2Cl2, -78 °C
+
(S)-t-Bu-box
(S)-Ph-box
(S)-Bn-box
(S)-i-Pr-box
93% ee (2R,4R)
93% ee (2S,4S)
58% ee (2S,4S)
39% ee (2S,4S)
 
Scheme 4.2 Formation of dihydropyrans 7 from crotonyl phosphonates 5 
Based on these studies and in contrast to Jørgensen, Evans suggested a 
mechanism in which π-stabilisation of the product-like transition state is responsible 
for the observed reversal of selectivity.2 Jørgensen and coworkers then rebutted that 
this reversal was not exclusively observed in going from alkyl- to aryl-substituted 
box ligands. In the previously discussed hetero-Diels–Alder reaction, reversal was 
also observed for Ph- and Bn-box vs. t-Bu-box and even for i-Pr-box, clearly 
suggesting that π-stabilisation cannot be the exclusive reason (Scheme 4.2).4 
Therefore, new studies were initiated and based on theoretical calculations in 
combination with X-ray structures of Ph- and t-Bu-box-complexes with CuCl2 and 
CuBr2, they again stated that the reversal of selectivity is mainly caused by a 
geometrical change, probably of steric origin.4 Their earlier focus on static square 
planar and tetrahedral intermediates was replaced by a more flexible model, in 
which the complexes probably exist in conformations that are in between these two 
extremes. The more flexible character of the Ph-box compared to t-Bu-box complexes, 
allowing interconversion between square planar and tetrahedral conformations 
(Figure 4.1), and ‘flipping’ of the oxazoline substituent between pseudo-axial and 
pseudo-equatorial positions, may then account for the observed effect. 
tetrahedralsquare planar
M
LL
L L
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L L
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Figure 4.1 Square planar versus tetrahedral 
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In this Chapter, experimental and theoretical investigations on the geometry 
of the [Cu(II)box] complexes will be described in order to acquire more insight in the 
reversal phenomenon. Several techniques have been applied, such as X-ray 
crystallography, modelling studies and EPR measurements. 
4.2 X-ray crystallography 
Various attempts have been made to obtain crystals of the [Cu(II)box] 
catalysts and the corresponding substrate-bound complexes, that are suitable for X-
ray analysis. However, it appeared to be difficult to get crystals of good quality, 
especially for complexes bound to substrates, which is underlined by the fact that up 
till now only a small number of such crystal structures have been reported. 
Generally, the water- or halogen-bound complexes are more suitable to generate 
crystals. Hence, we used the latter type of crystal structures to investigate the 
geometry of the complexes and to initiate modelling studies (Section 4.3). 
In the group of Evans, water-bound crystal structures were used to explain 
the stereochemical outcome of the catalysis, i.e. [Cu(H2O)2(Ph-box)](OTf)25 and 
[Cu(H2O)2(Ph-box)](SbF6)26 (not depicted). These structures typically have two 
coordinating water-molecules and show a square planar geometry around the 
copper centre, or an octahedral geometry when the anions are included.7 From the 
same group the water-bound crystal structures of the corresponding t-Bu-box 
complexes, i.e. [Cu(H2O)2(t-Bu-box)](OTf)2 and [Cu(H2O)2(t-Bu-box)](SbF6)2 (not 
depicted) were also reported.2b 
In order to investigate these complexes, Jørgensen and coworkers reported 
crystal structures of CuCl2- and CuBr2-complexes of t-Bu- and Ph-box ligands.4 The 
chloride- and bromide-substituted copper complexes were almost identical. One 
common trend in all complexes is that the angle between the halogen-copper-
halogen plane and the box-copper plane is very similar and lies typically between 41° 
and 56°.4 This is somewhere in between a square planar – which has in the ideal case 
a value of 0° – and a tetrahedral geometry. A remarkable abnormality was observed 
in the case of the Ph-box complexes. Whereas the t-Bu-box complexes are completely 
C2-symmetric, the Ph-box complexes are far from this, as shown in Figure 4.2. The 
phenyl substituents are differently oriented with respect to each other, namely circa 
90° relative to each other, with the ´left-phenyl substituent´ perpendicular and the 
´right-phenyl substituent´ parallel to the halogen ions that coordinate to the 
copper(II) center. This could be a subtle effect from the packing of the crystals, but it 
could also well be a more important conformation in solution. A similar asymmetry 
in the ligand has been observed for titanium-TADDOL complexes by Seebach and 
coworkers.8 
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[CuCl2(Ph-box)] complex, the phenyl substituents are oriented perpendicular with 
respect to each other. In addition, the [ZnCl2(t-Bu-box)] complex exhibits a lower 
average twist angle out of the square planar conformation compared to the 
corresponding Ph-box complex, indicative for the flexibility of the complex. 
We obtained crystal structures of the [CuCl2(1-Np-box)] and [CuCl2(2-Np-
box)] complexes, as depicted in Figure 4.3, enabling us to compare them to the 
previously reported structures of [CuCl2(Ph-box)] and [CuCl2(t-Bu-box)]. For the 
[CuCl2(2-Np-box)] complex, we observed a similar phenomenon as for the 
[CuCl2(Ph-box)] complex: the naphthyl substituents are also oriented perpendicular 
with respect to each other. Interestingly, the [CuCl2(1-Np-box)] complex was almost 
C2-symmetric and therefore more similar to the corresponding t-Bu-box complex. 
A more quantitative manner to determine the relative orientation of the 
phenyl substituents was used by the group of Jørgensen.4 They determined the two 
dihedral angles between the C4-substituent and the oxazoline ring, i.e. C1-C2-N1-C4 
and C9-C8-N2-C6 (Table 4.1). It was assumed that a dihedral angle <115° indicates a 
pseudo-axial position of the substituent and that one of >115° is indicative for a 
pseudo-equatorial positioning. 
Table 4.1 Dihedral angles for X-ray structures of box ligands and [CuCl2-box] complexes 
 
entry Complex C1-C2-N1-C4 C9-C8-N2-C6 
  angle (°) ax/eqa angle (°) ax/eqa 
1 t-Bu-boxb,c 134.7 eq 124.9 eq 
2 1-Np-box 135.6 eq 127.5 eq 
3 [CuCl2(t-Bu-box)]b 106.6 ax 106.6 ax 
4 [CuCl2(Ph-box)]b 105.7 ax 119.3 eq 
5 [CuCl2(1-Np-box)] 111.3 ax 112.8 ax 
6 [CuCl2(2-Np-box)] 109.5 ax 116.9 eq 
a Dihedral angle <115° indicates a pseudo-axial orientation, >115° pseudo-equatorial. b Values 
reported by Jørgensen and coworkers.4 c X-ray structure is not depicted. 
In the free box ligands, t-Bu-box and 1-Np-box,11 both substituents occupy a 
pseudo-equatorial orientation, which is assumed to be energetically favoured (Table 
4.1, entries 1 and 2). In the [Cu(II)(t-Bu-box)] complexes, the substituents are oriented 
in a rather strained pseudo-axial position, while the [Cu(II)(Ph-box)] complex has 
one of the phenyl substituents pseudo-axial and the other one pseudo-equatorial. 
 
Mechanistic studies on aryl-substituted bisoxazoline ligands 
75 
 
In the free box ligands, t-Bu-box and 1-Np-box,11 both substituents occupy a 
pseudo-equatorial orientation, which is assumed to be energetically favoured (Table 
4.1, entries 1 and 2). In the [Cu(II)(t-Bu-box)] complexes, the substituents are oriented 
in a rather strained pseudo-axial position, while the [Cu(II)(Ph-box)] complex has 
one of the phenyl substituents pseudo-axial and the other one pseudo-equatorial. 
Hence, Jørgensen concluded that the [Cu(II)(Ph-box)] complex is more 
flexible than the corresponding t-Bu-box containing complex so that the phenyl 
substituents are able to flip between a pseudo-axial and a (energetically more 
favoured) pseudo-equatorial position.4 
Regarding the dihedral angles observed for both naphthyl-substituted box-
CuCl2 complexes, we could indeed confirm the resemblance that we already noticed 
by looking at the pictures (vide supra): the structure of [CuCl2(1-Np-box)] resembles 
that of [Cu(II)(t-Bu-box)], whereas [CuCl2(2-Np-box)] is more similar to [Cu(II)(Ph-
box)]. Following the reasoning of Jørgensen, this suggests that the [CuCl2(2-Np-box)] 
complex is more flexible the [CuCl2(1-Np-box)] complex.  
Moreover, we were able to determine the crystal structure of the [CuBr2(1-Np-
box)] and [ZnCl2(1-Np-box)] complexes, which are depicted in Figure 4.4. Not 
surprisingly, it was observed that the CuCl2- and the CuBr2-complex show minor 
differences and also the [CuBr2(1-Np-box)] complex is close to C2-symmetric. The 
[ZnCl2(1-Np-box)] complex indeed clearly shows a different orientation at the metal 
centre, i.e. the geometry is close to tetrahedral, as was observed for the ZnCl2-
complexes of t-Bu-box and Ph-box. 
Finally, the dihedral angles in these complexes were determined in order to 
assign the orientation of the C4-substituents and compare their geometry to the 
corresponding t-Bu- and Ph-box complexes (Table 4.2). Indeed, this confirms our 
previous observations that the [CuBr2(1-Np-box)] complex resembles the [CuBr2(t-
Bu-box)] more than the [CuBr2(Ph-box)] complex. In contrast and to our surprise, the 
[ZnCl2(1-Np-box)] complex is able to adapt a conformation in which both 
substituents are in an energetically more favoured pseudo-equatorial position. 
Table 4.2 Dihedral angles for X-ray structures of [CuBr2box] and [ZnCl2box] complexes 
entry complex C1-C2-N1-C4 C9-C8-N2-C6 
  angle (°) ax/eqa angle (°) ax/eqa 
1 [CuBr2(t-Bu-box)]b 110.2 ax 110.2 ax 
2 [CuBr2(Ph-box)]b 106.0 ax 118.0 eq 
3 [CuBr2(1-Np-box)] 114.1 ax 112.0 ax 
4 [ZnCl2(t-Bu-box)]b 113.3 ax 127.9 eq 
5 [ZnCl2(Ph-box)]b 105.2 ax 121.8 eq 
6 [ZnCl2(1-Np-box)] 118.7 eq 116.1 eq 
a Dihedral angle <115° indicates a pseudo-axial orientation, >115° pseudo-equatorial. b Values 
reported by Jørgensen and coworkers.4 
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Figure 4.2 X-ray structures of the [CuCl2(t-Bu-box)] and [CuCl2(Ph-box)] complex9 
 
 
Figure 4.3 X-ray structures of the [CuCl2(1-Np-box)] and [CuCl2(2-Np-box)] complex10 
 
 
Figure 4.4 X-ray structures of the [CuBr2(1-Np-box)] and [ZnCl2(1-Np-box)] complex12 
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Figure 4.5 PM3-modelling structures of [Cu(II)(t-Bu-box)] and [Cu(II)(Ph-box)] complexed 
to methyl pyruvate 
 
 
 
Figure 4.6 PM3-modelling structures of [Cu(II)(1-Np-box)], [Cu(II)(2-Np-box)] and 
[Cu(II)(9-Ant-box)] complexed to methyl pyruvate 
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In conclusion, we have performed X-ray analyses on four different naphthyl-
substituted box complexes, i.e. [CuCl2(1-Np-box)], [CuCl2(2-Np-box)], [CuBr2(1-Np-
box)] and [ZnCl2(1-Np-box)]. We compared their geometry with those of the 
corresponding t-Bu- and Ph-box complexes, which have already been reported in 
literature. We observed that the [CuCl2(1-Np-box)] complex strongly resembles the 
[CuCl2(t-Bu-box)] complex, whereas the [CuCl2(2-Np-box)] complex is more similar 
to the [CuCl2(Ph-box)] complex. Moreover, we confirmed that the [CuCl2(1-Np-box)] 
and the [CuBr2(1-Np-box)] complexes are almost identical, having both a geometry 
that is right in between square planar and tetrahedral. Replacement of copper by zinc 
resulted in a geometrical change at the metal center to a distorted tetrahedral 
conformation. 
4.3 Modelling studies 
Since we were unable to obtain crystal structures of [Cu(II)-box] complexes 
bound to the substrates described in Chapter 3, we searched the Cambridge 
Crystallographic Data Centre13 database for substrate-bound box catalyst complexes. 
A few examples were found (e.g. [Cu(II)box] complexes bound to β-dicarbonyl 
substrates, [Pd(II)box] complexes bound to π-allyl substrates), but no crystal 
structures for [Cu(II)box] catalyst complexes bound to α-dicarbonyl substrates have 
been reported.  
Nevertheless, in a second attempt to get more insight into the geometry of the 
catalyst complexes, we initiated modelling studies on the intermediates that exist 
during catalysis. We performed PM3-level calculations14 on the proposed [Cu(II)-
box] intermediate complexes, using the crystal structures of the corresponding 
CuCl2-complexes (discussed in Section 4.2) as the starting point. We chose methyl 
pyruvate and 2-benzylidenemalonic acid dimethyl ester as the complexing agents, 
since these dicarbonyl compounds were used as substrates in reactions where we 
observed a reversal in facial selectivity (see Chapter 3). 
In theory, several different substrate-bound complexes could be present 
during catalysis, each having a distinct geometry. The simplest forms contain one 
chiral ligand and one substrate molecule bound to the copper (d9) centre, with or 
without one or two coordinating anions or solvent molecules, as has already been 
described by the Jørgensen group.15 Thus, the four-coordinated complex, containing 
one ligand and one substrate molecule is a 17-electron species16 and will typically 
adapt a tetrahedral or a square planar geometry. When a solvent molecule or an 
anion is bound to this species, a 19-electron complex is obtained resulting in a five-
coordinated species, which will exist in a trigonal-bipyramidal or in a square-
pyramidal conformation. The corresponding six-coordinated complex, with two 
solvent molecules, two anions or one of both coordinating, is a 21-electron complex 
and will presumably adapt an octahedral geometry. 
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Modelling experiments, i.e. DFT ROFH-optimisations, were performed by 
Jørgensen and coworkers on all three complexes bound to methyl glyoxylate. These 
studies revealed that the nominally 21-electron complex is in fact a 19-electron 
complex. Furthermore, it was concluded that the LUMO positioned on the substrate 
is the lowest in energy for the 17-electron complex. Indeed, it was expected that the 
cationic complex containing no anions would be the most reactive species during 
catalysis.15 Surprisingly, this 17-electron complex was also calculated to be the most 
stable complex. In our PM3-modelling studies, we examined the 17-electron 
complexes of the proposed [Cu(II)-box] complexes. As a result, the effects of solvent 
molecules (and counterions) were not included in the calculations, although we were 
aware of the effect that the solvent can have on the enantioselectivity and the 
stereochemical outcome of the reaction. 
4.3.1 Complexes bound to methyl pyruvate 
The structures from the modelling studies on the [Cu(II)(t-Bu-box)] and 
[Cu(II)(Ph-box)] complexes bound to methyl pyruvate are shown in Figure 4.5. These 
structures clearly reveal that the substrate and t-Bu-box are almost in the same plane, 
resulting in a complex that has a slightly distorted square planar geometry. On the 
other hand, we noticed that the Ph-box ligand is far from C2-symmetric, having both 
phenyl substituents in completely different orientations. This effect originates from 
the crystal structure which was used as starting point and it seems that the original 
conformation is retained as the most favourable orientation. As a result, the substrate 
could theoretically complex to copper in two ways, resulting in two different catalyst 
complexes. Nevertheless, the complex shown in Figure 4.5 is the thermodynamically 
favoured complex and is therefore assumed to be the active catalyst species, 
especially since these reactions were carried out at –78 °C. Taking a closer look, we 
noticed that the substrate in the Ph-box-containing complex bends out of the plane of 
the ligand, resulting in a distorted and therefore rather strained geometry around the 
copper. This could indicate that the complex is more susceptible to small adaptations 
in its geometry depending on the environment, e.g. the solvent. 
Comparing the structures from the modelling studies on the [Cu(II)(1-Np-
box)] and [Cu(II)(2-Np-box)] complexes bound to methyl pyruvate, we immediately 
observed significant differences (Figure 4.6). The [Cu(II)(1-Np-box)] complex clearly 
resembles the [Cu(II)(t-Bu-box)] complex, adapting a geometry that is almost C2-
symmetric. In contrast, the [Cu(II)(2-Np-box)] complex is closely related to its Ph-
box-containing analogue. Similarly, the substituents are oriented differently with 
respect to each other and the substrate bends out of the plane of the ligand. In 
addition, we performed modelling studies on the [Cu(II)(9-Ant-box)] complex bound 
to methyl pyruvate. The bulkiness of the anthryl substituents becomes evident from 
complex E (Figure 4.6). The orientation of the substrate in this complex is rather 
similar to the [Cu(II)(1-Np-box)] and the [Cu(II)(t-Bu-box)] complex, suggesting a 
close to C2-symmetric geometry. 
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Figure 4.7 PM3-modelling structures of [Cu(II)(t-Bu-box)] and [Cu(II)(Ph-box)] complexed 
to 2-benzylidenemalonic acid dimethyl ester 
 
 
 
 
Figure 4.9 X-ray structures of [Cu(SbF6)2(t-Bu-box)] and [Cu(SbF6)2(Ph-box)] complexed to 
2-benzylidenemalonic acid dimethyl ester18 
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Figure 4.8 PM3-modelling structures of [Cu(II)(1-Np-box)], [Cu(II)(2-Np-box)] and 
[Cu(II)(9-Ant-box)] complexed to 2-benzylidenemalonic acid dimethyl ester 
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In order to determine the orientation of the substrate relative to the ligand in 
a more quantitative manner, we calculated the twist angle of the substrate out of the 
square planar geometry. Concluding from the data in Table 4.3, especially the Ph-box 
and the 2-Np-box-based complexes exhibit a strong distortion with both dihedral 
angles >15° out-of-plane of an ideal square planar geometry, in which both angles 
are 0° by definition. Moreover, for [Cu(II)(1-Np-box)] the geometry of the substrate 
bound complex is almost square planar. A remarkable feature is observed for the 
[Cu(II)(t-Bu-box)] complex, in which the bound substrate lies slightly out of the plane 
of the ligand, probably due to the bulky substituents on the ligand. A similar 
distortion of the square planar geometry upon binding of the substrate was also 
observed for the [Cu(II)(9-Ant-box)] complex, indicating that the bulkiness of the 
anthryl substituents approaches that of the tert-butyl substituents. The absence of this 
effect for the other complexes suggests that the phenyl and both naphthyl 
substituents are considerably less bulky, which could largely explain the degree of 
enantioselectivity. 
Table 4.3 Dihedral angles for PM3-modelling structures including methyl pyruvate 
 
entry complexa C4-N1-Cu1-O4 (°) C6-N2-Cu1-O3 (°) 
1 [Cu(II)(t-Bu-box)] 20.7 11.0 
2 [Cu(II)(Ph-box)] 18.0 31.0 
3 [Cu(II)(1-Np-box)] 7.4 5.2 
4 [Cu(II)(2-Np-box)] 31.5 37.0 
5 [Cu(II)(9-Ant-box)] 20.9 7.9 
a [Cu(II)box] complexes bound to methyl pyruvate 
The PM3-modelling experiments of the [Cu(II)box] complexes bound to 
methyl pyruvate confirm the conclusions that were already drawn from the X-ray 
data. Indeed, the [Cu(II)(1-Np-box)] complex resembles the [Cu(II)(t-Bu-box)] 
complex, whereas the [Cu(II)(2-Np-box)] complex is more similar to the [Cu(II)(Ph-
box)] complex. We observed that the [Cu(II)(9-Ant-box)] complex adapts a geometry 
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which is closely related to that of the [Cu(II)(t-Bu-box)] complex, suggesting that 
anthryl groups are equally bulky as the tert-butyl substituents. 
4.3.2 Complexes bound to 2-benzylidenemalonic acid dimethyl ester 
Since our new naphthyl-substituted box ligands were reasonably successful in 
the Mukaiyama Michael additions to 2-benzylidenemalonic acid dimethyl ester 
(Section 3.2.3), we also performed modelling experiments on all catalyst complexes 
involved. In this case, we could to some extent verify the results of our modelling 
studies by comparing them to the solid state crystal structures of two of these 
complexes, which have been published previously by Evans and coworkers.17 
Thus, we performed PM3-modelling studies on the [Cu(II)(t-Bu-box)] and 
[Cu(II)(Ph-box)] complex bound to 2-benzylidenemalonic acid dimethyl ester (Figure 
4.7). These complexes seem to resemble each other, adapting a geometry in which the 
ligand is close to square planar. The substrate is bound to the copper with a 
remarkable distortion out of the square planar geometry. Surprisingly, the phenyl 
substituents in this [Cu(II)(Ph-box)] complex are in identical orientations in a C2-
symmetric manner, in contrast to the earlier described [Cu(II)(Ph-box)] complexes. In 
Figure 4.8, the complexes of [Cu(II)(1-Np-box)], [Cu(II)(2-Np-box)] and [Cu(II)(9-
Ant-box)] bound to 2-benzylidenemalonic acid dimethyl ester according to PM3 
modelling studies are depicted. These complexes are again very similar to the 
corresponding [Cu(II)(t-Bu-box)] and [Cu(II)(Ph-box)] complexes, adapting a 
remarkably distorted square planar geometry. 
Table 4.4 Dihedral angles for X-ray and PM3-modelling structures including 2-benzylidene-
malonic acid dimethyl ester 
entry Complex C4-N1-Cu1-O4 (°) C6-N2-Cu1-O3 (°) 
1 [Cu(II)(t-Bu-box)] 33.1 37.2 
2 [Cu(II)(t-Bu-box)]a 29.6 23.3 
3 [Cu(II)(Ph-box)] 33.0 27.2 
4 [Cu(II)(Ph-box)]a 9.0 2.4 
5 [Cu(II)(1-Np-box)] 32.0 26.1 
6 [Cu(II)(2-Np-box)] 35.9 24.5 
7 [Cu(II)(9-Ant-box)] 33.2 27.2 
a Values for X-ray structures. 
Quantitative calculations on the orientation of the substrate with respect to 
the box ligand plane were performed and are summarised in Table 4.4. The 
distortion of the substrate out of the square planar geometry is determined by 
calculating the dihedral angle, which range typically from 25° to 37°. Since the crystal 
structures of the [Cu(II)(t-Bu-box)] and [Cu(II)(Ph-box)] complexes bound to 2-
benzylidenemalonic acid dimethyl ester have been reported previously, we could 
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easily compare these with the outcome of our modelling experiments (Figure 4.9).17 
As expected, the structure of the [Cu(II)(t-Bu-box)] complex obtained from the 
modelling experiment was almost identical to the corresponding X-ray structure. 
Inversely, for the [Cu(II)(Ph-box)] complex we observed a great discrepancy between 
the crystal structure and the modelling data. In the latter, the substrate is bound with 
a strong distortion out of a square planar geometry, while the crystal structure 
suggests a close to square planar geometry. These observations are confirmed by 
calculating the dihedral angle of the substrate out of the square planar geometry 
(Table 4.4). 
In conclusion, we observed minor differences between all PM3-modelling 
structures of [Cu(II)box] complexes bound to 2-benzylidenemalonic acid dimethyl 
ester. In case of the [(Cu(II)(t-Bu-box)], this fits well with X-ray data, but for the 
[Cu(II)(Ph-box)] there are large differences. A possible explanation can lie in the fact 
that the crystal structure is in the solid state, while modelling simulates a gas-like 
environment. Furthermore, intermolecular interactions such as π,π-stacking are only 
partially taken into account in modelling studies, although these interactions can 
largely influence the actual conformation of the catalyst complex. 
4.4 EPR spectroscopic studies 
We also searched for other spectroscopic techniques in order to be able to 
closely examine the geometry of the transition state complex. NMR spectroscopy 
obviously is not suitable, since the paramagnetic character of copper(II) causes a 
strong broadening of the resonance signals. A less conventional, and therefore less 
frequently used technique to determine the geometry of copper(II) complexes is EPR 
spectroscopy. This may provide a useful method to characterise our complexes – in 
particular their symmetry – by determining how the unpaired electrons are 
influenced by their environment.19 
Surprisingly, EPR spectroscopic studies on [Cu(II)box] complexes were 
performed only once by Evans and coworkers.20 They stated that the EPR data of t-
Bu-box and i-Pr-pybox complexed to Cu(OTf)2 in the absence and presence of methyl 
pyruvate indicate a strong square planar pattern, which is consistent with either a 
square planar or square-pyramidal copper geometry. However, they did not report 
EPR studies on other bisoxazoline-based complexes. Moreover, these attempts were 
conducted under non-optimal EPR conditions, i.e. in a poor CH2Cl2 glass and 
measured at relative high temperature (134 K).  
Therefore, we reinvestigated substrate binding to [Cu(OTf)2box] complexes in 
CH2Cl2 at 40 K. Studying the complexes as frozen solutions, so-called powder EPR, 
allowed us to observe all possible orientations at the same time. In order to further 
optimise the spectral conditions, an excess of tetra-n-butylammonium 
hexafluorophosphate, [(n-Bu)4N]PF6, was added to the catalyst solution to enhance 
glass formation of CH2Cl2, thereby assuring magnetic dilution of the Cu(II)-species. 
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The X-band EPR spectrum of the [Cu(OTf)2(Ph-box)] complex is relatively 
sharp, but quite complicated due to the presence of at least three different Cu(II) 
species, as depicted in Figure 4.10 (left). Most probably, the observed mixture can be 
assigned to a (mixed) triflate, hexafluorophosphate and/or solvent adducts of the 
[Cu(II)(Ph-box)] complex. Remarkably, upon addition of an excess of methyl 
pyruvate, the spectrum simplifies and apparently only one Cu(II) species remains 
(Figure 4.10, right). 
 
2700 3000 3300 
Ay
Cu = 50 Mhz 
Ax
Cu = 20 Mhz 
Az
Cu= 470 Mhz 
Ay
N = 40 Mhz 
Ax
N = 40 Mhz 
Az
N = 35 Mhz 
g y  = 2.066
g x  = 2.087
g z  = 2.333
Exp 
Sim 
g-value 
dX
''/
dB
 
B [Gaus] 
2.6 2.4 2.2 2 
2700 3000 3300
g-value 
dX
''/
dB
 
B [Gaus] 
2.6 2.4 2.2 2
 
Figure 4.10 X-band EPR spectra of [Cu(OTf)2(Ph-box)] before (left) and after (right) addition 
of an excess of methyl pyruvate; for the latter EPR spectrum, the simulated spectrum (Sim) 
and the simulation parameters are also shown. 
Simulation of the rhombic spectrum reveals gx = 2.006, gy = 2.086 and gz = 
2.333, with a copper hyperfine coupling of 470 MHz at gz.21 Remarkably, gx reveals 
an unusually sharp coupling pattern, which could be adequately simulated by 
assuming superhyperfine coupling with two equivalent nitrogen nuclei. Thus, the 
EPR spectrum is in good agreement with the expected (approximate) C2-symmetry of 
the [Cu(II)(Ph-box)] complex. The equivalence of the nitrogen superhyperfine tensors 
in the gx direction implies that in the presence of methyl pyruvate, the complex binds 
two similar, if not identical, donor atoms L and L’ (Figure 4.11). 
Only a slight difference of donor strength towards Cu(II) is expected from 
both carbonyl groups of methyl pyruvate. Therefore, it is difficult to discriminate 
between a complex binding two monodentate (η1-coordinated) methyl pyruvate 
molecules and a complex binding a single chelating bidentate (η 2-coordinated) 
methyl pyruvate on the basis of these results. 
 
Chapter 4 
86 
 
N
O
R
N
O
R Cu
R = Ph, 1-Np, 2-Np
L L´
xy
x2-y2
yz
z2
xz
x
y
 
Figure 4.11 Geometry and electronic configuration of the Cu(II) centre of methyl pyruvate 
adducts of [Cu(II)box(L)(L’)]2+ species derived from their EPR spectra; the defined spectral 
axis are also shown (x-axis along the C2-symmetry axis). 
Most likely, the SOMO of the [Cu(II)(Ph-box)(L)(L’)] complex consists mainly 
of a copper d-orbital (dxy along the defined spectral axis) with a small but significant 
anti-bonding contribution of orbitals on the Ph-box imine N-donors. Figure 4.11 
shows the geometry of this species and the expected electronic configuration as 
derived from EPR. 
Addition of methyl pyruvate to a Cu(II) species complexed to 1-Np-box or 
2-Np-box afforded similar EPR spectra (not depicted). Again, the X-band EPR 
spectrum of the [Cu(OTf)2(box)] complex shows the presence of several different 
Cu(II) species and simplifies upon addition of methyl pyruvate, indicating the 
presence of only one dominant Cu(II) species. Only small differences were observed 
in the line width parameters, but simulation of these spectra reveals otherwise 
identical spectral parameters to those shown in Figure 4.10. 
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Figure 4.12 Experimental and simulated X-band EPR spectra of [Cu(OTf)2(t-Bu-box)] (in the 
absence of methyl pyruvate), including simulation parameters (NR = not resolved). 
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In contrast, the results obtained for the [Cu(II)(t-Bu-box)] complex are quite 
different compared to the other complexes. In the absence of methyl pyruvate, this 
species reveals only one Cu(II) species instead of a complex mixture (Figure 4.12). 
Addition of methyl pyruvate does not influence the EPR spectrum of this species. 
Also remarkable is the fact that the [Cu(II)(t-Bu-box)] complex does not show any 
resolved superhyperfine coupling with nitrogen nuclei. Simulation of the slightly 
rhombic spectrum yields the following parameters: gy = 2.067, gx = 2.092 , gz = 2.315, 
ACuz= 450 MHz. Although Evans does not report any data, these spectra are roughly 
similar to those reported by Evans.20 
A clear difference is observed regarding the EPR spectra of the [Cu(II)(t-Bu-
box)] complex compared to the complexes bound to aryl-substituted box ligands. The 
[Cu(II)(t-Bu-box)] complex already shows a clear EPR spectrum, while the other 
complexes are present as at least three different species. Upon addition of methyl 
pyruvate, in all cases one Cu(II) species remains. In these spectra, hyperfine coupling 
was observed for the the aryl-substituted box complexes whereas the [Cu(II)(t-Bu-
box)] complex shows no hyperfine coupling. 
4.5 Discussion 
It is clear that these different studies did not lead to fully conclusive results. 
The X-ray analysis unambiguously indicates that the Cu(II)-complexes of t-Bu- and 
Ph-box differ from each other. Our PM3-modelling experiments, initiated from the X-
ray structures, similarly reveal this unambiguous difference. Moreover, both studies 
seem to indicate that the [Cu(II)(1-Np-box)] complex strongly resembles the [Cu(II)(t-
Bu-box)] complex, while the [Cu(II)(2-Np-box)] complex is more similar to the 
[Cu(II)(Ph-box)] complex. To our surprise, the experimental reactions involving 
methyl pyruvate gave opposite results, especially in the hetero-Diels–Alder reaction 
(Section 3.2.2) and the addition reaction to the dioxenone (Section 3.4); herein, the 
[Cu(II)(1-Np-box)] complex resulted in the same enantiomer of the product as the 
[Cu(II)(Ph-box)] complex, while the [Cu(II)(2-Np-box)] and the [Cu(II)(t-Bu-box)] 
complex also afforded the same stereochemical outcome. 
From the modelling experiments, we observed that the [Cu(II)(9-Ant-box)] 
complex adapts a geometry that is even more similar to that of the [Cu(II)(t-Bu-box)] 
complex, suggesting that the anthryl groups are virtually as bulky as tert-butyl 
substituents. Although we indeed noticed a significant increase in enantiopurity in 
the hetero-Diels–Alder reaction going from 1-Np- and 1-Ph-box to 9-Ant-box, it was 
still considerably less satisfactory than the result observed for the t-Bu-box (Section 
3.2.2). 
The results from the PM3-modelling studies on the [Cu(II)box] complexes 
bound to 2-benzylidenemalonic acid dimethyl ester must be considered more 
carefully; comparison with the reported X-ray structures indicated an adequate 
similarity for the [Cu(II)(t-Bu-box)] complex, while for the [Cu(II)(Ph-box)] complex 
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rather large geometrical differences were observed. Although the modelling suggests 
that all substrate bound complexes adapt a similar geometry, from the results of the 
Mukaiyama Michael addition to this substrate, we expected that the Cu(II) 
complexes of the aryl-substituted box ligands adapt a different geometry than the 
[Cu(II)(t-Bu-box)] complex (Section 3.2.3). 
Comparison of the EPR spectra of the Cu(II) complexes reveals that there is an 
obvious difference between the t-Bu-box containing complex and the complexes 
bound to the aryl-box ligands. Especially in the absence of substrate (i.e. methyl 
pyruvate), the [Cu(II)(t-Bu-box)] complex already exists as one defined species, 
whereas the aryl-substituted box complexes show a complex mixture of (at least 
three) different complexes. Upon addition of methyl pyruvate, in all cases only one 
Cu(II) species remains. Remarkably, the [Cu(II)(t-Bu-box)] complex shows no 
hyperfine coupling, while the complexes containing an aryl-substituted box ligand 
clearly do show hyperfine coupling.  
In conclusion, we observed a clear difference between the complexes bound 
to an alkyl-box ligand and those bound to an aryl-box ligand, which was clearly 
confirmed by the EPR measurements. Nevertheless, based on these studies we were 
unable to provide a satisfactory explanation for the reversal in stereochemical 
outcome described in Chapter 3. Apparently, there are significant differences 
between the solid state X-ray structures of the complexes and the actual substrate-
bound complexes that are present during the catalytic reactions. Finally, the 
modelling studies appeared to be unsufficiently adequate to predict the 
stereochemical outcome of the reactions. 
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4.7 Experimental section 
Crystal structure determination of [CuCl2(1-Np-box)] 
Reference number of the [CuCl2(1-Np-box)] complex in 
the Cambridge Crystallographic Data Centre: CCDC 
206608. The crystal data and a summary of the data 
collection and structure refinement are given below.21 
Selected bond distances and angles are given in Tables 
4.5 and 4.6, respectively (for atomic numbering vide 
infra). 
C29H26Cl2CuN2O2, M = 569, crystallises in the orthorombic space group P212121, with 
a = 10.066(1) Å, b = 12.920(2) Å, c = 19.424(2) Å, V = 2526(1) Å3, T = 120 K, Z = 4, µ = 
1.106 mm-1; 30861 reflections were measured, giving 7316 independent, of which 6592 
with I > 3σ(I) were used in the refinements. The internal agreement had R = 0.087, the 
final R = 0.028, Rw = 0.035, GOF = 1.21, for the significant reflections. 
 
Table 4.5 Bond distances of the non-hydrogen atoms (Å) of [CuCl2(1-Np-box)] 
Cu(1)-Cl(2) 2.217 C(9)-C(10) 1.366 C(21)-C(24) 1.499 
Cu(1)-Cl(3) 2.229 C(10)-C(11) 1.414 C(25)-C(26) 1.543 
Cu(1)-N(6) 1.996 C(11)-C(12) 1.426 C(26)-C(27) 1.519 
Cu(1)-N(7) 1.981 C(11)-C(16) 1.425 C(27)-C(28) 1.432 
O(4)-C(19) 1.465 C(12)-C(13) 1.371 C(27)-C(36) 1.377 
O(4)-C(20) 1.334 C(13)-C(14) 1.407 C(28)-C(29) 1.410 
O(5)-C(24) 1.340 C(14)-C(15) 1.370 C(28)-C(33) 1.436 
O(5)-C(25) 1.470 C(15)-C(16) 1.425 C(29)-C(30) 1.370 
N(6)-C(18) 1.489 C(16)-C(17) 1.427 C(30)-C(31) 1.414 
N(6)-C(20) 1.279 C(17)-C(18) 1.520 C(31)-C(32) 1.355 
N(7)-C(24) 1.281 C(18)-C(19) 1.543 C(32)-C(33) 1.417 
N(7)-C(26) 1.490 C(20)-C(21) 1.515 C(33)-C(34) 1.417 
C(8)-C(9) 1.414 C(21)-C(22) 1.548 C(34)-C(35) 1.359 
C(8)-C(17) 1.373 C(21)-C(23) 1.539 C(35)-C(36) 1.415 
 
Table 4.6 Bond angles of the non-hydrogen atoms (°) of [CuCl2(1-Np-box)] 
Cl(2)-Cu(1)-Cl(3) 99.759 C(13)-C(14)-C(15) 120.446 O(5)-C(24)-C(21) 114.770 
Cl(2)-Cu(1)-N(6) 95.519 C(14)-C(15)-C(16) 121.231 N(7)-C(24)-C(21) 127.980 
Cl(2)-Cu(1)-N(7) 145.740 C(11)-C(16)-C(15) 118.201 O(5)-C(25)-C(26) 103.791 
Cl(3)-Cu(1)-N(6) 147.448 C(11)-C(16)-C(17) 118.818 N(7)-C(26)-C(25) 102.674 
Cl(3)-Cu(1)-N(7) 94.807 C(15)-C(16)-C(17) 122.984 N(7)-C(26)-C(27) 109.386 
N(6)-Cu(1)-N(7) 88.271 C(8)-C(17)-C(16) 119.730 C(25)-C(26)-C(27) 115.163 
C(19)-O(4)-C(20) 106.700 C(8)-C(17)-C(18) 122.140 C(26)-C(27)-C(28) 119.304 
C(24)-O(5)-C(25) 106.839 C(16)-C(17)-C(18) 118.101 C(26)-C(27)-C(36) 120.989 
Cu(1)-N(6)-C(18) 123.595 N(6)-C(18)-C(17) 112.311 C(28)-C(27)-C(36) 119.690 
Cu(1)-N(6)-C(20) 128.258 N(6)-C(18)-C(19) 102.481 C(27)-C(28)-C(29) 123.243 
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C(18)-N(6)-C(20) 107.951 C(17)-C(18)-C(19) 112.721 C(27)-C(28)-C(33) 118.215 
Cu(1)-N(7)-C(24) 130.096 O(4)-C(19)-C(18) 103.703 C(29)-C(28)-C(33) 118.519 
Cu(1)-N(7)-C(26) 121.552 O(4)-C(20)-N(6) 117.491 C(28)-C(29)-C(30) 120.818 
C(24)-N(7)-C(26) 108.129 O(4)-C(20)-C(21) 113.758 C(29)-C(30)-C(31) 120.893 
C(9)-C(8)-C(17) 120.979 N(6)-C(20)-C(21) 128.562 C(30)-C(31)-C(32) 119.475 
C(8)-C(9)-C(10) 120.495 C(20)-C(21)-C(22) 106.912 C(31)-C(32)-C(33) 121.872 
C(9)-C(10)-C(11) 120.213 C(20)-C(21)-C(23) 110.687 C(28)-C(33)-C(32) 118.421 
C(10)-C(11)-C(12) 121.163 C(20)-C(21)-C(24) 111.467 C(28)-C(33)-C(34) 119.487 
C(10)-C(11)-C(16) 119.762 C(22)-C(21)-C(23) 109.886 C(32)-C(33)-C(34) 122.021 
C(12)-C(11)-C(16) 119.052 C(22)-C(21)-C(24) 108.575 C(33)-C(34)-C(35) 121.128 
C(11)-C(12)-C(13) 120.822 C(23)-C(21)-C(24) 109.260 C(34)-C(35)-C(36) 119.828 
C(12)-C(13)-C(14) 120.178 O(5)-C(24)-N(7) 117.251 C(27)-C(36)-C(35) 121.556 
 
Crystal structure determination of [CuBr2(1-Np-box)] 
Reference number of the [CuBr2(1-Np-box)] complex in 
the Cambridge Crystallographic Data Centre: CCDC 
206609. The crystal data and a summary of the data 
collection and structure refinement are given below.21 
Selected bond distances and angles are given in Tables 
4.7 and 4.8, respectively (for atomic numbering vide infra). 
C29H26Cl2CuN2O2, M = 657.91, crystallises in the orthorombic space group P212121, 
with a = 10.2389(9) Å, b = 13.089(1) Å, c = 19.466(2) Å, V = 2608.8(4) Å3, T = 120 K, Z = 
4, µ = 3.940 mm-1; 24177 reflections were measured, giving 7639 independent, of 
which 5147 with I > 3σ(I) were used in the refinements. The internal agreement had R 
= 0.079, the final R = 0.033, Rw = 0.035, GOF = 0.90, for the significant reflections. 
 
Table 4.7 Bond distances of the non-hydrogen atoms (Å) of [CuBr2(1-Np-box)] 
Br(1)-Cu(3) 2.352 C(9)-C(10) 1.362 C(21)-C(24) 1.512 
Br(2)-Cu(3) 2.368 C(10)-C(11) 1.426 C(25)-C(26) 1.539 
Cu(3)-N(6) 1.992 C(11)-C(12) 1.417 C(26)-C(27) 1.527 
Cu(3)-N(7) 1.979 C(11)-C(16) 1.438 C(27)-C(28) 1.429 
O(4)-C(19) 1.458 C(12)-C(13) 1.365 C(27)-C(36) 1.362 
O(4)-C(20) 1.342 C(13)-C(14) 1.409 C(28)-C(29) 1.415 
O(5)-C(24) 1.336 C(14)-C(15) 1.373 C(28)-C(33) 1.432 
O(5)-C(25) 1.472 C(15)-C(16) 1.420 C(29)-C(30) 1.363 
N(6)-C(18) 1.497 C(16)-C(17) 1.421 C(30)-C(31) 1.407 
N(6)-C(20) 1.282 C(17)-C(18) 1.529 C(31)-C(32) 1.363 
N(7)-C(24) 1.272 C(18)-C(19) 1.543 C(32)-C(33) 1.422 
N(7)-C(26) 1.499 C(20)-C(21) 1.510 C(33)-C(34) 1.420 
C(8)-C(9) 1.397 C(21)-C(22) 1.559 C(34)-C(35) 1.355 
C(8)-C(17) 1.370 C(21)-C(23) 1.535 C(35)-C(36) 1.409 
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Table 4.8 Bond angles of the non-hydrogen atoms (°) of [CuBr2(1-Np-box)] 
Br(1)-Cu(3)-Br(2) 98.035 C(13)-C(14)-C(15) 120.059 O(5)-C(24)-C(21) 114.041 
Br(1)-Cu(3)-N(6) 96.078 C(14)-C(15)-C(16) 121.507 N(7)-C(24)-C(21) 127.859 
Br(1)-Cu(3)-N(7) 146.077 C(11)-C(16)-C(15) 117.784 O(5)-C(25)-C(26) 103.821 
Br(2)-Cu(3)-N(6) 147.920 C(11)-C(16)-C(17) 118.643 N(7)-C(26)-C(25) 102.805 
Br(2)-Cu(3)-N(7) 95.370 C(15)-C(16)-C(17) 123.572 N(7)-C(26)-C(27) 109.141 
N(6)-Cu(3)-N(7) 88.621 C(8)-C(17)-C(16) 119.916 C(25)-C(26)-C(27) 115.212 
C(19)-O(4)-C(20) 106.849 C(8)-C(17)-C(18) 121.991 C(26)-C(27)-C(28) 119.865 
C(24)-O(5)-C(25) 106.601 C(16)-C(17)-C(18) 118.055 C(26)-C(27)-C(36) 120.940 
Cu(3)-N(6)-C(18) 124.327 N(6)-C(18)-C(17) 111.813 C(28)-C(27)-C(36) 119.183 
Cu(3)-N(6)-C(20) 127.998 N(6)-C(18)-C(19) 102.642 C(27)-C(28)-C(29) 123.728 
C(18)-N(6)-C(20) 107.552 C(17)-C(18)-C(19) 112.743 C(27)-C(28)-C(33) 118.517 
Cu(3)-N(7)-C(24) 130.243 O(4)-C(19)-C(18) 104.090 C(29)-C(28)-C(33) 117.720 
Cu(3)-N(7)-C(26) 121.843 O(4)-C(20)-N(6) 117.501 C(28)-C(29)-C(30) 121.600 
C(24)-N(7)-C(26) 107.662 O(4)-C(20)-C(21) 113.333 C(29)-C(30)-C(31) 120.944 
C(9)-C(8)-C(17) 121.493 N(6)-C(20)-C(21) 129.059 C(30)-C(31)-C(32) 119.304 
C(8)-C(9)-C(10) 120.774 C(20)-C(21)-C(22) 106.604 C(31)-C(32)-C(33) 121.594 
C(9)-C(10)-C(11) 120.203 C(20)-C(21)-C(23) 111.068 C(28)-C(33)-C(32) 118.818 
C(10)-C(11)-C(12) 121.888 C(20)-C(21)-C(24) 111.694 C(28)-C(33)-C(34) 119.538 
C(10)-C(11)-C(16) 118.968 C(22)-C(21)-C(23) 109.834 C(32)-C(33)-C(34) 121.587 
C(12)-C(11)-C(16) 119.122 C(22)-C(21)-C(24) 107.809 C(33)-C(34)-C(35) 120.409 
C(11)-C(12)-C(13) 120.977 C(23)-C(21)-C(24) 109.725 C(34)-C(35)-C(36) 119.982 
C(12)-C(13)-C(14) 120.514 O(5)-C(24)-N(7) 118.080 C(27)-C(36)-C(35) 122.334 
 
Crystal structure determination of [ZnCl2(1-Np-box)] 
Reference number of the [ZnCl2(1-Np-box)] complex in 
the Cambridge Crystallographic Data Centre. The 
crystal data and a summary of the data collection and 
structure refinement are given below.21 Selected bond 
distances and angles are given in Tables 4.9 and 4.10, 
respectively (for atomic numbering vide infra). 
C29H26Cl2N2O2Zn, M = 570.79, crystallises in the orthorombic space group P212121, 
with a = 9.5190(6) Å, b = 13.4788(17) Å, c = 19.9641(14) Å, V = 2561.5(4) Å3, T = 208(2) 
K, Z = 4, µ = 1.198 mm-1; 39047 reflections were measured, giving 5856 independent, 
of which 4851 with I > 2σ(I) were used in the refinements. The internal agreement 
had R = 0.0374, the final R = 0.0316, Rw = 0.0585, GOF = 1.024, for the significant 
reflections. 
 
Table 4.9 Bond distances of the non-hydrogen atoms (Å) of [ZnCl2(1-Np-box)] 
Zn(1)-N(2) 2.0416(18) C(1)-C(3) 1.525(5) C(15)-C(16) 1.408(4) 
Zn(1)-N(1) 2.0472(17) C(1)-C(2) 1.548(4) C(18)-C(19) 1.539(3) 
Zn(1)-Cl(1) 2.2098(7) C(5)-C(6) 1.538(3) C(19)-C(20) 1.510(3) 
Zn(1)-Cl(2) 2.2169(7) C(6)-C(7) 1.509(3) C(20)-C(29) 1.353(4) 
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O(1)-C(4) 1.331(3) C(7)-C(16) 1.362(3) C(20)-C(21) 1.431(3) 
O(1)-C(5) 1.436(3) C(7)-C(8) 1.430(3) C(21)-C(22) 1.405(3) 
O(2)-C(17) 1.338(3) C(8)-C(9) 1.403(3) C(21)-C(26) 1.424(3) 
O(2)-C(18) 1.446(3) C(8)-C(13) 1.427(3) C(22)-C(23) 1.369(3) 
N(1)-C(4) 1.273(3) C(9)-C(10) 1.365(3) C(23)-C(24) 1.394(4) 
N(1)-C(6) 1.489(3) C(10)-C(11) 1.402(4) C(24)-C(25) 1.346(4) 
N(2)-C(17) 1.268(3) C(11)-C(12) 1.349(4) C(25)-C(26) 1.419(3) 
N(2)-C(19) 1.490(3) C(12)-C(13) 1.417(3) C(26)-C(27) 1.410(4) 
C(1)-C(4) 1.500(3) C(13)-C(14) 1.405(4) C(27)-C(28) 1.348(4) 
C(1)-C(17) 1.507(3) C(14)-C(15) 1.353(4) C(28)-C(29) 1.412(4) 
 
Table 4.10 Bond angles of the non-hydrogen atoms (°) of [ZnCl2(1-Np-box)] 
N(2)-Zn(1)-N(1) 90.52(7) O(1)-C(4)-C(1) 112.28(18) N(2)-C(17)-C(1) 129.2(2) 
N(2)-Zn(1)-Cl(1) 115.69(6) O(1)-C(5)-C(6) 104.72(18) O(2)-C(17)-C(1) 113.03(19) 
N(1)-Zn(1)-Cl(1) 111.64(6) N(1)-C(6)-C(7) 113.08(18) O(2)-C(18)-C(19) 104.38(18) 
N(2)-Zn(1)-Cl(2) 102.80(6) N(1)-C(6)-C(5) 102.25(17) N(2)-C(19)-C(20) 112.37(18) 
N(1)-Zn(1)-Cl(2) 116.25(6) C(7)-C(6)-C(5) 112.31(19) N(2)-C(19)-C(18) 102.78(17) 
Cl(1)-Zn(1)-Cl(2) 116.77(3) C(16)-C(7)-C(8) 119.6(2) C(20)-C(19)-C(18) 113.47(19) 
C(4)-O(1)-C(5) 107.43(17) C(16)-C(7)-C(6) 122.2(2) C(29)-C(20)-C(21) 120.3(2) 
C(17)-O(2)-C(18) 107.00(18) C(8)-C(7)-C(6) 118.08(19) C(29)-C(20)-C(19) 122.1(2) 
C(4)-N(1)-C(6) 107.99(18) C(9)-C(8)-C(13) 117.8(2) C(21)-C(20)-C(19) 117.6(2) 
C(4)-N(1)-Zn(1) 124.37(15) C(9)-C(8)-C(7) 124.0(2) C(22)-C(21)-C(26) 118.4(2) 
C(6)-N(1)-Zn(1) 126.44(13) C(13)-C(8)-C(7) 118.2(2) C(22)-C(21)-C(20) 123.4(2) 
C(17)-N(2)-C(19) 107.77(18) C(10)-C(9)-C(8) 121.4(3) C(26)-C(21)-C(20) 118.3(2) 
C(17)-N(2)-Zn(1) 124.69(15) C(9)-C(10)-C(11) 120.4(3) C(23)-C(22)-C(21) 121.1(2) 
C(19)-N(2)-Zn(1) 123.10(14) C(12)-C(11)-C(10) 120.3(2) C(22)-C(23)-C(24) 120.3(3) 
C(4)-C(1)-C(17) 114.53(18) C(11)-C(12)-C(13) 120.8(3) C(25)-C(24)-C(23) 120.6(2) 
C(4)-C(1)-C(3) 106.4(2) C(14)-C(13)-C(12) 120.8(3) C(24)-C(25)-C(26) 121.2(3) 
C(17)-C(1)-C(3) 108.2(2) C(14)-C(13)-C(8) 119.9(2) C(27)-C(26)-C(25) 122.8(2) 
C(4)-C(1)-C(2) 108.8(2) C(12)-C(13)-C(8) 119.2(2) C(27)-C(26)-C(21) 118.8(2) 
C(17)-C(1)-C(2) 107.7(2) C(15)-C(14)-C(13) 120.3(3) C(25)-C(26)-C(21) 118.5(3) 
C(3)-C(1)-C(2) 111.2(3) C(14)-C(15)-C(16) 120.6(3) C(28)-C(27)-C(26) 121.6(2) 
N(1)-C(4)-O(1) 117.3(2) C(7)-C(16)-C(15) 121.2(3) C(27)-C(28)-C(29) 119.9(3) 
N(1)-C(4)-C(1) 130.3(2) N(2)-C(17)-O(2) 117.8(2) C(20)-C(29)-C(28) 120.9(3) 
 
Crystal structure determination of [CuCl2(2-Np-box)] 
Reference number of the [CuCl2(2-Np-box)] complex in 
the Cambridge Crystallographic Data Centre. The crystal 
data and a summary of the data collection and structure 
refinement are given below.21 Selected bond distances and 
angles are given in Tables 4.11 and 4.12, respectively (for 
atomic numbering vide infra). 
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C29H26Cl2CuN2O2, M = 568.96, crystallises in the orthorombic space group P212121, 
with a = 11.7629(12) Å, b = 11.7891(6) Å, c = 19.4027(17) Å, V = 2690.7(4) Å3, T = 208(2) 
K, Z = 4, µ = 1.039 mm-1; 78222 reflections were measured, giving 4708 independent, 
of which 4050 with I > 2σ(I) were used in the refinements. The internal agreement 
had R = 0.0623, the final R = 0.0465, Rw = 0.1155, GOF = 1.110, for the significant 
reflections. 
 
Table 4.11 Bond distances of the non-hydrogen atoms (Å) of [CuCl2(2-Np-box)] 
Cu(1)-N(1) 1.974(4) O(2)-C(9) 1.443(7) C(16)-C(17) 1.438(7) 
Cu(1)-N(2) 1.977(4) N(2)-C(8) 1.491(6) C(17)-C(18) 1.407(7) 
Cu(1)-Cl(1) 2.2112(13) C(6)-C(10) 1.489(7) C(18)-C(19) 1.363(6) 
Cu(1)-Cl(2) 2.2234(14) C(6)-C(7) 1.529(7) C(20)-C(21) 1.388(6) 
C(1)-C(2) 1.500(7) C(8)-C(20) 1.500(7) C(20)-C(29) 1.399(6) 
C(1)-C(3) 1.510(8) C(8)-C(9) 1.522(7) C(21)-C(22) 1.424(6) 
C(1)-C(4) 1.522(8) C(10)-C(11) 1.384(6) C(22)-C(23) 1.369(8) 
C(1)-C(5) 1.542(9) C(10)-C(19) 1.410(6) C(22)-C(27) 1.406(7) 
C(2)-N(1) 1.264(6) C(11)-C(12) 1.427(6) C(23)-C(24) 1.328(9) 
C(2)-O(1) 1.327(6) C(12)-C(13) 1.378(7) C(24)-C(25) 1.350(10) 
O(1)-C(7) 1.452(7) C(12)-C(17) 1.406(7) C(25)-C(26) 1.359(9) 
N(1)-C(6) 1.489(6) C(13)-C(14) 1.333(8) C(26)-C(27) 1.448(7) 
C(3)-N(2) 1.261(6) C(14)-C(15) 1.362(9) C(27)-C(28) 1.405(7) 
C(3)-O(2) 1.343(6) C(15)-C(16) 1.358(9) C(28)-C(29) 1.364(6) 
 
Table 4.12 Bond angles of the non-hydrogen atoms (°) of CuCl2(2-Np-box)] 
N(1)-Cu(1)-N(2) 89.31(17) C(3)-O(2)-C(9) 106.1(4) C(15)-C(16)-C(17) 117.7(6) 
N(1)-Cu(1)-Cl(1) 148.54(12) C(3)-N(2)-C(8) 107.7(4) C(12)-C(17)-C(18) 119.0(4) 
N(2)-Cu(1)-Cl(1) 97.88(13) C(3)-N(2)-Cu(1) 128.5(4) C(12)-C(17)-C(16) 119.2(5) 
N(1)-Cu(1)-Cl(2) 94.74(12) C(8)-N(2)-Cu(1) 123.5(3) C(18)-C(17)-C(16) 121.9(5) 
N(2)-Cu(1)-Cl(2) 139.83(12) N(1)-C(6)-C(10) 110.4(4) C(19)-C(18)-C(17) 121.1(5) 
Cl(1)-Cu(1)Cl(2) 99.03(5) N(1)-C(6)-C(7) 102.3(4) C(18)-C(19)-C(10) 121.5(5) 
C(2)-C(1)-C(3) 112.3(4) C(10)-C(6)-C(7) 117.6(5) C(21)-C(20)-C(29) 117.9(4) 
C(2)-C(1)-C(4) 108.9(4) O(1)-C(7)-C(6) 103.8(4) C(21)-C(20)-C(8) 118.7(4) 
C(3)-C(1)-C(4) 110.2(5) N(2)-C(8)-C(20) 112.0(4) C(29)-C(20)-C(8) 123.3(4) 
C(2)-C(1)-C(5) 106.3(5) N(2)-C(8)-C(9) 101.9(4) C(20)-C(21)-C(22) 120.5(5) 
C(3)-C(1)-C(5) 107.4(4) C(20)-C(8)-C(9) 113.8(4) C(23)-C(22)-C(27) 116.7(6) 
C(4)-C(1)-C(5) 111.6(6) O(2)-C(9)-C(8) 104.2(4) C(23)-C(22)-C(21) 123.1(6) 
N(1)-C(2)-O(1) 117.4(4) C(11)-C(10)-C(19) 118.2(4) C(27)-C(22)-C(21) 120.1(5) 
N(1)-C(2)-C(1) 129.9(5) C(11)-C(10)-C(6) 122.3(4) C(24)-C(23)-C(22) 123.5(8) 
O(1)-C(2)-C(1) 112.7(4) C(19)-C(10)-C(6) 119.4(4) C(23)-C(24)-C(25) 119.4(8) 
C(2)-O(1)-C(7) 106.9(4) C(10)-C(11)-C(12) 121.3(4) C(24)-C(25)-C(26) 123.9(7) 
C(2)-N(1)-C(6) 108.0(4) C(13)-C(12)-C(17) 117.9(5) C(25)-C(26)-C(27) 115.2(6) 
C(2)-N(1)-Cu(1) 128.1(3) C(13)-C(12)-C(11) 123.2(5) C(28)-C(27)-C(22) 118.1(4) 
C(6)-N(1)-Cu(1) 123.7(3) C(17)-C(12)-C(11) 118.9(5) C(28)-C(27)-C(26) 121.1(6) 
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N(2)-C(3)-O(2) 117.1(5) C(14)-C(13)-C(12) 123.1(7) C(22)-C(27)-C(26) 120.8(6) 
N(2)-C(3)-C(1) 129.4(4) C(13)-C(14)-C(15) 119.4(7) C(29)-C(28)-C(27) 120.8(5) 
O(2)-C(3)-C(1) 113.4(4) C(16)-C(15)-C(14) 122.7(6) C(28)-C(29)-C(20) 122.5(5) 
 
EPR measurements on [Cu(II)box] complexes 
For EPR measurements, Cu(OTf)2 (18 mg, 50 µmol) and box ligand (50 µmol) were 
dissolved in CH2Cl2 (1.0 mL); [(n-Bu)4N]PF6 (50 mg, 0.13 mmol) was added to the 
mixture to obtain a good glass during the EPR-experiment. The EPR-spectrum was 
recorded before and after addition of an excess of methyl pyruvate (ca. 0.2 mL, 2.0 
mmol).  
Experimental X-band EPR spectra were recorded on an Bruker ER220 spectrometer at 
40 K at a frequency of 9.30 GHz (gain = 4 × 104, modulation amplitude = 4 gaus, 
attenuation = 30 dB). The simulated spectra were simulated by iteration of the 
anisotropic g-values, (super)hyperfine coupling constants, and line widths.22 
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a Multipurpose Crystallographic Tool developed by A. L. Spek, 2003, University of 
Utrecht, The Netherlands). The calculations revealed no higher symmetry and no 
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Institut für Bioanorganische Chemie, Mülheim a/d Ruhr, Germany. 
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5 Formation of chromanes via an enantioselective tandem reaction1 
5.1 Introduction 
An important class of oxygenated heterocyclic compounds is constituted by 
functionalised chromanes (3,4-dihydro-1H-1-benzopyrans). These types of 
compounds have attracted synthetic interest because of the biological activity of 
naturally occuring representatives.2 An evident example of a naturally occurring 
chromane is vitamin E (A, Figure 5.1), which acts as an antioxidant.3 A similar 
structural moiety is found in sorbinil (B), which functions as an aldose reductase 
inhibitor.4 Other examples of biologically active chromanes are compounds C, which 
are able to inhibit a multidrug transporter that decreases drug accumulation in 
resistant cells.5 Additionally, structurally related N-containing analogues D appear to 
be part of this new class of multidrug resistance modulators.5 
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Figure 5.1 Biologically active chromanes and tetrahydroquinolines 
Although numerous synthetic routes towards highly functionalised 
chromanes have been reported over the past decades,8 we set out to investigate a 
tandem approach to access such functionality. We wished to synthesise chromanes 2 
starting from phenols 3 and the β,γ-unsaturated α-keto esters 4 (Scheme 5.1). Ring 
closure of the pyran moiety was envisaged to be established by a Friedel–Crafts type 
alkylation of the intermediate resulting from an oxa-Michael addition of the phenol 
onto the α,β-unsaturated carbonyl compound. 
A particular challenge is to develop an enantio- and diastereoselective 
process, which proceeds in a tandem fashion. This means that an enantiomerically 
pure catalyst should induce enantioselectivity in the first step, after which the newly 
generated stereogenic center directs the diastereoselectivity in the next steps. Our 
route, depicted in Scheme 5.2, initially involved a chiral Lewis acid-catalysed oxa-
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Michael addition of phenol 3 to the β,γ-unsaturated α-keto ester 4. The resulting 
Michael adduct 5 immediately should undergo intramolecular Friedel–Crafts type 
alkylation to form chromane 2 in a diastereoselective fashion. 
HO
O
OH
CO2Me
Ar
R
R
Ar CO2Me
O
+
3 42  
Scheme 5.1 Retrosynthesis 
Although several examples of oxa-Michael additions are known, only one 
enantioselective catalytic version has been reported by Ishikawa and coworkers.10 In 
the presence of (–)-quinine, intramolecular addition of a phenol to an α,β-
unsaturated ketone afforded a 4:1 mixture of cis- and trans-chromanones, with 98% 
ee for the cis-isomer. 
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Scheme 5.2 The consecutive steps of the tandem process 
We were aiming for the use of bisoxazolines11 in combination with different 
metals, since these Lewis acid catalysts have been frequently used for Michael 
additions12 and Friedel–Crafts alkylations.13 Considering the fact that bisoxazolines 
have been applied before in tandem processes,14 and that they are known to catalyse 
each of these reaction types, we reasoned that such catalysts may be useful for 
perform our targeted tandem reaction in the desired fashion. 
5.2 Results and discussion 
A variety of Lewis acids in combination with the chiral box ligands 1a-f were 
evaluated as catalysts. Other chiral ligands, e.g. (DBFOX)/Ph, BINOL and salen type 
ligands15 in combination with various Lewis acids did not induce enantioselectivity, 
or catalyse the reaction toward the tandem product. Preliminary studies suggested 
that especially the C2-symmetric bisoxazolines were the best ligands for this tandem 
reaction. Beside commercially available t-Bu- and Ph-box, we included a range of 
readily available more extended aryl-box ligands: 1-Np-box16, 2-Np-box, 9-Ant-box 
and (4R,5S)-diPh-box17 (Figure 5.2). 
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Figure 5.2 Bisoxazoline ligands applied in the tandem reaction 
5.2.1 Search for an optimal catalytic system 
Initially, we subjected a mixture of m-methoxyphenol 3a and the β,γ-
unsaturated α-keto ester 4a to a catalyst that was prepared from Cu(OTf)2 and box 
ligands 1a-c. As shown in Table 5.1 (entries 1-3), we successfully applied box ligands 
in the synthesis of chromane 2a in moderate yields (49–58%). Concluding from NMR, 
the chromane was formed diastereoselectively in all cases; the relative 
stereochemistry was elucidated by NOESY studies and the absolute stereochemistry 
was assigned in a later stage based on vibrational circular dichroism (VCD) 
measurements (Section 5.4). 
The desired tandem product could be readily purified by flash column 
chromatography. In this purification, 1-Np-box ligand (1c) could be quantitatively 
recovered, whereas the other box ligands were filtered off together with the Lewis 
acid during workup. 
Table 5.1 Variation of ligand and solvent in the tandem reaction 
OH
OMe
O
HO CO2Me
ArMeOAr CO2Me
O
+
3a 4a (Ar = p-ClC6H4) 2a (Ar = p-ClC6H4)
box·Cu(OTf)2 CO2Me
OAr
6a (Ar = p-ClC6H4)
R
OH
+
solvent, rt
 
entry ligand solvent yield 2a (%)a ee 2a (%)b,c yield 6a (%)a 
1 t-Bu-box CH2Cl2 57 36 (2R,4S) nd 
2 Ph-box CH2Cl2 58 16 (2R,4S) 21 
3 1-Np-box CH2Cl2 49 21 (2R,4S) 21 
4 1-Np-box THF 26 16 (2R,4S) 43 
5 1-Np-box Et2O 31 4 (2R,4S) 37 
6 1-Np-box toluene 65 28 (2R,4S) 20 
a Isolated yields. b Enantiomeric excesses were determined by chiral HPLC analysis on a 
Chiralcel OD column (hexane/i-PrOH 95:5, 0.5 mL/min) or by GC analysis using a chiral β-
CD column (200 °C). c Geometry of the major enantiomer was assigned based on VCD 
measurements studies (Section 5.4). 
In addition to the desired tandem product 2a, we observed the direct Friedel–
Crafts alkylation product 6a, which resulted from C-nucleophilic 1,4-addition of the 
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phenol to the α,β-unsaturated carbonyl compound (Scheme 5.3).13c Concluding from 
Table 5.1, side product 6a was obtained in varying amounts, but could be readily 
separated from the Friedel–Crafts product by flash column chromatography.  
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Scheme 5.3 Tandem process vs.C-conjugate addition 
Although it is clear from Table 5.1 that the best enantiomeric excess was 
obtained in the presence of t-Bu-box (entry 1, 36% ee), we anticipated that the 1-Np-
box eventually may give higher enantioselectivities under optimised conditions. 
From preliminary studies, we had concluded that 1-Np-box was especially suited for 
reactions where the reacting centre is relatively remote from the coordination site 
(Chapter 3).16 Therefore, we initially ensued our optimisation studies in the presence 
of the 1-Np-box ligand in a range of different solvents. First of all, it was found that 
toluene was the best solvent (entry 6), giving both the highest enantiomeric excess 
(28% ee) and highest yield (65%). Moreover, formation of the undesired direct 
Friedel–Crafts alkylation of the α,β-unsaturated ketone to give 6a was maximally 
suppressed. 
Table 5.2 Different metal salts and different box ligands 
OH
OMe
O
HO CO2Me
ArMeOAr CO2Me
O
+
3a 4a (Ar = p-ClC6H4) 2a (Ar = p-ClC6H4)
box·MX2
toluene, rt
 
entry ligand Lewis acid yield (%)a ee (%) 
1 1-Np-box Cu(OTf)2 65 28 (2R,4S) 
2 1-Np-box Zn(OTf)2 32 17 (2S,4R)b 
3 1-Np-box Mg(OTf)2 53 62 (2R,4S) 
4 1-Np-box Mg(ClO4)2 66 40 (2R,4S) 
5c 1-Np-box MgI2 62 24 (2R,4S) 
6 1-Np-box MgI2d 64 42 (2R,4S) 
7 t-Bu-box Mg(OTf)2 67 2 (2S,4R)b 
8 Ph-box Mg(OTf)2 32 44 (2R,4S) 
9 diPh-box Mg(OTf)2 20 50 (2S,4R)b 
a Isolated yields. b The opposite enantiomer was obtained.  c The reaction was started at 0 °C 
and allowed to warm to rt.  d The addition of iodide (0.5 equiv with respect to MgI2) is known 
to activate MgI2.18  
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Replacement of Cu(OTf)2 by Zn(OTf)2 led to a decreased enantioselectivity 
(28% to 17% ee), whereas Mg(OTf)2 resulted in a remarkable increase of the 
enantiomeric excess of 2a to 62% ee (Table 5.2, entries 1-3). In the presence of other 
Mg(II) salts, i.e. using different counter ions (entries 4-6), a decrease in 
enantioselectivity was observed. By applying other commercially and readily 
available box ligands under the aforementioned reaction conditions, we tried to 
optimise the best result so far (Mg(OTf)2, 1-Np-box, toluene: 62% ee). Surprisingly, in 
the presence of t-Bu-box (1a), no enantioselectivity was observed, while Ph-box (1b) 
and (4R,5S)-diPh-box (1f) resulted in  a decrease of enantioselectivity to 44% and 50% 
ee, respectively. 
Table 5.3 Comparison of different solvents 
1-Np-box·Mg(OTf)2
OH
OMe
O
HO CO2Me
ArMeOAr CO2Me
O
+
3a 4a (Ar = p-ClC6H4) 2a (Ar = p-ClC6H4)
solvent, temp
 
entry solvent temp yield (%)a ee (%) 
1 toluene rt 53 62 (2R,4S) 
2 Et2O rt 0 — 
3 THF rt 0 — 
4 CH2Cl2 rt 60 47 (2R,4S) 
5 ClCH2CH2Cl rt 57 45 (2R,4S) 
6 toluene 0 °C  39 74 (2R,4S) 
7 toluene –14 °C 0 — 
a Isolated yields. 
In order to verify the suitability of toluene for this catalytic system, we 
performed the tandem process in a range of solvents (Table 5.3, entries 1-5). 
Nevertheless, in the presence of Mg(OTf)2 and 1-Np-box, toluene appeared to be the 
most appropriate solvent. The tandem reaction did not proceed at all in THF and 
Et2O, i.e. only starting material was recovered. On the other hand, we observed a 
good conversion into chromane 2a in dichloromethane and dichloroethane, but the 
enantioselectivity was significantly reduced to 47% ee and 45% ee, respectively.  
Additionally, a positive effect was observed by decreasing the temperature to 
0 °C, leading to an enhanced enantioselectivity of 74% ee with a slightly lower yield 
(entry 6). In addition, at this temperature the formation of the direct Friedel–Crafts 
alkylation product 6a was reduced. Further decrease of the temperature led to a 
complete loss of reactivity; i.e. at –14 °C, no reaction took place. 
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5.2.2 Effect of addition of base 
Previously, it was found in similar nucleophilic addition reactions that yield 
and enantiomeric excess could be significantly improved upon addition of a tertiary 
amine base, probably due to facilitated addition of the nucleophile by 
deprotonation.19 Thus, we performed the tandem reaction in the presence of 10 mol% 
of Et3N, resulting in an improved yield of 2a from 39% to 87% (Table 5.4). The 
concomitant decrease in enantioselectivity (from 74% ee to 63% ee) was probably due 
to background catalysis by Et3N. This background reaction was verified by 
performing the tandem reaction in the presence of 10 mol% of solely Et3N affording 
racemic chromane 2a in 23% yield and side product 6a in 31% yield after a common 
reaction time. In order to diminish this undesired background reaction, the amount 
of Et3N was reduced to 2 mol%, affording chromane 2a in a somewhat lower yield 
(61%) – but still improved compared to the yield in the absence of Et3N – and slightly 
enhanced enantioselectivity (74%). 
Table 5.4 Influence of bases on the tandem reaction 
OH
OMe
O
HO CO2Me
ArMeOAr CO2Me
O
+
3a 4a (Ar = p-ClC6H4) 2a (Ar = p-ClC6H4)
1-Np-box·Mg(OTf)2 CO2Me
OAr
6a (Ar = p-ClC6H4)
R
OH
+
toluene, 0 °C
additive
 
entry additive mol % yield 2a (%)a ee 2a (%) yield 6a 
(%)a 
1 none — 39 74 (2R,4S) 6 
2 Et3N 10 87 63 (2R,4S) nd 
3 Et3N 5 54 72 (2R,4S) 18 
4 Et3N 2 61 74 (2R,4S) 15 
5 KOt-Bu 10 59 73 (2R,4S) 28 
6 NMM 10 31 56 (2R,4S) 24 
7 DABCO 10 24 59 (2R,4S) 65 
8 proton spongeb 10 21 81 (2R,4S) 74 
9 EtNiPr2 10 30 72 (2R,4S) 43 
10 PhNBn2 10 31 69 (2R,4S) <5 
11 p-TolNMe2 10 89 73 (2R,4S) <5 
a Isolated yields. b Proton sponge = 1,8-bis(dimethylamino)naphthalene. 
In the presence of KOt-Bu (10 mol%), the tandem product was formed with 
an enantioselectivity of 73% ee (Table 5.4, entry 5). Although the yield was slightly 
better than in the absence of base, addition of Et3N resulted in a better enhancement 
of the yield. Other bases such as N-methylmorpholine (NMM) and 1,4-
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diazabicyclo[2.2.2]octane (DABCO) resulted in a decrease of enantioselectivity and 
lower yields, partially due to enhanced formation of the direct Friedel–Crafts 
alkylation product. Use of proton sponge (1,8-bis(dimethylamino)naphthalene) 
resulted in an enhanced enantioselectivity of 81% ee. Unfortunately, the rate of the 
direct Friedel–Crafts alkylation reaction was also increased, affording mainly side 
product (6a) and only 21% of the desired tandem product. 
Addition of other amine-based additives such as Hünig´s base and 
dibenzylphenylamine did not improve the enantioselectivity, and even resulted in a 
decrease of the yield. Finally, in the presence of N,N-dimethyl-p-toluidine, the 
tandem reaction proceeded smoothly affording chromane 2a with similar 
enantioselectivity and in enhanced yield (89%), rendering this the method of choice. 
5.2.3 Comparison of different box ligands 
So far, the tandem reaction has been optimised for 1-Np-box in combination 
with Mg(OTf)2 as the catalyst (10 mol%), i.e. in toluene at 0 °C and in the presence of 
10 mol% of N,N-dimethyl-p-toluidine. In order to compare several box ligands, we 
applied t-Bu-box and some aryl-substituted ligands in the tandem reaction under 
these conditions (Table 5.5). Apparently, t-Bu-box is not an appropriate ligand for 
this reaction, since tandem product 2a was obtained with only 18% ee (entry 1). Also 
in the presence of Cu(OTf)2 instead of Mg(OTf)2, the product was formed in only 26% 
yield and with <15% ee.  
Table 5.5 Comparison of different ligands under optimised reaction conditions 
OH
OMe
O
HO CO2Me
ArMeOAr CO2Me
O
+
3a 4a (Ar = p-ClC6H4) 2a (Ar = p-ClC6H4)
box·Mg(OTf)2
toluene, 0 °C
p-TolNMe2
 
entry ligand toluene 
  yield (%)a ee (%) 
1 t-Bu-box 77 18 (2S,4R)b 
2 Ph-box 75 65 (2S,4R)b 
3 1-Np-box 39 74 (2R,4S) 
4 2-Np-box 67 62 (2R,4S) 
5 9-Ant-box nd 20 (2R,4S) 
a Isolated yields. b The opposite enantiomer was obtained. 
Surprisingly, the presence of Ph-box resulted in the opposite enantiomer of 2a 
compared to both 1-Np- and 2-Np-box, whereas t-Bu-box resulted in the same 
enantiomer (see for a similar phenomenon, Chapter 3). The 1-Np-box ligand clearly 
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resulted in the best enantioselectivity (74% ee), whereas in the presence of both Ph- 
and 2-Np-box, the product was formed with remarkably better yield, but a slight 
decrease in enantioselectivity (65% ee and 62% ee, respectively). To our surprise, the 
more bulky 9-Ant-box in combination with Mg(OTf)2 resulted in a drastic decrease in 
enantioselectivity (20% ee). A possible explanation for the low enantiopurity can lie 
in the relatively long reaction time (ca. 20 h) in combination with slow decomposition 
of the 9-Ant-box ligand at 0 °C (Chapter 2). 
5.2.4 Variation of electrophile and nucleophile 
Hitherto, 1-Np-box has been identified as the ligand of choice. Under the 
aforementioned reaction conditions, m-methoxyphenol was reacted with a range of 
aryl-substituted β,γ-unsaturated α-keto esters (4b-d, Table 5.6, entries 1-4) to give the 
tandem products in high yields and as a single diastereomer, as proven by 1H-NMR 
studies. For the phenyl-substituted enone 4b, a decrease of both yield and 
enantiomeric excess was observed in the absence of N,N-dimethyl-p-toluidine 
(compare entry 1 and entry 2), which was similar to the results for β,γ-unsaturated α-
keto esters 4a (Table 5.4). The enantioselectivity appeared to be weakly dependent on 
the aryl substituent, resulting in enantiomeric excesses ranging from 66% to 80%. In 
contrast, replacement of the aryl substituent by a methyl group resulted in the 
formation of a mixture of diastereoisomers (4:1) both with low enantioselectivity.  
Table 5.6 Variation of acceptor molecule and Michael donor 
OH
R
Ar CO2Me
O
O
HO CO2Me
ArMeO
+
3 4 2
1-Np-box·Cu(OTf)2
toluene, 0 °C
 
entry R Ar product yield (%)a ee (%) 
1 OMe C6H5 2b 67 73 
2b OMe C6H5 2b 77 80 
3b OMe p-FC6H4 2c 43 74 
4b OMe p-BrC6H4 2d 45 66 
5 NMe2 p-ClC6H4 2e >95 <18 
6 NMe2 C6H5 2f >95 13 
a Isolated yields. b The reaction was performed in the presence of N,N-dimethyl-p-toluidine. 
In order to vary the nucleophile, the methoxy substituent of phenol 3a was 
replaced with a dimethylamine group. m-(Dimethylamino)phenol 3b was reacted 
with both aryl-substituted β,γ-unsaturated α-keto esters 4a (R = Cl) and 4b (R = H), 
affording the corresponding chromanes as single diastereoisomers in excellent yield 
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(>95%), but with low enantioselectivity (<20% ee). Most likely, the higher electron-
donating character of the dimethylamine substituent (compared to the methoxy 
group) rendered the nucleophile sufficiently reactive for an uncatalysed (non-
selective) oxa-Michael addition. 
An analogous effect was observed during our attempts to prepare 
tetrahydroquinolines,20 where in a similar process m-methoxy-N-methylaniline (7) 
was reacted with β,γ-unsaturated α-keto ester 4a (Scheme 5.4). Indeed, the 
corresponding tetrahydroquinoline (8) was formed quantitatively — with complete 
suppression of the direct Friedel–Crafts alkylation — and in diastereomerically pure 
form, but unfortunately without any enantioselectivity. The relative stereochemistry 
of 8 has not been determined, but is assumed to be identical to the oxygen 
heterocycles. 
NHMe
OMe
N
Me
HO CO2Me
ArMeOAr CO2Me
O
+
7 4a (Ar = p-ClC6H4) 8 (Ar = p-ClC6H4)
>99% yield
>99:1 dr
0% ee
1-Np-box·Mg(OTf)2
toluene, 0 °C
 
Scheme 5.4 Formation of the tetrahydroquinoline 8 
5.3 Mechanistic studies 
Since it was observed that the enantioselectivity of the initial oxa-Michael 
reaction was highly nucleophile- and condition-dependent, we decided to investigate 
the role of the base. Therefore, sodium m-methoxyphenolate (9) was prepared and 
subjected to the tandem reaction conditions. In the absence of Lewis acid, the 
expected oxa-Michael product 5 was not detected, nor tandem product 2. After 
addition of a catalytic amount of [Mg(OTf)2(1-Np-box)], however, tandem product 2 
was obtained in good yield, but without enantioselectivity. We speculate that Le 
Chatelier´s principle is operative here, i.e. phenolate 9 is sufficiently nucleophilic to 
give (non-selective) conjugate addition onto β,γ-unsaturated α-keto ester 4, but 
unless the adduct 5 is further transformed by Lewis acid- or base-catalysed formation 
of chromane 2, the equilibrium of addition lies far to the left (Scheme 5.5). 
ONa
R
O
HO CO2Me
ArRAr CO2Me
OOR
Ar CO2Me
O
+
9 4 25
Lewis acid
or base
 
Scheme 5.5 Profile of the tandem reaction 
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Close examination revealed that the tandem product 2 was formed in 
diastereomerically pure form so that the second reaction step must be highly 
diastereoselective. The enantioselectivity of the reaction is determined in the oxa-
Michael addition, but since the equilibrium of this first reaction step lies heavily at 
the side of the substrates, we were not able to detect intermediate 5 with NMR-
studies. By decreasing the temperature to 0 °C, formation of the kinetically more 
stable enantiomer of oxa-Michael addition adduct 5 is favoured, thereby leading to 
enhanced enantioselectivity (Table 5.3). 
Replacement of phenol 3a by m-methoxy-N-methylaniline (7) afforded solely 
racemic tetrahydroquinoline 8 (Scheme 5.4). In this case, the aza-Michael addition 
proceeded smoothly in a non-selective way due to the relatively high nucleophilicity 
of the aniline. This has also as a result that the competitive formation of the 
undesired direct Friedel–Crafts alkylation product is not observed. 
5.4 Assignment of the stereochemistry of the tandem product 
The relative stereochemistry of chromane 2a was deduced from a NOESY-
experiment (Figure 5.3). The two-dimensional spectrum revealed that H2 is in close 
proximity to both H1 and OH; OH shows no NOE-correlations to H3 and H1 shows a 
much stronger NOE-correlation to H2 than to H3. This led to the conclusion that H1 
and OH are cis with respect to each other, resulting in the diastereoisomer depicted 
in Figure 5.3. This is in line with results from simple MM2-modelling studies 
showing that this is the thermodynamically most stable configuration (∆Ecis/trans = 
4.11 kcal/mol).21 
 
Figure 5.3 Elucidation of the relative stereochemistry by NOESY-studies 
O
MeO2C O
Ar
H1
MeO
H3
H2
H
2a (Ar = p-ClC6H4)
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Several attemps have also been made to reveal the absolute stereochemistry 
of the product. Unfortunately, the chloro-substituted chromane 2a did not afford a 
crystalline compound that was suitable for X-ray analysis. Additional attempts to 
obtain crystals remained unsuccessful, e.g. by conversion of the ester function of the 
chromane into the corresponding (R)-α-methylbenzylamide22 and (S)-α-methoxy-α-
(trifluoromethyl)phenylacetic (MTPA) ester.23 
Initially, in order to gain insight into the enantiodifferentiation of the reaction, 
we performed PM3-level calculations24 on the proposed intermediate, the complex of 
the [Mg(II)(1-Np-box)] catalyst bound to β,γ-unsaturated α-keto ester 4b (Figure 5.4). 
Since we were not able to obtain crystals of a [Mg(II)(1-Np-box)] complex that were 
suitable for X-ray analysis, we used the ligand parameters of the [CuCl2(1-Np-box)]25 
as input for molecular modelling. These PM3-calculations then showed a strong 
preference for a (distorted) tetrahedral geometry. 
 
Figure 5.4 PM3 model of [Mg(II)(1-Np-box)] complex with 4b 
As depicted in Figure 5.4, in this conformation the re-face of the β,γ-
unsaturated α-keto ester 4b, coordinated to magnesium perpendicular to the box 
ligand, is blocked from attack by a nucleophile due to the naphthyl substituent on 
the right side. This suggests that attack on the si-face is favoured, resulting in the (S)-
enantiomer of Michael adduct 5b and subsequently the (2S,4R)-enantiomer of 
chromane 2b (Figure 5.3). Based on X-ray analysis of α,β-unsaturated ester 4a, we 
assumed that the α,β-unsaturated ester is present in its s-cis conformation during the 
reaction. Consequently, modelling studies tentatively predicted a stereochemical 
outcome of the reaction to form the (2S,4R)-enantiomer. Logically, if the α,β-
unsaturated ester would be complexed in the s-trans configuration, this would lead 
to the opposite enantiomer of the tandem product.  
In addition to the modeling studies, vibrational circular dichroism (VCD) 
analysis was applied in an attempt to determine the absolute configuration of the 
compounds. VCD has recently emerged as a reliable spectroscopic method for 
assigning the absolute configuration by calculating the IR and VCD spectra of both 
enantiomers based on a database.26 It resembles circular dichroism, but originates in 
vibrational transitions (IR area). In collaboration with BioTools (Wauconda, Illinois, 
USA), the IR and VCD spectra for both enantiomers of chromane 2a were calculated 
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based on spectra of a Boltzmann population-weighted composite of the lowest 
energy conformers.27 
Initially, calculations were performed for the two low-energy isolated (gas-
phase) conformers. However, the agreement between experiment and calculation 
was not sufficient for unambiguous assignment of the absolute configuration, as 
depicted in Figure 5.5 (left). Therefore, additional calculations were initiated on three 
dimeric species, which all showed an improved agreement with both experimental 
spectra (right). 
 
 
Figure 5.5 Comparison of IR (lower frame) and VCD (upper frame) spectra observed for 
chromane 2a (right axes) with calculated spectra (left axes) for Boltzman population-weighted 
sum of monomer (left) and for dimer conformers (right). 
The experimental VCD spectrum obtained from chromane 2a (with 74% ee) 
was then compared to the calculated spectra for both enantiomers, as shown in 
Figure 5.6. The Boltzmann population composite calculated spectrum for the three 
dimer conformers of the (2R,4S)-enantiomer demonstrates many regions of 
agreement with the experimental spectrum (left). Therefore, we may conclude that 
the major enantiomer of chromane 2a formed in the tandem reaction in the presence 
of 1-Np-box possesses the (2R,4S)-configuration. 
 
 
Formation of chromanes via an enantioselective tandem reaction 
109 
 
 
O
MeO2C OH
MeO Ar O
MeO2C OH
MeO Ar
(2R,4S)-2a
(Ar = p-ClC6H4)
(2S,4R)-2a
(Ar = p-ClC6H4)  
Figure 5.6 VCD spectra observed and calculated for both enantiomers of chromane 2a 
5.5 Conclusions 
In summary, we have developed a novel enantio- and diastereoselective 
catalytic tandem reaction involving an oxa-Michael addition and subsequent Friedel–
Crafts type alkylation providing facile access to diastereomerically pure 
functionalised chromanes (dihydrobenzopyrans) 2 with enantioselectivities up to 
81% ee. This reaction represents the first example where the bulky 1-Np-box ligand 
gives results that are superior to the existing box ligands under optimised conditions 
(Mg(OTf)2, 0 °C, toluene). Addition of N,N-dimethyl-p-toluidine (10 mol%) resulted 
in an enhanced yield without loss of ee. Under these conditions, undesired C-
nucleophilic 1,4-addition to side product 6 was maximally suppressed. 
Variation of the nucleophile revealed that replacement of the methoxy 
substituent by the more electron-donating dimethylamino group resulted in a 
dramatic decrease of enantioselectivity. Applying somewhat less reactive m-
methoxy-N-methylaniline, afforded exclusively the desired tetrahydroquinoline 8, 
although without any enantioselectivity. 
Using NOESY studies, the relative stereochemistry of the tandem products 
was established. So far, we were unable to establish the absolute configuration of the 
products; based on VCD measurements, which is more reliable than the modelling 
results, the stereochemical outcome of the reaction was assigned to be the (2R,4S)-
enantiomer of chromanes 2. 
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5.7 Experimental section 
General methods 
For general experimental details, see Section 2.9. 
NMR spectra were recorded with a Varian Inova 400 MHz spectrometer in CDCl3 
solutions. Flash chromatography was performed with Merck silica gel 60 (230–400 
mesh). 
 
Materials 
Aryl-substituted β,γ-unsaturated α-keto esters 4a-d were synthesised by the group of 
Jørgensen. 
 
Representive experimental procedure for VCD measurements 
A solution of ~10 mg chromane 2a (74% ee) in 85 µL CDCl3 was prepared and placed 
in a 75 µm path length BaF2 cell. IR and VCD spectra were recorded at 4 cm-1 
resolution on a modified ChiralIR spectrometer, with 7 h collection for the sample, 
and 8 h collection for the solvent. 
 
Representative experimental procedure 
To a flame-dried Schlenk tube was added Mg(OTf)2 (8.0 mg, 0.025 mmol) and (S)-1c 
(12 mg, 0.028 mmol). The mixture was dried in vacuo for 0.5 h and distilled 
anhydrous toluene (0.5 mL) was added. After stirring for 0.5 h, 4a (58 mg, 0.25 mmol) 
and N,N-dimethyl-p-toluidine (3.6 µl, 0.025 mmol) were added and the mixture was 
cooled to 0 °C. After addition of 3a (55 µl, 0.50 mmol), the mixture was stirred 
overnight at 0 °C. Flash chromatography (Et2O/pentane 1:4) afforded 2a as a 
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colourless oil (77 mg, 89%): the ee was determined by HPLC to be 73%: OD column; 
hexane/i-PrOH 95:5; 1.0 mL/min; tR(major) = 12.9 min, tR(minor) = 14.4 min. 
 
Methyl 2-(4-chlorophenyl)-4-hydroxy-7-methoxychromane-4-carboxylate (2a) 
Chromane 2a was isolated as a colourless oil; [α]D25 = +0.28 (c 
0.63, CHCl3, 73% ee); 1H-NMR (CDCl3, 400 MHz): δ = 7.31 (dt, J = 
2.0, 8.4 Hz, 2H), 7.19 (dt, J = 2.0, 8.4 Hz, 2H), 6.60 (dd, J = 0.8, 8.8 
Hz, 1H), 6.45–6.41 (m, 2H), 4.43 (d, J = 2.0 Hz, 1H), 4.27 (dd, J = 
6.0, 13.2 Hz, 1H), 3.90 (s, 3H), 3.74 (s, 3H), 2.38 (td, J = 2.0, 13.2 Hz, 1H), 2.24 (dd, J = 
5.6, 13.2 Hz, 1H); 13C-NMR (CDCl3, 100 MHz): δ = 170.3, 159.8, 152.4, 142.3, 132.9, 
130.4, 130.1, 129.1, 117.4, 108.8, 102.1, 101.9, 94.6, 55.6, 55.5, 53.8, 36.9, 36.8; 
HRMS(FAB) calcd for C18H17ClO5 (MNa+) 371.0662, found 371.0665. 
 
Methyl 4-hydroxy-7-methoxy-2-phenyl-chromane-4-carboxylate (2b) 
Chromane 2b was isolated as a colourless oil; [α]D25 = +1.36 (c 
1.55, CHCl3, 80% ee); 1H-NMR (CDCl3, 400 MHz): δ = 7.28–7.17 
(m, 5H), 6.56 (d, J = 8.4 Hz, 1H), 6.38–6.33 (m, 2H), 4.38 (s, 1H), 
4.21 (dd, J = 5.6, 13.2 Hz, 1H), 3.83 (s, 3H), 3.67 (s, 3H), 2.38 (t, J = 
13.2 Hz, 1H), 2.24 (dd, J = 5.6, 13.2 Hz, 1H); 13C-NMR (CDCl3, 100 MHz): δ = 170.5, 
159.6, 152.3, 143.7, 130.2, 129.1, 129.0, 128.8, 127.2, 118.0, 108.7, 108.0, 106.6, 101.9, 94.8, 
55.5, 53.8, 37.0; HRMS(FAB) calcd for C18H18O5 (MNa+) 337.1052, found 337.1044. 
 
Methyl 2-(4-fluorophenyl)-4-hydroxy-7-methoxychromane-4-carboxylate (2c) 
Chromane 1c was isolated as a colourless oil; [α]D25 = +0.09 (c 
0.85, CHCl3, 74% ee); 1H-NMR (CDCl3, 400 MHz): δ = 7.21–7.18 
(m, 2H), 7.03–6.99 (m, 2H), 6.60–6.58 (m, 1H), 6.43–6.40 (m, 2H), 
4.35 (d, J = 1.2 Hz, 1H), 4.25 (dd, J = 5.2, 13.2 Hz, 1H), 3.89 (s, 3H), 
3.73 (s, 3H), 2.38 (td, J = 1.2, 13.2 Hz, 1H), 2.22 (dd, J = 5.6, 14.4 Hz, 1H); 13C-NMR 
(CDCl3, 100 MHz): δ = 170.3, 163.3, 160.8, 159.7, 152.3, 139.4, 130.5, 130.0, 117.7, 115.9, 
115.7, 108.8, 102.0, 94.6, 55.6, 53.9, 37.1, 36.6; HRMS(FAB) calcd for C18H17FO5 (MNa+) 
355.0958, found 355.0966. 
 
Methyl 2-(4-bromophenyl)-4-hydroxy-7-methoxychromane-4-carboxylate (2d) 
Chromane 2d was isolated as a colourless oil; [α]D25 = +0.23 (c 
0.94, CHCl3, 66% ee), 1H-NMR (CDCl3, 400 MHz): δ = 7.46 (dd, J = 
2.0, 8.0 Hz, 2H), 7.13 (dd, J = 2.0, 8.0 Hz, 2H), 6.60 (dd, J = 0.8, 8.8 
Hz, 2H), 6.44–6.41 (m, 2H), 4.45 (d, J = 2.0 Hz, 1H), 4.25 (dd, J = 
6.0, 13.2 Hz, 1H), 3.90 (s, 3H), 3.74 (s, 3H), 2.38 (td, J = 2.0, 13.2 Hz, 1H), 2.24 (dd, J = 
6.0, 13.2 Hz, 1H); 13C-NMR (CDCl3, 100 MHz): δ = 170.3, 159.8, 152.3, 142.8, 132.1, 
130.8, 130.0, 120.9, 117.3, 108.8, 102.0, 94.5, 55.6, 53.9, 36.8; HRMS(FAB) calcd for 
C18H17BrO5 (MNa+) 415.0157, found 415.0173. 
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Methyl 2-(4-chlorophenyl)-7-(dimethylamino)-4-hydroxychromane-4-carboxylate (2e) 
Chromane 2e was isolated as a purple oil; 1H-NMR (CDCl3, 400 
MHz): δ = 7.31–7.19 (m, 4H), 6.55 (d, J = 8.4 Hz, 1H), 6.34–6.21 
(m, 2H), 4.25 (dd, J = 5.6, 12.8 Hz, 1H), 3.89 (s, 3H), 2.90 (s, 3H), 
2.89 (s, 3H), 2.38 (t, J = 12.8 Hz, 1H), 2.24 (dd, J = 5.6, 13.2 Hz, 
1H); 13C-NMR (CDCl3, 100 MHz): δ = 170.5, 152.2, 151.0, 142.8, 132.7, 130.4, 130.2, 
129.7, 129.0, 113.3, 107.3, 100.8, 94.6, 53.8, 40.8, 37.2, 36.7; HRMS(FAB) calcd for 
C19H20ClNO4 (MNa+) 384.0979, found 384.0986. 
 
Methyl 7-(dimethylamino)-4-hydroxy-2-phenylchromane-4-carboxylate (2f) 
Chromane 2f was isolated as a purple oil; 1H-NMR (CDCl3, 400 
MHz): δ = 7.36–7.24 (m, 3H), 6.60 (d, J = 8.0 Hz, 1H), 6.34–6.22 
(m, 3H), 4.28 (dd, J = 5.6, 13.2 Hz, 1H), 3.89 (s, 3H), 2.90 (s, 3H), 
2.89 (s, 3H), 2.44 (t, J = 12.8 Hz, 1H), 2.28 (dd, J = 5.6, 13.2 Hz, 
1H); 13C-NMR (CDCl3, 100 MHz): δ = 170.7, 152.3, 150.1, 144.2, 130.2, 129.9, 129.1, 
128.9, 127.0, 114.0, 107.3, 105.6, 104.1, 100.8, 94.7, 53.7, 40.9, 37.3, 37.2; HRMS(FAB) 
calcd for C19H21NO4 (MNa+) 350.1368, found 350.1377. 
 
Methyl 2-(4-chlorophenyl)-4-hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydroquinoline-4-
carboxylate (8) 
Tetrahydroquinoline 8 was isolated as a colourless oil; 1H-NMR 
(CDCl3, 400 MHz): δ = 7.30 (d, J = 8.0 Hz, 2H), 7.18 (d, J = 8.0 Hz, 
2H), 6.39 (d, J = 8.0 Hz, 1H), 6.29 (d, J = 2.0 Hz, 1H), 6.17 (dd, J = 
2.0, 8.0 Hz, 1H), 4.16 (s, 1H), 4.08 (dd, J = 4.0, 14.0 Hz, 1H), 3.84 (s, 
3H), 3.75 (s, 3H), 2.84 (s, 3H), 2.29 (t, J = 12.8 Hz, 1H), 2.08 (dd, J = 
4.0, 12.8 Hz, 1H); 13C-NMR (CDCl3, 100 MHz): δ = 175.0, 159.6, 144.8, 141.8, 132.8, 
130.5, 130.1, 129.0, 128.9, 128.3, 120.5, 102.1, 99.1, 85.9, 55.5, 54.0, 42.1, 38.0, 33.7; 
HRMS(FAB) calcd for C19H21NO4 (MNa+) calcd 384.0979, found 384.0982. 
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6 Synthesis of a new non-symmetric  4-(2-hydroxyphenyl)oxazoline ligand 
6.1 Introduction 
The importance of C2-symmetry in ligand design has been recognised for 
quite some time.1 The value of this concept was initially demonstrated by Kagan and 
coworkers, who introduced DIOP – the first C2-symmetric ligand – resulting in the 
first examples of general catalytic processes with high levels of stereoselectivity.2 
Since then, C2-symmetric ligands have been a dominant factor in asymmetric 
catalysis for a long time. An example of an extensively used class of C2-symmetric 
ligands are the chiral bisoxazoline (box) ligands.3 Indeed, box ligands have been used 
in an impressive range of metal-catalysed processes and have established themselves 
as so-called privileged ligands in asymmetric catalysis. 
One of the benefits of C2-symmetry is that it reduces the number of possible 
catalyst–substrate arrangements and therefore also the number of possible reaction 
pathways and transition states. Although this indeed simplifies mechanistic and 
structural studies, there is no fundamental reason why a C2-symmetric ligand would 
be superior to a non-symmetric counterpart. In fact, one can imagine that reactions 
could even benefit from non-symmetrical ligands having two different coordinating 
heteroatoms. Especially in reactions where the substrate coordinates to the metal in a 
nearly symmetrical fashion, a more effective control of enantioselectivity can be 
achieved by using ligands that coordinate through two electronically different 
groups. Consequently, it can be argued that chiral ligands possessing two different 
coordinating atoms allow more effective enantiocontrol than C2-symmetric ligands. 
An example of such non-symmetric ligands is the class of bidentate phosphinamine 
ligands, so-called P,N-ligands.4 
Recently, the groups of Pfaltz,5 Helmchen6 and Williams7 independently 
developed a new type of non-C2-symmetric oxazoline-based P,N-ligands, so-called 
PHOX-ligands (A, Figure 6.1). These 2-aryloxazoline ligands have been synthesised 
from the corresponding enantiomerically pure amino acids. They have been 
successfully applied in palladium-catalysed Diels-Alder and Heck reactions and 
iridium-catalysed hydrogenations resulting in excellent enantioselectivities.8 
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Figure 6.1 Oxazoline-based P,N-ligands 
More recently, another class of P,N-ligands has been developed in the group 
of Burgess, the so-called JM-Phos ligands (B), which were also synthesised from the 
corresponding amino acids.9 They differ from the PHOX ligands in the positioning of 
the oxazoline moiety, i.e. in the JM-Phos ligands the chiral oxazoline carbon is 
attached to the ligand backbone. The JM-Phos ligands have been applied in amongst 
others enantioselective palladium-catalysed allylic substitution reactions and 
iridium-catalysed olefin hydrogenations.10 A structurally related class of 
phosphonite-oxazoline ligands has been developed by Pfaltz and coworkers (C).11 An 
advantage of these ligands is their applicability to a wider range of substrates 
compared to the phosphine-oxazoline analogues, e.g. in iridium-catalysed 
hydrogenations,12 palladium-catalysed allylic substitutions13 and copper-catalysed 
1,4-addition reactions of organozinc reagents to enones.14 In the latter reaction type, 
introduction of a methyl group at the C4-position (R3) resulted in an unexpectedly 
strong enhancement of the enantioselectivity for a number of substrates. This effect 
may be ascribed to a restriction in the conformational flexibility of the ligand 
backbone due to the additional substituent. More explicitly, this example shows that 
a more rigid ligand backbone may generally result in an improvement of 
enantiofacial differentiation of the chiral catalyst leading to higher 
enantioselectivities.  
Based on these considerations, we aimed to modify the JM-Phos ligand by 
introduction of a more constrained backbone, resembling the backbone of the PHOX 
ligand, resulting in PhP-ox (D). We envisaged that we would have relatively facile 
access to this ligand starting from enantiopure (2-hydroxyphenyl)glycine, which is 
readily available via enzymatic resolution. 
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Figure 6.2 Alternative non-symmetric oxazoline-based ligands 
Besides PhP-ox, we aimed at variations of this ligand by replacing the 
phosphine group by a phosphonite group, resulting in the PhOP-ox ligand (E, Figure 
6.2). Additionally, we considered synthesising the N,O-analogue of PhP-ox by 
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introducing a hydroxyl group instead of a phosphine substituent, affording the so-
called PhOH-ox (F). 
A variety of PHOX-based bidentate N,O-ligands (G), have already been 
synthesised and applied in numerous asymmetric reactions by several groups.15 The 
first synthesis of such 2-aryloxazolines was reported by the group of Brunner.16 
Nicholas and coworkers prepared and characterised a series of Pd(η3-allyl) 
derivatives of these chiral N,O-ligands and applied these complexes as catalysts in 
allylic oxidation and substitution reactions, resulting in moderate rates and 
selectivities.17 Williams and coworkers applied similar ligands of type G in 
stereoselective diethylzinc additions to aromatic aldehydes, again with disappointing 
enantioselectivities (Scheme 6.1).18 Surprisingly, when they applied N,O-ligand H, 
with the alcohol tethered to the C4-position of the oxazoline ring, a significant 
increase of yield and enantioselectivity was observed, although the absolute values 
were still moderate.  
H
O ligand (6 mol%)
Et2Zn (2 equiv)
hexane
18 h, rt
OH G (R
1 = i-Pr)             8% (14% ee)
H (R1 = Me)             60% (50% ee)
H (R1 = Ph)             65% (57% ee)
I (R = H, R1 = Ph)   96% (93% ee)  
Scheme 6.1 Diethylzinc addition in the presence of N,O-ligands 
The C2-symmetric bisoxazoline variant of this ligand (I, Figure 6.3) was 
synthesised in the group of Reiser and applied in the diethylzinc addition to 
benzaldehyde, resulting in an increase of both yield and enantiopurity (Scheme 
6.1).19 In fact, the latter N,O-ligands can be compared to the C2-symmetric salen 
ligands J (X = OH) that have been frequently used in the Jacobsen group for a wide 
variety of stereoselective reactions, e.g. hetero Diels-Alder reactions, cyanide 
additions to aldehydes, Michael additions, epoxide ring-opening and Strecker 
reactions.20 The P,N-analogue of this ligand is also known to be an excellent ligand in 
mainly palladium-catalysed reactions.21 Moreover, non-symmetric dipeptide Schiff 
bases such as K have been applied by Hoveyda and coworkers as ligands in several 
types of reactions.22 Hoveyda suggested that the phenolic ligands (X = OH) are better 
suited for binding early transition metals (such as Ti or Zr), and the corresponding 
P,N-analogues (X = PPh2), due to the ‘softer’ binding site, may be more appropriate 
for late transition metals (such as Cu or Zn).23 
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Figure 6.3 Alternative ligands applied in the groups of Jacobsen and Hoveyda 
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Given the literature precedent, and considering that we had ready access to 
enantiopure (2-hydroxyphenyl)glycine, we set out to develop synthetic routes to the 
4-aryloxazoline ligands PhP-ox, PhOP-ox and PhOH-ox.  
6.2 Synthesis of 4-aryloxazoline ligands 
A retrosynthetic analysis suggested that the target 4-aryloxazoline ligands 1 
may be accessible from N-acylated (2-hydroxyphenyl)glycinol (2), which may be 
obtained from the corresponding enantiopure amino acid 3 (Scheme 6.2). 
Enantiopure (R)-(2-hydroxyphenyl)glycine, in turn, can be derived from the racemic 
hydantoin 4, through an enzymatic resolution process that was developed by DSM 
(Geleen, The Netherlands).24  
HO
HN
OH
H2N
OH
O
HO HO
4321
X = PPh2, OPPh2, OH
R = t-Bu, Ph
X
N
O
R R O
HN
NH
O
O
 
Scheme 6.2 Retrosynthesis 
The required racemic hydantoin 4 can be synthesised according to the method 
reported by Mayoral and coworkers.25 The enzymatic resolution was carried out 
using whole cells of Agrobacterium radiobacter, containing three different enzymes 
(Scheme 6.3).24b In such a process, a D-hydantoinase converts the (R)-enantiomer of 
hydantoin 4 into the corresponding carbamoylated amino acid 5, which is then 
converted by a carbamoylase into (2-hydroxyphenyl)glycine (3). Additionally, a 
hydantoin racemase is present, which under the reaction conditions can racemise the 
remaining (S)-enantiomer of hydantoin 4, so that, in principle, eventually 100% of the 
(R)-product can be obtained. In this particular event, the racemisation proceeded 
relatively slowly and the reaction was stopped after approximately 60% conversion, 
resulting in (R)-(2-hydroxyphenyl)glycine with an ee of 94%. The enantiopurity of 3 
could be further improved to >99% by crystallisation. 
HO
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Scheme 6.3 Enzymatic resolution to (R)-(2-hydroxyphenyl)glycine 
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Next, the amino acid was reduced in the presence of LiAlH4 to afford the 
corresponding amino alcohol 6, which was difficult to purify due its poor solubility 
in organic solvents (Scheme 6.4). Eventually, we chose to continue with the crude 
product, containing a significant amount of inorganic salts, and apply further 
purification in the subsequent step. 
H2N
OH
O
HO
LiAlH4
THF, reflux
H2N
OH
HO CH2Cl2
PivCl, Et3N
HN
OH
HO
Piv
HN
OPiv
HO
Piv
+
3 6 2a
15% from 3
7
21% from 3  
Scheme 6.4 Synthesis of N-pivaloyl-(2-hydroxyphenyl)glycinol (2a) 
Initially, we were aiming for a final oxazoline ligand (1) with a tert-butyl 
group at the C2-position of the oxazoline ring. Therefore, (2-hydroxyphenyl)glycinol 
(6) was reacted with pivaloyl chloride to selectively acylate the amine group. 
Unfortunately, the desired product 2a was only formed in 15% yield, along with an 
almost equal amount of the diacylated amino alcohol 7. Surprisingly, even a trace of 
the triacylated product was observed. Apparently, (double) O-acylation is inevitable 
so that we had to selectively hydrolyse the ester functions. Considering that selective 
hydrolysis of pivaloyl esters in the presence of amides is rather difficult, we decided 
to introduce a benzoyl group instead, of which the corresponding ester can be 
cleaved more easily. Thus, we changed our strategy somewhat, now aiming at a 
ligand bearing a phenyl substituent. 
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Scheme 6.5 Synthesis of aryl triflate 9 
To this end, (2-hydroxyphenyl)glycinol (6) was reacted with an excess of 
benzoyl chloride to obtain the triacylated amino alcohol 8 (Scheme 6.5). Subsequent 
selective hydrolysis of both ester functions proceeded smoothly using aqueous 
lithium hydroxide. The resulting N-benzoyl amino alcohol 2b was crystallised and 
the enantiopurity was determined by HPLC to be >99% ee. We anticipated that ring 
closure of the oxazoline ring by means of triflic anhydride would additionally afford 
a triflate group at the phenolic position, which could be used as a synthetic ‘handle’ 
in a later stage to introduce the phosphine moiety via palladium catalysis. Indeed, 
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upon treatment of alcohol 2b with a large excess of triflic anhydride, aryl triflate 9 
was obtained, which may be a key intermediate for the synthesis of both the 
corresponding P,N- and N,O-ligand. 
Smooth hydrolysis of the triflate in the presence of aqueous lithium 
hydroxide resulted in PhOH-ox ligand 1a in excellent yield and without loss of 
enantiopurity despite the basic conditions (Scheme 6.6). 
HO
N
O
Ph
LiOH TfO
N
O
Ph
Pd(OAc)2/dppe
HPPh2, DABCO
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Scheme 6.6 Synthesis of oxazoline derivatives  
The structure was unambiguously confirmed by X-ray crystallography 
(Figure 6.4).26 Thus, the synthesis of PhOH-ox was accomplished in 35% overall yield 
starting from (R)-(2-hydroxyphenyl)glycine. 
 
Figure 6.4 Crystal structure of PhOH-ox 1a 
In contrast, phosphorylation of triflate 9 turned out to be extremely difficult. 
Although a number of different literature procedures exist, we were unsuccessful in 
converting the triflate into a phosphine group. For example, treatment with KPPh2 
resulted in decomposition of the product,27 while our attempts to apply nickel-
catalysed phosphorylation (i.e. NiCl2dppe with either HPPh228 or ClPPh2/Zn29) gave 
no conversion at all. Additional experiments were carried out including palladium-
mediated conditions, i.e. Pd(OAc)2, dppe and DABCO, which seemed to afford the 
desired phosphorylated product.30 The major product after workup, however, was 
the corresponding phosphine oxide 1b, which was probably formed via in situ 
oxidation under the reaction conditions. 
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Since several further experiments showed that this undesired oxidation could 
not be easily prevented, and attempts to introduce borane-protected 
diphenylphosphine turned out to be unsuccessful as well,31 we considered the 
deliberate synthesis of the phosphine oxide and subsequent reduction to the desired 
PhP-ox (1c). Phosphine oxide reduction is well-known in literature, e.g. treatment 
with HSiCl332 or H3SiPh usually leads to smooth phosphine formation.33 However, 
before we were able to probe this promising strategy, Zhang and coworkers reported 
the synthesis of a series of exactly these PhP-ox ligands.34 They developed two routes 
to this class of P,N-ligands, each starting from N,O-protected phenylglycinol, as 
depicted in Scheme 6.7. In route A, iodination at the ortho-position of the phenyl ring 
was followed by construction of the oxazoline moiety, leaving phosphorylation for 
the last step and thereby the possibility to tune the phosphine site. In a second route 
(B), the phosphine was directly introduced, protected as the phosphine sulfide, 
allowing introduction of different substituents on the oxazoline ring. The ligands 
were applied in iridium-catalysed hydrogenation of methylstilbene, resulting in 
quantitative yields and excellent enantioselectivities (up to 99% ee). These novel 
ligands thus outperform the more flexible JM-Phos ligand, which afforded the 
hydrogenation product with 95% ee. 
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Scheme 6.7 Two different routes to series of PhP-ox ligands 1 
6.3 Application of PhOH-ox as ligand 
Initially, we wanted to apply PhOH-ox (1a) in an allylic substitution reaction, 
as discussed in Section 3.2.5. This reaction involves the substitution of (E)-1,3-
diphenyl-2-propenyl acetate (14) by dimethyl malonate in the presence of 
bis(trimethylsilyl)acetamide (BSA) and a catalytic amount of potassium acetate 
(Scheme 6.8).35 Besides aryl-substituted box ligands, as discussed in Section 2.1, new 
non-symmetric P,N-ligands of type A (Figure 6.1) have also been applied in this 
reaction.35a Surprisingly, in the presence of N,O-ox ligand PhOH-ox (1a), the reaction 
did not proceed at all. 
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Scheme 6.8 Attempted allylic substitution of dimethyl malonate 
Therefore, we investigated the use of PhOH-ox (1a) in a different reaction, i.e. 
the addition of diethylzinc to aldehydes. In the last few years, there have been many 
reports describing the use of optically pure amino alcohols as catalysts for the 
addition of organozinc compounds to aldehydes, often with high levels of 
stereoselective induction.36 The use of a ligand is not only necessary to control the 
stereochemical outcome of the reaction, but it also accelerates the reaction by 
activating the zinc reagent through polarisation of the carbon-zinc bond. Recently, 
several examples of oxazoline-based ligands in organozinc additions have been 
reported.37 
Thus, we applied PhOH-ox (1a) in diethylzinc additions to benzaldehyde 
(Table 6.1, entry 1). Analysis of a sample taken after 20 h, showed that the resulting 
alcohol 18 was obtained in 46% yield and with 53% ee. Leaving the reaction for 
another 24 h at room temperature resulted in an increase of the yield to 83%, but a 
decrease of the enantiomeric excess to 39%. 
Table 6.1 Results of the Et2Zn addition to benzaldehyde 
H
O
17 (R)-18
ligand, Et2Zn
toluene
-78 °C to rt
OH
 
entry ligand after 20 h after 44 h 
  yield (%)a ee (%)b yield (%)a ee (%)b 
1 PhOH-ox 46 53 (R) 83 39 (R) 
2 t-Bu-boxc 90 30 (S) 100 27 (S) 
3 Ph-box 68 47 (S) 99 43 (S) 
4 1-Np-box 41  5 (R) 82  3 (R) 
5 2-Np-box 14 52 (S) 93 55 (S) 
a Conversions were determined by GC. b Enantiomeric excesses were determined by GC 
analysis using a chiral β-CD column (110 °C). c Data correspond to literature values.19 
Furthermore, we investigated several bisoxazoline ligands in the diethylzinc 
addition. In the presence of t-Bu-box (entry 2), the secondary alcohol 18 was formed 
in good yield, but with low enantioselectivity (27% ee). Aryl-substituted 
bisoxazolines Ph-box (entry 3) and 2-Np-box (entry 5) both afforded the addition 
adduct in good yield and with increased enantioselectivity (43% and 55% ee, 
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respectively). Surprisingly, 1-Np-box (entry 4) afforded addition product 18 with no 
detectable enantioselectivity. In contrast with the result of the reaction with PhOH-
ox, no significant change in enantiopurity was observed in the reactions with the 
bisoxazoline ligands upon extension of the reaction time. 
The remarkable decrease in ee during the PhOH-ox-catalyzed reaction seems 
to indicate that this ligand has a reduced capacity to activate the carbon–zinc bond, 
thereby allowing an increased contribution of the uncatalysed (racemic) reaction. 
This effect appears to be less pronounced at low temperature, but upon warming to 
room temperature seems to become increasingly dominant. 
Nevertheless, we used the unoptimised conditions with PhOH-ox ligand, to 
perform the diethylzinc addition reaction in a range of different solvents and solvent 
mixtures (Table 6.2). In the presence of CH2Cl2, i.e. using a 1:1 toluene/CH2Cl2 
mixture (entry 2), both yield and enantioselectivity were dramatically reduced 
compared to the reaction in toluene (entry 1). On the other hand, in a 1:1 mixture of 
toluene/heptane, the enantiopurity was enhanced with a slight decrease of the yield. 
It turned out that heptane was the best solvent for the diethylzinc addition to 
benzaldehyde, giving both the highest yield and enantiopurity (entry 4). 
Table 6.2 Results of the Et2Zn addition to benzaldehyde 
H
O
17 (R)-18
1a, Et2Zn
solvent
-78 °C to rt
OH
 
entry solvent conversion (%) (ee (%)a) 
  18hb 24hb 47hb isolatedc 
1 toluene 46 (53) nd 83 (39) nd 
2 toluene/CH2Cl2d 14 (52) 23 (35) 44 (18) 72 (17) 
3 toluene/heptaned 46 (66) 56 (50) 79 (32) 93 (32) 
4 heptane 54 (67) 70 (52) 88 (37) 97 (36) 
a Enantiomeric excesses were determined by GC analysis using a chiral β-CD column (110 °C); 
Configuration of the major enantiomer was in all cases (R). b A sample of the reaction mixture 
was taken to determine the conversion by GC. c Isolated yields after chromatography. d 
Solvents were mixed in a 1:1 ratio. 
6.4 Conclusions 
We have developed an efficient synthesis of PhOH-ox (1a) from optically 
active (R)-(2-hydroxyphenyl)glycine (94% ee) in five steps in an overall yield of 35%. 
Our studies on the use of the PhOH-ox ligand revealed that it was not suitable for 
palladium-catalysed allylic substitution reactions. Diethylzinc addition to 
benzaldehyde in the presence of PhOH-ox proceeded in moderate yield and 
enantioselectivity. The best result was obtained in heptane, affording alcohol 18 in 
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54% yield and with 67% ee. In the course of our research, Zhang and coworkers 
reported the synthesis of a series of PhP-ox ligands. They demonstrated the potency 
of these ligands by successful application in iridium-catalysed hydrogenations.  
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6.6 Experimental section 
General methods and materials 
For general experimental details, see Section 2.9. 
 
Procedure for the ee-determination of (R)-(2-hydroxyphenyl)glycine (3) by 1H-NMR38 
To a solution of the amino acid 3 (2.5 mg, 14 µmol) in a Na2B4O7 buffer (0.4 M in D2O, 
0.5 mL), (S,S)-dibenzoyl tartaric anhydride ((S,S)-DBTAAN, 50 mM in CD3CN, 0.5 
mL, 15 µmol) was added in three portions; after each portion the sample was shaken 
vigorously for 5 min. The sample was left overnight to react before 1H-NMR was 
measured: 1H-NMR (D2O/CD3CN, 300 MHz): δ = 6.14 (d, J = 2.5 Hz, (R)-3), 6.04 (d, J 
= 2.8 Hz, (S)-3), 5.76 (d, J = 2.7 Hz, (S)-3), 5.69 (d, J = 2.5 Hz, (R)-3) (other signals were 
omitted for clarity). 
 
N-[(R)-2-Hydroxy-1-(2-hydroxyphenyl)ethyl]-2,2-dimethylpropanamide (2a) and (R)-2-(2-
hydroxyphenyl)-2-[2,2-dimethylpropanoyl)amino]ethyl 2,2,-dimethylpropanoate (7) 
To a suspension of (R)-(2-hydroxyphenyl)glycine (3) 
(300 mg, 1.78 mmol) in THF (75 mL) was added LiAlH4 
(0.69 g, 18.2 mmol) and the mixture was heated to reflux 
for 24 h. After cooling to 0 °C, the mixture was 
quenched by addition of H2O (0.65 mL), aqueous NaOH 
(4 M, 0.90 mL) and H2O (2.0 mL) over a period of 15 min. After stirring for 30 min at 
rt, EtOH (25 mL) was added to dissolve the product and the remaining solids were 
removed by filtration. The filtrate was concentrated in vacuo, yielding amino alcohol 
6 as a yellow oil.39 This product was not further purified, but used as such for the 
next step: 1H-NMR (D2O, 200 MHz): δ = 7.15–7.08 (m, 2H), 6.69–6.62 (m, 2H), 4.28 
HN
OH
HO
Piv
HN
OPiv
HO
Piv
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(dd, J = 5.1, 7.2 Hz, 1H), 3.79–3.61 (m, 2H); 13C-NMR (CD3OD, 75 MHz): δ = 159.0, 
129.4, 129.1, 127.4, 119.6, 117.6, 66.8, 57.2. 
Crude (R)-(2-hydroxyphenyl)glycinol (6) (1.78 mmol) was dissolved in CH2Cl2 (25 
mL) and triethylamine (1.55 mL, 11.2 mmol) was added. The mixture was cooled to –
20 °C and a solution of pivaloyl chloride (229 mg, 1.89 mmol) in CH2Cl2 (10 mL) was 
added via a cannula. After stirring at rt for 20 h, CH2Cl2 (70 mL) was added and the 
mixture was washed with aqueous HCl (1 M, 60 mL). The aqueous layer was 
extracted with CH2Cl2 (3 × 50 mL). The combined organic layers were dried (MgSO4) 
and concentrated in vacuo, affording a yellow solid. Purification by column 
chromatography (EtOAc/heptane 1:1) yielded 2a as an off-white solid (70 mg, 15% 
from 3): 1H-NMR (CDCl3, 200 MHz): δ = 8.99 (bs, 1H), 7.11–6.78 (m, 4H), 5.39 (m, 1H), 
4.58 (dd, J = 8.9, 11.0 Hz, 1H), 4.26 (dd, J = 5.4, 11.2 Hz, 1H), 1.14 (s, 9H); 13C-NMR 
(CDCl3, 50MHz): δ = 179.3, 155.1, 129.4, 128.5, 123.6, 120.0, 116.7, 64.6, 50.7, 38.9, 27.2; 
Rf (EtOAc/heptane 1:1) = 0.10. 
Purification by column chromatography (EtOAc/heptane 1:1) also afforded 7 as a 
yellow oil (113 mg, 21% from 3): 1H-NMR (CDCl3, 200 MHz): δ = 7.33–6.95 (m, 3H), 
6.82–6.59 (m, 1H), 5.46–5.30 (m, 1H), 4.64 (dd, J = 8.6, 11.3 Hz, 1H), 4.22 (dd, J = 4.3, 
11.3 Hz, 1H), 1.20 (s, 9H), 1.16 (s, 9H); 13C-NMR (CDCl3, 50 MHz): δ = 180.2, 180.0, 
155.7, 129.7, 127.8, 124.4, 120.2, 117.3, 65.5, 50.9, 39.5, 39.4, 28.1, 27.8; Rf 
(EtOAc/heptane 1:1) = 0.35. 
 
2-[(R)-1-Benzoylamino)-2-(benzoyloxy)ethyl]phenyl benzoate (8) 
To a suspension of (R)-(2-hydroxyphenyl)glycine (3) (1.16 g, 6.97 
mmol) in THF (250 mL) was added LiAlH4 (2.70 g, 71.1 mmol) and 
the mixture was heated to reflux for 21 h. After cooling to 0 °C, the 
mixture was quenched by addition of H2O (2.6 mL), aqueous NaOH 
(4 M, 3.6 mL) and H2O (7.9 mL) over a period of 15 min. After stirring 
for 30 min at rt, EtOH (100 mL) was added to dissolve the product and the remaining 
solids were removed by filtration. The filtrate was concentrated in vacuo, yielding 6 
as a yellow oil.39 Analytical data were were identical as reported above. 
Crude (R)-(2-hydroxyphenyl)glycinol (6) (6.97 mmol) was dissolved in CH2Cl2 (100 
mL) and triethylamine (12.5 mL, 90.1 mmol) was added. The mixture was cooled to 0 
°C and a solution of benzoyl chloride (3.91 g, 27.8 mmol) in CH2Cl2 (10 mL) was 
added via a cannula. After stirring at rt for 25 h, CH2Cl2 (50 mL) was added and the 
mixture was washed with aqueous HCl (1 M, 125 mL). The aqueous layer was 
extracted with CH2Cl2 (2 × 50 mL). The combined organic layers were washed with 
saturated aqueous NaHCO3 (150 mL) and the aqueous layer was extracted with 
CH2Cl2 (2 × 50 mL). The combined organic layers were dried (MgSO4) and 
concentrated in vacuo, affording a slightly brown solid. Recrystallisation 
(EtOAc/heptane) yielded 8 as a white solid (2.21 g, 68% from 3): mp 140 °C; IR: νmax 
(cm-1) = 2358, 2336, 1718, 1273; 1H-NMR (CDCl3, 300 MHz): δ = 8.24 (d, J = 6.9 Hz, 
2H), 7.96 (d, J = 7.1 Hz, 2H), 7.69–7.26 (m, 15H), 7.10 (d, J = 7.4 Hz, 1H), 5.85 (dd, J = 
2.4, 7.4 Hz, 1H), 4.85 (dd, J = 7.6, 11.5 Hz, 1H), 4.62 (dd, J = 5.0, 11.5 Hz, 1H); 
HN
OBz
BzO
Bz
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13C-NMR (CDCl3, 50 MHz): δ = 167.4, 166.8, 165.5, 149.0, 134.1, 133.5, 131.7, 130.5, 
129.9, 129.6, 129.4, 129.0, 128.9, 128.6, 128.6, 128.4, 127.1, 126.7, 123.5, 65.7, 49.7; Rf 
(EtOAc/heptane 1:1) = 0.42. 
 
N-[(R)-2-Hydroxy-1-(2-hydroxyphenyl)ethyl]benzamide (2b) 
To a solution of 8 (2.21 g, 4.75 mmol) in THF (100 mL) was added 
aqueous LiOH (0.5 M, 140 mL, 70 mmol). After stirring for 2 h, the 
mixture was extracted with EtOAc (3 × 150 mL). Brine was added to 
minimise the emulsion between the layers. The combined organic 
layers were dried (Na2SO4) and concentrated in vacuo. The resulting off-white solid 
was recrystallised from EtOAc/heptane, affording 2b as a white solid (1.10 g, 90%). 
The ee was determined by HPLC to be >99%: AD Chiralpak column (heptane/i-
PrOH 90:10, 1.0 ml/min), tR(minor) = 18.3 min, tR(major) = 21.7 min; mp 152 °C; 
[α]D25 +27 (c = 0.50, MeOH); IR: νmax (cm-1) = 3271, 1638, 1530, 1453, 1065, 1035; 1H-
NMR (CD3CN, 300 MHz): δ = 7.84 (m, 2H), 7.61 (bs, 1H), 7.58–7.44 (m, 3H), 7.29–7.12 
(m, 2H), 6.86 (m, 2H), 5.31 (m, 1H), 3.92 (m, 2H), 2.22 (bs); 13C-NMR (CD3CN, 75 
MHz): δ = 167.8, 155.9, 135.1, 132.7, 129.8, 129.5, 128.8, 128.2, 127.5, 121.0, 117.4, 64.2, 
52.6; C15H15NO3 calcd C 70.02, H 5.88, N 5.44, found C 69.65, H 5.55, N 5.40; Rf 
(EtOAc/heptane 1:1) = 0.13. 
 
2-[(R)-2-Phenyl-4,5-dihydro-1,3-oxazol-4-yl]phenyl trifluoromethanesulfonate (9) 
To a solution of 2b (894 mg, 3.48 mmol) in CH2Cl2 (20 mL) at 0 °C was 
added Et3N (5.0 mL, 36.2 mmol) and DMAP (85 mg, 0.70 mmol). After 
addition of a solution of Tf2O (2.88 g, 101 mmol) in CH2Cl2 (15 ml) via a 
cannula, the solution was stirred for 48 h. The mixture was washed with 
aqueous saturated NH4Cl (100 mL) and the aqueous layer was extracted 
with CH2Cl2 (2 × 50 mL). The combined organic layers were washed using aqueous 
saturated NaHCO3 (150 mL) and the aqueous layer was extracted with CH2Cl2 (2 × 50 
ml). The combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Purification by column chromatography (EtOAc/heptane 1:6) yielded 9 as a slightly 
yellow oil (802 mg, 62%): IR: νmax (cm-1) = 2968, 2901, 1646; 1H-NMR (CDCl3, 300 
MHz): δ = 8.05 (d, J = 8.3 Hz, 2H), 7.56–7.29 (m, 7H), 5.71 (dd, J = 8.4, 10.4 Hz, 1H), 
4.89 (dd, J = 8.7, 10.2 Hz, 1H), 4.19 (t, J = 8.7 Hz, 1H); 13C-NMR (CDCl3, 50 MHz): δ = 
166.6, 147.2, 136.4, 132.5, 130.0, 129.7, 129.6, 129.2, 129.1, 127.8, 122.4, 121.8, 116.0, 74.9, 
64.8; Rf (EtOAc/heptane 1:6) = 0.23. 
 
2-[(R)-2-Phenyl-4,5-dihydro-1,3-oxazol-4-yl]phenol (1a) 
To a solution of 9 (44 mg, 0.12 mmol) in THF (10 ml) was added aqueous 
LiOH (1 M, 1.2 mL, 1.2 mmol). After stirring for 90 min, H2O (5 mL) was 
added and the mixture was extracted using CH2Cl2 (3 × 25 mL). The 
combined organic layers were dried (MgSO4) and concentrated in vacuo. 
Crystallisation (EtOAc/heptane) afforded 1a as a white solid (26 mg, 91%) 
and the ee was determined by HPLC to be >99%: OD Chiralcel column 
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(heptane/i-PrOH 80:20, 1.0 ml/min), tR(major) = 6.9 min, tR(minor) = 9.5 min; mp 152 
°C; [α]D25 –133 (c = 0.50, CH2Cl2); mp 176 °C; IR: νmax (cm-1) = 2967, 1644; 1H-NMR 
(CDCl3, 300 MHz): δ = 10.08 (s, 1H), 7.97 (dt, J = 1.5, 7.2 Hz, 2H), 7.55–7.41 (m, 3H), 
7.17 (m, 1H), 6.87 (m, 3H), 5.64 (t, J = 10.2 Hz, 1H), 5.02 (dd, J = 8.1, 10.3 Hz, 1H), 4.55 
(dd, J = 8.1, 10.2 Hz, 1H); 13C-NMR (CDCl3, 75 MHz): δ = 164.7, 155.8, 132.0, 128.5, 
128.4, 128.3, 126.3, 125.7, 124.8, 119.5, 117.1, 73.6, 67.3; C15H13NO2 calcd C 75.30, H 
5.48, N 5.85, found: C 74.97, H 5.06, N 5.81; Rf (EtOAc/heptane 1:1) = 0.39. 
 
Crystal structure determination of PhOH-ox (1a) 
 The crystal data and a summary of the data collection and structure 
refinement are given in Table 6.2. The structure was solved by the 
program CRUNCH.40 All non-hydrogen atoms were refined with 
anisotropic temperature factors. The hydrogen atoms were placed at 
calculated positions, and refined isotropically in riding mode. Selected 
bond distances and angles are given in Tables 6.3 and 6.4, respectively 
(for atomic numbering vide infra).41 Geometrical calculations revealed 
neither unusual geometric features, nor unusual short intermolecular contacts. The 
calculations revealed no higher symmetry and no (further) solvent accessible areas.  
 
Table 6.2 Crystal data and structure refinement for PhOH-ox 1a 
Crystal colour transparent 
colourless 
θ range for data 
collection 
5.03° to 24.99° 
Crystal shape 
Crystal size 
Empirical formula 
regular fragment 
0.28 x 0.18 x 0.13 mm 
C15H13NO2 
Index ranges -8 ≤ h ≤ 8 
-12 ≤ k ≤ 12 
-19 ≤ l ≤ 19 
Formula weight 239.26 Reflections collected 13430 
Temperature 208(2) K unique 2101  
Radiation 
(graph. monochrom.) 
Wavelength 
MoKα 
 
0.71073 Å 
[Rint] 
Reflections observed 
[Io > 2σ(Io)] 
0.0613 
1798 
Crystal system 
space group 
Orthorhombic 
P 21 21 21 
Absorption correction SADABS multiscan 
correction42 
Unit cell: 
no. of  reflections 
13430 Refinement method Full-matrix 
least-squares on F2 
θ range 5.030 to 24.990 Computing SHELXL-9743 
a 7.310(2) Å Data 2101 
b 10.117(2) Å restraints 0 
c 16.221(2) Å parameters 164 
α 90° Goodness-of-fit on F2 1.054 
β 
γ 
90° 
90° 
SHELXL-97 weight 
parameters 
0.0431, 0.1197 
Volume 
Z 
1199.5(4) Å3 
4 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0405 
wR2 = 0.0820 
HO
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1
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Calculated density 
Absorption coefficient 
1.325 Mg/m3 
0.088 mm-1 
R indices 
(all data) 
R1 = 0.0530 
wR2 = 0.0861 
Diffractometer NoniusKappaCCD 
with area detector 
Absolute structure 
parameter 
1.7(15) 
scan f and w scan Largest diff. peak 0.150 e/Å3 
F(000) 504 Largest hole  -0.153 e/Å3 
 
Table 6.3 Bond distances of the non-hydrogen atoms (Å) of PhOH-ox 1a 
C(1)-N(5) 1.260(2) C(6)-C(11) 1.382(3) C(12)-C(13) 1.388(2) 
C(1)-O(2) 1.347(2) C(6)-C(7) 1.390(3) C(13)-O(18) 1.358(2) 
C(1)-C(6) 1.469(3) C(7)-C(8) 1.374(3) C(13)-C(14) 1.388(3) 
O(2)-C(3) 1.446(2) C(8)-C(9) 1.379(3) C(14)-C(15) 1.370(3) 
C(3)-C(4) 1.542(3) C(9)-C(10) 1.371(3) C(15)-C(16) 1.373(3) 
C(4)-N(5) 1.473(2) C(10)-C(11) 1.372(3) C(16)-C(17) 1.381(3) 
C(4)-C(12) 1.505(3) C(12)-C(17) 1.376(3)   
 
Table 6.4 Bond angles of the non-hydrogen atoms (°) of PhOH-ox 1a 
N(5)-C(1)-O(2) 117.62(17) C(11)-C(6)-C(1) 121.01(18) O(18)-C(13)-C(12) 117.98(17) 
N(5)-C(1)-C(6) 126.19(17) C(7)-C(6)-C(1) 120.03(16) O(18)-C(13)-C(14) 122.17(16) 
O(2)-C(1)-C(6) 116.19(15) C(8)-C(7)-C(6) 120.36(18)
  
C(12)-C(13)-C(14) 119.84(18) 
C(1)-O(2)-C(3) 106.65(13) C(7)-C(8)-C(9) 119.9(2) C(15)-C(14)-C(13) 120.19(18) 
O(2)-C(3)-C(4) 104.05(14) C(10)-C(9)-C(8) 120.1(2) C(14)-C(15)-C(16) 120.6(2) 
N(5)-C(4)-C(12) 110.90(16) C(9)-C(10)-C(11) 120.28(19) C(15)-C(16)-C(17) 119.1(2) 
N(5)-C(4)-C(3) 103.08(15) C(10)-C(11)-C(6) 120.4(2) C(12)-C(17)-C(16) 121.51(18) 
C(12)-C(4)-C(3) 115.45(17) C(17)-C(12)-C(13) 118.78(17)   
C(1)-N(5)-C(4) 108.29(16) C(17)-C(12)-C(4) 122.41(17)   
C(11)-C(6)-C(7) 118.96(19) C(13)-C(12)-C(4) 118.80(17)   
 
(R)-4-[2-(Diphenylphosphinoyl)phenyl]-2-phenyl-4,5-dihydro-oxazole (2b) 
A solution of 9 (83 mg, 223 µmol), Pd(OAc)2 (3 mg, 12 µmol), dppe (5 mg, 
12 µmol) and DABCO (50 mg, 446 µmol) in DMF (2 mL) was stirred for 
15 min at 50 °C under an Ar atmosphere using standard Schlenk 
techniques. After addition of HPPh2 (15 µL, 85 µmol), the mixture was 
stirred for 30 min at 50 °C. An additional portion of HPPh2 (27 µL, 154 
µmol) was added and the mixture was stirred for 22 h at 110 °C. The solvent was 
removed in vacuo and purification by column chromatography (EtOAc/heptane 1:7 
to 4:7) yielded 2b as a colourless oil (20 mg, 23%): 1H-NMR (CDCl3, 300MHz): δ = 
7.99 (m, 2H), 7.67–7.38 (m, 16H), 7.22 (m, 1H), 7.04 (m, 1H), 5.95 (t, J = 8.7 Hz, 1H), 
4.89 (t, J = 9.6 Hz, 1H), 4.12 (t, J = 9.0 Hz, 1H); 31P-NMR (CDCl3, 121 MHz) δ = 32.39 
(P=O); Rf (EtOAc/heptane 1:1) = 0.14. 
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Representative experimental procedure for the diethylzinc addition to benzaldehyde 
To a flame-dried Schlenk tube was added 1a (12 mg, 50 µmol). The 
mixture was dried under vacuum for 0.5 h and distilled anhydrous 
heptane (2.0 mL) was added. After stirring for 1 h, freshly distilled 
benzaldehyde (17) (101 µL, 1.0 mmol) was added and the mixture was cooled to –78 
°C. After addition of Et2Zn (1 M in heptane, 2.0 mL, 2.0 mmol), the mixture was 
allowed to warm to rt overnight. According to TLC and GC, there was still starting 
material present. The mixture was stirred for another 24 h. After quenching using 
aqueous saturated NH4Cl (5 mL), the mixture was extracted using Et2O (3 × 10 mL). 
The combined organic layers were dried (MgSO4) and concentrated in vacuo, 
yielding 18 as a colourless oil (132 mg, 97%). The enantiomeric excess was 
determined by GC to be 36%: chiral β-CD column (110 °C): tR (major) = 31.3 min (R), 
tR (minor) = 22.8 min (S). 
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Summary 
Asymmetric catalysis is a powerful tool in the synthesis of optically pure 
compounds by providing excellent possibilities to introduce enantioselectivity using 
small amounts of an enantiomerically pure catalyst. The value and impact of 
asymmetric catalysis in organic synthesis was ultimately recognised by awarding the 
Nobel Price in Chemistry to its inventors, Knowles, Noyori and Sharpless in 2002. 
Among the large variety of asymmetric ligands that have emerged since the start of 
aymmetric catalysis, enantiopure C2-symmetric bisoxazoline ligands have been 
identified as a ‘privileged’ class of ligands with applications in a wide range of 
enantioselective metal-catalysed transformations. More recently, metal complexes of 
non-C2-symmetric oxazoline-based P,N-ligands have also been increasingly used in 
additional types of asymmetric transformations. 
This thesis deals with the synthesis and application of oxazoline-based 
ligands in enantioselective Lewis acid-catalysed reactions. The research especially 
focusses on the scope and limitations of various novel bisoxazoline ligands 
substituted with extended aryl groups. 
Chapter 1 presents a selection of recent applications of bisoxazoline ligands in 
catalytic reactions, providing an impression of the state-of–the-art, scope and 
limitations of this particular type of ligand. This chapter ends with an outline of this 
thesis. 
N
O
Ar
N
O
Ar
Ar
H2N
OH
O
Ar
H2N
NH2
O
1 (S)-2 (S)-3
Ar
H2N
OH
(S)-4  
Scheme 1 Synthesis of (S)-bisoxazolines 
Chapter 2 describes the synthesis of a series of extended aryl-substituted 
bisoxazoline ligands as depicted in Scheme 1. In the cases of phenylbisoxazoline, (1-
naphthyl)-, and (2-naphthyl)bisoxazoline, the ligands were obtained from the 
corresponding enantiopure amino acids 2. These amino acids, in turn, could be 
derived from the readily available racemic amino acid amides 1 through an 
enzymatic resolution process using an aminopeptidase. Alternatively, (9-
anthryl)bisoxazoline was prepared from the corresponding amino alcohol 4, of which 
both enantiomers were separated by preparative chiral HPLC. The absolute 
stereochemistry of the amino alcohol was elucidated by circular dichroism (CD) 
measurements. 
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Chapter 3 details the scope and limitations of the new bisoxazoline ligands in 
asymmetric catalysis, and more specifically the steric influence of the aryl 
substituent. The bisoxazoline ligands were used in combination with several 
transition metals to generate various new catalysts that were subjected to a range of 
reactions to explore their enantioselective and catalytic properties. Besides 
performing known reactions, e.g. Mukaiyama aldol and Michael reactions, hetero-
Diels-Alder reactions, allylic oxidations and allylic alkylation reactions, the ligands 
were tested in a number of new reactions. One of these reactions, the addition of the 
bulky dioxenone-derived nucleophile 6 to α-keto ester 5, led to an optically active 
building block that was used in studies towards a synthesis of the natural product 
(+)-tanikolide (Scheme 2).  
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HO O OHO
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(  )9 O O
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Scheme 2 Synthetic approach towards tanikolide 
Chapter 4 describes various approaches to characterise the catalyst complexes 
in order to be able to explain the outcome of the reactions in Chapter 3. Several 
techniques, i.e. X-ray crystallography on the catalyst complexes, modelling studies 
and EPR measurements, are discussed which were aimed at obtaining more insight 
into the reversal of enantiofacial selectivity that we and others observed in going 
from alkyl- to aryl-substituted bisoxazoline ligands, in several stereoselective 
transformations. 
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Scheme 3 The consecutive steps of the tandem process 
Chapter 5 details an enantio- and diastereoselective tandem reaction which 
leads to the chromanes 12 as shown in Scheme 3. The first step involved a chiral 
Lewis acid-catalysed oxa-Michael addition of phenol 9 to the β,γ-unsaturated α-keto 
ester 10. The intermediate Michael adduct 11 immediately underwent an 
intramolecular Friedel-Crafts type alkylation to form chromane 12 as a single 
diastereomer. After the optically pure catalyst has ensured the enantioselectivity in 
the first step, the newly formed stereocentre completely dictates the 
diastereoselectivity in the second step. The absolute stereochemistry of the tandem 
product was assigned by vibrational circular dichroism (VCD) analysis. 
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Scheme 4 Synthesis of PhOH-ox 
Chapter 6 deals with the synthesis of PhOH-ox (Scheme 4), which belongs to 
a new class of oxazoline-based bidentate ligands where the chiral centre is located in 
the backbone. The N,O-ligand 16 was prepared from N-benzoyl-(2-
hydroxyphenyl)glycinol (15), which was obtained from enantiopure (2-
hydroxyphenyl)glycine (14). This amino acid, in turn, can be derived from the 
racemic hydantoin 13 through an enzymatic resolution process. The ligand, PhOH-
ox, was used in the enantioselective addition of diethylzinc to benzaldehyde. 
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Samenvatting 
Asymmetrische katalyse is een bijzonder functionele methode voor de 
synthese van optisch zuivere verbindingen waarbij enantioselectiviteit wordt 
geïntroduceerd door gebruik te maken van kleine hoeveelheden van een 
enantiomeerzuivere katalysator. De erkenning voor de waarde en kracht van 
asymmetrische katalyse in organische synthese werd benadrukt door het feit dat de 
grondleggers, Knowles, Noyori en Sharpless, hiervoor in 2002 de Nobelprijs voor de 
Chemie ontvingen. Een grote verscheidenheid aan asymmetrische liganden is 
ontwikkeld sinds het ontstaan van asymmetrische katalyse, waaronder C2-
symmetrische bisoxazoline liganden. Deze liganden worden inmiddels gezien als een 
zogenaamde ‘bevoorrechte’ klasse van verbindingen met toepassingen in een grote 
verscheidenheid aan enantioselective metaal-gekatalyseerde reacties. Recentelijk is 
ook een groeiende belangstelling ontstaan voor de toepassing van een nieuwe klasse 
van metaalkatalysatoren, die niet-C2-symmetrische oxazoline-gebaseerde P,N-
liganden bevatten. Dit proefschrift beschrijft de synthese en toepassing van 
oxazoline-bevattende liganden in enantioselectieve Lewiszuur-gekatalyseerde 
reacties. Het onderzoek is met name toegespitst op de mogelijkheden en beperkingen 
van nieuwe bisoxazoline liganden met verlengde aryl substituenten. 
Hoofdstuk 1 behandelt een selectie van recente toepassingen van bisoxazoline 
liganden in katalytische reacties waarin uitstekende enantioselectiviteiten worden 
behaald en verschaft daarmee een actueel beeld van de mogelijkheden van dit type 
ligand in de asymmetrische katalyse. Dit hoofdstuk besluit met een opsomming van 
de hoofdlijnen van dit proefschrift. 
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Schema 1 Synthese van (S)-bisoxazolines 
Hoofdstuk 2 beschrijft de synthese van een reeks bisoxazoline liganden met 
verlengde aryl substituenten, zoals weergegeven in Schema 1. Voor 
fenylbisoxazoline, (1-naftyl)-, en (2-naftyl)bisoxazoline geldt dat het ligand 
gesynthetiseerd is uitgaande van de aminozuren 2. Deze aminozuren kunnen op hun 
beurt worden verkregen via een enzymatische resolutie in aanwezigheid van een 
aminopeptidase uit de racemische aminozuur amiden 1, die gemakkelijk toegankelijk 
zijn. (9-Antryl)bisoxazoline, daarentegen, kan gesynthetiseerd worden uitgaande van 
het amino alcohol 4, waarvan de enantiomeren kunnen worden gescheiden door 
middel van preparatieve chirale HPLC. De absolute stereochemie van het amino 
alcohol is bepaald door middel van circulair dichroisme (CD) metingen. 
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Hoofdstuk 3 biedt een overzicht van de mogelijkheden en beperkingen van 
toepassingen van de nieuwe bisoxazoline liganden in asymmetrische katalyse, en in 
het bijzonder of de sterische invloed van de aryl substituent voor- of nadelen 
oplevert in vergelijking met de bestaande liganden. De bisoxazoline liganden zijn 
gebruikt voor het samenstellen van verschillende nieuwe katalysatoren die getest 
zijn in een verscheidenheid aan reacties om hun enantioselectieve en katalytische 
eigenschappen te onderzoeken. Naast reacties uit de literatuur, zoals Mukaiyama 
aldol en Michael reacties, hetero-Diels-Alder reacties, allylische oxidaties en 
allylische alkyleringen, zijn de liganden getest in een aantal nieuwe omzettingen. Een 
van deze nieuwe reacties, de additie van het omvangrijke dioxenon-afgeleide 
nucleofiel 6 aan α-keto ester 5, heeft geresulteerd in een optisch actieve bouwsteen, 
die gebruikt is voor onderzoek naar een syntheseroute voor het natuurproduct (+)-
tanikolide (Schema 2).  
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Schema 2 Mogelijke route voor de synthese van tanikolide 
Hoofdstuk 4 beschrijft verschillende benaderingen voor het karakteriseren 
van de katalytische complexen om sluitende verklaringen te vinden voor het verloop 
van de diverse soorten reacties in Hoofdstuk 3. Verschillende technieken, waaronder 
kristalstructuurbepalingen van de katalysatorcomplexen, ‘modelling’ studies en EPR 
metingen, worden met elkaar vergeleken. Op deze manier is geprobeerd een beter 
inzicht te krijgen in het omkeren van de enantioselectiviteit in verschillende 
stereoselectieve reacties, een fenomeen dat zowel door ons als door anderen is 
waargenomen gaande van alkyl- naar aryl-gesubstitueerde bisoxazoline liganden. 
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Schema 3 De verschillende reactiestappen van het tandemproces 
Hoofdstuk 5 behandelt een enantio- and diastereoselectieve tandemreactie, 
waarbij chromaan 12 wordt verkregen, zoals weergegeven in Schema 3. De eerste 
stap is een oxa-Michael additie van fenol 9 aan de β,γ-onverzadigde α-keto ester 10 
gekatalyseerd door een chiraal Lewiszuur. Het intermediaire Michael product 11 
reageert direct verder via een intramoleculaire Friedel-Crafts type alkylering tot 
chromaan 12, waarbij slechts één diastereomeer wordt gevormd. Nadat de optisch 
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zuivere katalysator de enantioselectiviteit in de eerste stap heeft vastgelegd, bepaalt 
dit nieuwe stereocentrum de diastereoselectiviteit van de tweede stap volledig. De 
absolute stereochemie van het tandem produkt is bepaald met behulp van een 
vibrationele circulair dichroisme (VCD) analyse. 
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Schema 4 Synthese van PhOH-ox 
Hoofdstuk 6 detailleert de synthese van PhOH-ox (Schema 4), dat behoort tot 
een nieuwe klasse van oxazoline-bevattende bidentaat liganden waarvan het chirale 
centrum in de ruggengraat is gelokaliseerd. Het N,O-ligand 16 is gesynthetiseerd uit 
N-benzoyl-(2-hydroxyfenyl)glycinol (15), dat is verkregen uit het enantiomeerzuivere 
(2-hydroxyfenyl)glycine (14). Dit aminozuur is weer via een enzymatische resolutie 
verkregen uit het racemische hydantoine 13. Het ligand, PhOH-ox, is gebruikt in de 
enantioselectieve additie van diethylzink aan benzaldehyde. 
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